10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended November 30, 2023

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

Commission File Number: 001-08495

CONSTELLATION BRANDS, INC.

(Exact name of registrant as specified in its charter)

Delaware	16-0716709
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

207 High Point Drive, Building 100, Victor, New York 14564

(Address of principal executive offices) (Zip code)

(585) 678-7100

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of Each Class	Trading Symbol(s)	Name of Each Exchange on Which Registered
Class A Common Stock	STZ	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  ☒  Yes    ☐  No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  ☒  Yes    ☐  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.   ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes  ☐  No  ☒

There were 182,796,408 shares of Class A Common Stock and 23,661 shares of Class 1 Common Stock outstanding as of December 31, 2023.

TABLE OF CONTENTS

		Page
DEFINED TERMS		i
PART I – FINANCIAL INFORMATION
Item 1. Financial Statements
Consolidated Balance Sheets		1
Consolidated Statements of Comprehensive Income (Loss)		2
Consolidated Statements of Changes in Stockholders’ Equity		3
Consolidated Statements of Cash Flows		5
Notes to Consolidated Financial Statements
	1. Basis of Presentation	7
	2. Inventories	7
	3. Derivative Instruments	7
	4. Fair Value of Financial Instruments	10
	5. Goodwill	13
	6. Intangible Assets	14
	7. Equity Method Investments	15
	8. Borrowings	16
	9. Income Taxes	18
	10. Stockholders' Equity	18
	11. Net Income (Loss) Per Common Share Attributable to CBI	20
	12. Comprehensive Income (Loss) Attributable to CBI	22
	13. Business Segment Information	24
	14. Subsequent Event	27
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations		28
Item 3. Quantitative and Qualitative Disclosures About Market Risk		52
Item 4. Controls and Procedures		53
PART II – OTHER INFORMATION
Item 1. Legal Proceedings		54
Item 1A. Risk Factors		54
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds		55
Item 5. Other Information		55
Item 6. Exhibits		56
SIGNATURES		59

This Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond the Company’s control, that could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements. For further information regarding such forward-looking statements, risks, and uncertainties, please see “Information Regarding Forward-Looking Statements” under MD&A.

Defined Terms

Unless the context otherwise requires, the terms “Company,” “CBI,” “we,” “our,” or “us” refer to Constellation Brands, Inc. and its subsidiaries. We use terms in this Form 10-Q and in our Notes that are specific to us or are abbreviations that may not be commonly known or used.

Term	Meaning
$	U.S. dollars
3.20% February 2018 Senior Notes	$600.0 million principal amount of 3.20% senior notes issued in February 2018, partially tendered in May 2022, and fully redeemed in June 2022, prior to maturity
4.25% May 2013 Senior Notes	$1,050.0 million principal amount of 4.25% senior notes issued in May 2013, partially tendered in May 2022, and fully redeemed in June 2022, prior to maturity
2021 Authorization	authority to repurchase up to $2.0 billion of our publicly traded common stock, authorized in January 2021 by our Board of Directors
2022 Credit Agreement	tenth amended and restated credit agreement, dated as of April 14, 2022, that provides for an aggregate revolving credit facility of $2.25 billion
2023 Annual Report	our Annual Report on Form 10-K for the fiscal year ended February 28, 2023
2023 Authorization	authority to repurchase up to $2.0 billion of our publicly traded common stock, authorized in November 2023 by our Board of Directors
2023 Canopy Promissory Note	C$100.0 million principal amount of 4.25% promissory note issued to us by Canopy in April 2023
3-tier	distribution channel where products are sold to a distributor (wholesaler) who then sells to a retailer; the retailer sells the products to a consumer
3-tier eCommerce	digital commerce experience for consumers to purchase beverage alcohol from retailers
ABA	alternative beverage alcohol
Administrative Agent	Bank of America, N.A., as administrative agent for the senior credit facility and term loan credit agreements
Amended and Restated By-Laws	our amended and restated by-laws which became effective at the Effective Time
Amended and Restated Charter	our amended and restated certificate of incorporation which effectuated the Reclassification at the Effective Time
AOCI	accumulated other comprehensive income (loss)
April 2022 Term Credit Agreement	amended and restated term loan credit agreement, dated as of March 26, 2020, that provided for aggregate facilities of $491.3 million, consisting of a five-year term loan facility, inclusive of amendments dated as of June 10, 2021, and April 14, 2022, now repaid in full
August 2022 Term Credit Agreement	term loan credit agreement, dated as of August 9, 2022, that provided for a $1.0 billion unsecured delayed draw three-year term loan facility, now repaid in full
Austin Cocktails	we made an initial investment in the Austin Cocktails business and subsequently acquired the remaining ownership interest
BioSteel	BioSteel Sports Nutrition Inc., formerly a subsidiary of Canopy
C$	Canadian dollars
Canopy	we made an investment in Canopy Growth Corporation, an Ontario, Canada-based public company
Canopy Amendment	a proposed resolution authorizing amending Canopy’s share capital to create Exchangeable Shares and providing for the conversion of Canopy common shares into Exchangeable Shares on a one-for-one basis at any time and at the option of the holder of such shares
Canopy Debt Securities	debt securities issued by Canopy in June 2018
Canopy Equity Method Investment	an investment in Canopy common shares
Canopy Strategic Transaction(s)	any potential acquisition, divestiture, investment, or other similar transaction made by Canopy, including but not limited to the Canopy Transaction

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    i

Term	Meaning
Canopy Transaction	proposed corporate transaction by Canopy, including the creation of Exchangeable Shares, designed to consolidate its U.S. cannabis assets into Canopy USA
Canopy USA	a U.S. holding company formed by Canopy
CB International	CB International Finance S.à r.l., a wholly-owned subsidiary of ours
Class 1 Stock	our Class 1 Convertible Common Stock, par value $0.01 per share
Class A Stock	our Class A Common Stock, par value $0.01 per share
Class B Stock	our Class B Convertible Common Stock, par value $0.01 per share, eliminated on November 10, 2022, pursuant to the Reclassification
CODM	chief operating decision maker
Comparable Adjustments	certain items affecting comparability that have been excluded by management
Consent Agreement	an agreement between Canopy and (i) Greenstar Canada Investment Limited Partnership and (ii) CBG Holdings LLC, our indirect, wholly-owned subsidiaries
CPG	consumer packaged goods
Craft Beer Divestitures	the Four Corners Divestiture and the Funky Buddha Divestiture, collectively
Daleville Facility	production facility located in Roanoke, Virginia
DEI	diversity, equity, and inclusion
Depletions	represent U.S. domestic distributor shipments of our respective branded products to retail customers, based on third-party data
Digital Business Acceleration	a phased initiative by the Company to create a cohesive digital strategy and build an advanced digital business in the coming years
DTC	direct-to-consumer inclusive of (i) a digital commerce experience for consumers to purchase directly from brand websites with inventory coming straight from the supplier and (ii) consumer purchases at hospitality locations (tasting rooms and tap rooms) from the supplier
Effective Time	the time that the Amended and Restated Charter was duly filed with the Secretary of State of the State of Delaware on November 10, 2022
ESG	environmental, social, and governance
Exchangeable Shares	proposed new class of non-voting and non-participating exchangeable shares in Canopy which will be convertible into common shares of Canopy
Exchange Act	Securities Exchange Act of 1934, as amended
Financial Statements	our consolidated financial statements and notes thereto included herein
Fiscal 2023	the Company’s fiscal year ended February 28, 2023
Fiscal 2024	the Company’s fiscal year ending February 29, 2024
Fiscal 2025	the Company’s fiscal year ending February 28, 2025
Fiscal 2026	the Company’s fiscal year ending February 28, 2026
Fiscal 2027	the Company’s fiscal year ending February 28, 2027
Fiscal 2028	the Company’s fiscal year ending February 29, 2028
Fiscal 2029	the Company’s fiscal year ending February 28, 2029
Form 10-Q	this Quarterly Report on Form 10-Q for the quarterly period ended November 30, 2023, unless otherwise specified
Four Corners Divestiture	sale of the Four Corners Brewing Company LLC business
Funky Buddha Divestiture	sale of the Funky Buddha Brewery LLC business
GHG	greenhouse gas
IRA	Inflation Reduction Act of 2022, signed into law in the U.S. on August 16, 2022
IT	information technology
Lingua Franca	Lingua Franca, LLC business, acquired by us
May 2023 Senior Notes	$750.0 million aggregate principal amount of senior notes issued in May 2023

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    ii

Term	Meaning
MD&A	Management’s Discussion and Analysis of Financial Condition and Results of Operations under Part I – Item 2. of this Form 10-Q
Mexicali Brewery	canceled brewery construction project located in Mexicali, Baja California, Mexico
Mexico Beer Projects	expansion, optimization, and/or construction activities at the Obregon Brewery, Nava Brewery, and Veracruz Brewery
M&T	Manufacturers and Traders Trust Company
NA	not applicable
Nava	Nava, Coahuila, Mexico
Nava Brewery	brewery located in Nava
Net sales	gross sales less promotions, returns and allowances, and excise taxes
Nine Months 2023	the Company’s nine months ended November 30, 2022
Nine Months 2024	the Company’s nine months ended November 30, 2023
NM	not meaningful
Note(s)	notes to the consolidated financial statements
November 2018 Canopy Warrants	warrants acquired in November 2018 which gave us the option to purchase common shares of Canopy, now expired
Obregon	Obregon, Sonora, Mexico
Obregon Brewery	brewery located in Obregon
OCI	other comprehensive income (loss)
October 2022 Credit Agreement Amendment	amendment dated as of October 18, 2022, to the 2022 Credit Agreement
Pre-issuance hedge contracts	treasury lock and/or swap lock contracts designated as cash flow hedges entered into to hedge treasury rate volatility on future debt issuances
Reclassification	the reclassification, exchange, and conversion of the Company’s common stock to eliminate the Class B Stock pursuant to the terms and conditions of the Reclassification Agreement
Reclassification Agreement	reclassification agreement in support of the Reclassification, dated June 30, 2022, among the Company and the Sands Family Stockholders
RTD	ready-to-drink
Sands Family Stockholders	RES Master LLC, RES Business Holdings LP, SER Business Holdings LP, RHT 2015 Business Holdings LP, RSS Master LLC, RSS Business Holdings LP, SSR Business Holdings LP, RSS 2015 Business Holdings LP, RCT 2015 Business Holdings LP, RCT 2020 Investments LLC, NSDT 2009 STZ LLC, NSDT 2011 STZ LLC, RSS Business Management LLC, SSR Business Management LLC, LES Lauren Holdings LLC, MES Mackenzie Holdings LLC, Abigail Bennett, Zachary Stern, A&Z 2015 Business Holdings LP (subsequently liquidated), Marilyn Sands Master Trust, MAS Business Holdings LP, Sands Family Foundation, Richard Sands, Robert Sands, WildStar Partners LLC, Astra Legacy LLC, AJB Business Holdings LP, and ZMSS Business Holdings LP
SEC	Securities and Exchange Commission
Securities Act	Securities Act of 1933, as amended
SOFR	secured overnight financing rate administered by the Federal Reserve Bank of New York
Third Quarter 2023	the Company’s three months ended November 30, 2022
Third Quarter 2024	the Company’s three months ended November 30, 2023
U.S.	United States of America
Veracruz	Heroica Veracruz, Veracruz, Mexico
Veracruz Brewery	a new brewery being constructed in Veracruz
Wine Divestiture	sale of certain mainstream and premium wine brands and related inventory

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    iii

FINANCIAL STATEMENTS Table of Contents

PART I – FINANCIAL INFORMATION

Item 1.    Financial Statements.

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

(unaudited)

	November 30, 2023		February 28, 2023
ASSETS
Current assets:
Cash and cash equivalents	$	78.7	$	133.5
Accounts receivable	897.3		901.6
Inventories	1,988.0		1,898.7
Prepaid expenses and other	587.4		562.3
Total current assets	3,551.4		3,496.1
Property, plant, and equipment	7,713.5		6,865.2
Goodwill	7,978.2		7,925.4
Intangible assets	2,732.2		2,728.1
Equity method investments	233.3		663.3
Deferred income taxes	2,086.1		2,193.3
Other assets	762.7		790.9
Total assets	$	25,057.4	$	24,662.3
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings	$	458.9	$	1,165.3
Current maturities of long-term debt	957.3		9.5
Accounts payable	1,028.8		941.5
Other accrued expenses and liabilities	934.9		852.0
Total current liabilities	3,379.9		2,968.3
Long-term debt, less current maturities	10,282.3		11,286.5
Deferred income taxes and other liabilities	1,596.8		1,673.6
Total liabilities	15,259.0		15,928.4
Commitments and contingencies
CBI stockholders’ equity:
Class A Stock, $0.01 par value – Authorized, 322,000,000 shares; Issued, 212,698,298 shares and 212,697,428 shares, respectively	2.1		2.1
Additional paid-in capital	2,019.2		1,903.0
Retained earnings	13,187.6		12,343.9
Accumulated other comprehensive income (loss)	364.4		28.5
	15,573.3		14,277.5
Less: Treasury stock –
Class A Stock, at cost, 29,905,366 shares and 29,498,426 shares, respectively	(6,102.3)		(5,863.9)
Total CBI stockholders’ equity	9,471.0		8,413.6
Noncontrolling interests	327.4		320.3
Total stockholders’ equity	9,798.4		8,733.9
Total liabilities and stockholders’ equity	$	25,057.4	$	24,662.3

The accompanying notes are an integral part of these statements.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    1

FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(in millions, except per share data)

(unaudited)

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
Sales	$	8,410.7	$	8,029.6	$	2,658.2	$	2,624.6
Excise taxes	(588.1)		(574.8)		(187.3)		(188.1)
Net sales	7,822.6		7,454.8		2,470.9		2,436.5
Cost of product sold	(3,844.3)		(3,647.0)		(1,200.3)		(1,209.6)
Gross profit	3,978.3		3,807.8		1,270.6		1,226.9
Selling, general, and administrative expenses	(1,438.0)		(1,431.6)		(473.7)		(480.2)
Operating income (loss)	2,540.3		2,376.2		796.9		746.7
Income (loss) from unconsolidated investments	(477.4)		(1,944.2)		(41.8)		(37.2)
Interest expense	(333.0)		(281.5)		(104.2)		(98.7)
Loss on extinguishment of debt	(0.7)		(23.3)		—		—
Income (loss) before income taxes	1,729.2		127.2		650.9		610.8
(Provision for) benefit from income taxes	(368.4)		(388.9)		(130.0)		(131.1)
Net income (loss)	1,360.8		(261.7)		520.9		479.7
Net (income) loss attributable to noncontrolling interests	(25.8)		(32.3)		(11.8)		(12.0)
Net income (loss) attributable to CBI	$	1,335.0	$	(294.0)	$	509.1	$	467.7
Comprehensive income (loss)	$	1,713.0	$	(32.8)	$	447.0	$	643.1
Comprehensive (income) loss attributable to noncontrolling interests	(42.1)		(49.4)		(7.9)		(20.9)
Comprehensive income (loss) attributable to CBI	$	1,670.9	$	(82.2)	$	439.1	$	622.2
Net income (loss) per common share attributable to CBI:
Basic – Class A Stock	$	7.28	$	(1.48)	$	2.77	$	2.58
Basic – Class B Stock	NA		$	(2.01)	NA		$	1.78
Diluted – Class A Stock	$	7.25	$	(1.48)	$	2.76	$	2.52
Diluted – Class B Stock	NA		$	(2.01)	NA		$	1.78
Weighted average common shares outstanding:
Basic – Class A Stock	183.431		164.573		183.525		166.677
Basic – Class B Stock	NA		23.206		NA		23.206
Diluted – Class A Stock	184.096		164.573		184.170		185.291
Diluted – Class B Stock	NA		23.206		NA		23.206
Cash dividends declared per common share:
Class A Stock	$	2.67	$	2.40	$	0.89	$	0.80
Class B Stock	NA		$	2.16	NA		$	0.72

The accompanying notes are an integral part of these statements.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    2

FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (in millions) (unaudited)
	Class A Stock		Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Non-controlling Interests		Total
Balance at February 28, 2023	$	2.1	$	1,903.0	$	12,343.9	$	28.5	$	(5,863.9)	$	320.3	$	8,733.9
Comprehensive income (loss):
Net income (loss)	—		—		135.9		—		—		3.3		139.2
Other comprehensive income (loss), net of income tax effect	—		—		—		214.4		—		10.9		225.3
Comprehensive income (loss)													364.5
Repurchase of shares	—		—		—		—		(35.0)		—		(35.0)
Dividends declared	—		—		(163.1)		—		—		—		(163.1)
Noncontrolling interest distributions	—		—		—		—		—		(11.3)		(11.3)
Shares issued under equity compensation plans	—		0.6		—		—		4.1		—		4.7
Stock-based compensation	—		14.5		—		—		—		—		14.5
Balance at May 31, 2023	2.1		1,918.1		12,316.7		242.9		(5,894.8)		323.2		8,908.2
Comprehensive income (loss):
Net income (loss)	—		—		690.0		—		—		10.7		700.7
Other comprehensive income (loss), net of income tax effect	—		—		—		191.5		—		9.3		200.8
Comprehensive income (loss)													901.5
Dividends declared	—		—		(164.0)		—		—		—		(164.0)
Noncontrolling interest distributions	—		—		—		—		—		(10.0)		(10.0)
Shares issued under equity compensation plans	—		62.6		—		—		7.6		—		70.2
Stock-based compensation	—		18.1		—		—		—		—		18.1
Balance at August 31, 2023	2.1		1,998.8		12,842.7		434.4		(5,887.2)		333.2		9,724.0
Comprehensive income (loss):
Net income (loss)	—		—		509.1		—		—		11.8		520.9
Other comprehensive income (loss), net of income tax effect	—		—		—		(70.0)		—		(3.9)		(73.9)
Comprehensive income (loss)													447.0
Repurchase of shares	—		—		—		—		(214.7)		—		(214.7)
Dividends declared	—		—		(164.2)		—		—		—		(164.2)
Noncontrolling interest distributions	—		—		—		—		—		(13.7)		(13.7)
Shares issued under equity compensation plans	—		3.4		—		—		(0.4)		—		3.0
Stock-based compensation	—		17.0		—		—		—		—		17.0
Balance at November 30, 2023	$	2.1	$	2,019.2	$	13,187.6	$	364.4	$	(6,102.3)	$	327.4	$	9,798.4

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    3

FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (in millions) (unaudited)
	Stock				Additional Paid-in Capital		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Non-controlling Interests		Total
	Class A		Class B
Balance at February 28, 2022	$	1.9	$	0.3	$	1,808.9	$	14,505.4	$	(412.7)	$	(4,171.9)	$	315.9	$	12,047.8
Comprehensive income (loss):
Net income (loss)	—		—		—		389.5		—		—		9.8		399.3
Other comprehensive income (loss), net of income tax effect	—		—		—		—		246.4		—		12.6		259.0
Comprehensive income (loss)															658.3
Repurchase of shares	—		—		—		—		—		(1,007.6)		—		(1,007.6)
Dividends declared	—		—		—		(148.7)		—		—		—		(148.7)
Noncontrolling interest distributions	—		—		—		—		—		—		(11.2)		(11.2)
Shares issued under equity compensation plans	—		—		(0.6)		—		—		3.8		—		3.2
Stock-based compensation	—		—		16.7		—		—		—		—		16.7
Balance at May 31, 2022	1.9		0.3		1,825.0		14,746.2		(166.3)		(5,175.7)		327.1		11,558.5
Comprehensive income (loss):
Net income (loss)	—		—		—		(1,151.2)		—		—		10.5		(1,140.7)
Other comprehensive income (loss), net of income tax effect	—		—		—		—		(189.1)		—		(4.4)		(193.5)
Comprehensive income (loss)															(1,334.2)
Repurchase of shares	—		—		—		—		—		(392.9)		—		(392.9)
Dividends declared	—		—		—		(146.6)		—		—		—		(146.6)
Noncontrolling interest distributions	—		—		—		—		—		—		(11.3)		(11.3)
Shares issued under equity compensation plans	—		—		14.5		—		—		2.0		—		16.5
Stock-based compensation	—		—		20.9		—		—		—		—		20.9
Balance at August 31, 2022	1.9		0.3		1,860.4		13,448.4		(355.4)		(5,566.6)		321.9		9,710.9
Comprehensive income (loss):
Net income (loss)	—		—		—		467.7		—		—		12.0		479.7
Other comprehensive income (loss), net of income tax effect	—		—		—		—		154.5		—		8.9		163.4
Comprehensive income (loss)															643.1
Reclassification payment	—		—		—		(1,500.0)		—		—		—		(1,500.0)
Retirement of treasury shares	—		(0.1)		—		(2.2)		—		2.3		—		—
Conversion of common shares	0.2		(0.2)		—		—		—		—		—		—
Dividends declared	—		—		—		(146.1)		—		—		—		(146.1)
Noncontrolling interest distributions	—		—		—		—		—		—		(15.6)		(15.6)
Shares issued under equity compensation plans	—		—		4.9		—		—		1.2		—		6.1
Stock-based compensation	—		—		18.3		—		—		—		—		18.3
Balance at November 30, 2022	$	2.1	$	—	$	1,883.6	$	12,267.8	$	(200.9)	$	(5,563.1)	$	327.2	$	8,716.7

The accompanying notes are an integral part of these statements.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    4

FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)

	For the Nine Months Ended November 30,
	2023		2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$	1,360.8	$	(261.7)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Unrealized net (gain) loss on securities measured at fair value	85.4		39.1
Deferred tax provision (benefit)	28.2		218.4
Depreciation	321.8		278.4
Stock-based compensation	49.5		56.1
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	257.3		845.4
Noncash lease expense	62.9		66.7
Amortization of debt issuance costs and loss on extinguishment of debt	8.9		31.1
Impairment of equity method investments	136.1		1,060.3
(Gain) loss on sale of business	15.1		(13.8)
Gain (loss) on settlement of Pre-issuance hedge contracts	1.4		20.7
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable	6.9		(25.3)
Inventories	(90.4)		(259.3)
Prepaid expenses and other current assets	(49.1)		204.7
Accounts payable	24.5		187.4
Other accrued expenses and liabilities	37.1		(247.0)
Other	90.4		79.4
Total adjustments	986.0		2,542.3
Net cash provided by (used in) operating activities	2,346.8		2,280.6
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(911.9)		(683.8)
Purchase of business, net of cash acquired	(7.5)		(37.1)
Investments in equity method investees and securities	(34.6)		(29.5)
Proceeds from sale of assets	21.8		6.6
Proceeds from sale of business	5.4		96.7
Other investing activities	(3.1)		0.5
Net cash provided by (used in) investing activities	(929.9)		(646.6)

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    5

FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions)

(unaudited)

	For the Nine Months Ended November 30,
	2023		2022
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt	744.8		2,845.8
Principal payments of long-term debt	(807.5)		(1,657.3)
Net proceeds from (repayments of) short-term borrowings	(706.4)		552.6
Dividends paid	(491.1)		(441.1)
Purchases of treasury stock	(249.7)		(1,400.5)
Proceeds from shares issued under equity compensation plans	89.0		36.7
Payments of minimum tax withholdings on stock-based payment awards	(11.2)		(10.5)
Payments of debt issuance, debt extinguishment, and other financing costs	(5.3)		(34.1)
Distributions to noncontrolling interests	(35.0)		(37.5)
Payment to holders of Class B Stock in connection with the Reclassification	—		(1,500.0)
Net cash provided by (used in) financing activities	(1,472.4)		(1,645.9)
Effect of exchange rate changes on cash and cash equivalents	0.7		(2.5)
Net increase (decrease) in cash and cash equivalents	(54.8)		(14.4)
Cash and cash equivalents, beginning of period	133.5		199.4
Cash and cash equivalents, end of period	$	78.7	$	185.0
Supplemental disclosures of noncash investing and financing activities
Additions to property, plant, and equipment	$	178.1	$	174.6

The accompanying notes are an integral part of these statements.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    6

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

CONSTELLATION BRANDS, INC. AND SUBSIDIARIES

NOVEMBER 30, 2023

(unaudited)

1.    BASIS OF PRESENTATION

We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2023 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. All financial information for the nine months and three months ended November 30, 2022, has been restated to conform to the new segment presentation. For additional information, refer to Note 13.

2.    INVENTORIES

Inventories are stated at the lower of cost (primarily computed in accordance with the first-in, first-out method) or net realizable value. Elements of cost include materials, labor, and overhead and consist of the following:

	November 30, 2023		February 28, 2023
(in millions)
Raw materials and supplies	$	244.0	$	245.5
In-process inventories	1,098.9		967.8
Finished case goods	645.1		685.4
	$	1,988.0	$	1,898.7

3.    DERIVATIVE INSTRUMENTS

Overview

Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2023 Annual Report and have not changed significantly for the nine months and three months ended November 30, 2023.

The aggregate notional value of outstanding derivative instruments is as follows:

	November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts	$	2,233.3	$	1,969.5
Pre-issuance hedge contracts	$	125.0	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts	$	578.9	$	831.7
Commodity derivative contracts	$	383.9	$	416.5

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    7

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

Credit risk

We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial.

In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of November 30, 2023, the estimated fair value of derivative instruments in a net liability position due to counterparties was $1.5 million. If we were required to settle the net liability position under these derivative instruments on November 30, 2023, we would have had sufficient available liquidity on hand to satisfy this obligation.

Results of period derivative activity

The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4):

Assets					Liabilities
	November 30, 2023		February 28, 2023			November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	152.6	$	109.1	Other accrued expenses and liabilities	$	4.3	$	9.8
Other assets	$	166.2	$	134.5	Deferred income taxes and other liabilities	$	0.4	$	3.5
Pre-issuance hedge contracts:
Prepaid expenses and other	$	—	$	—	Other accrued expenses and liabilities	$	0.1	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	8.1	$	5.9	Other accrued expenses and liabilities	$	5.7	$	3.9
Commodity derivative contracts:
Prepaid expenses and other	$	6.7	$	21.2	Other accrued expenses and liabilities	$	24.9	$	19.5
Other assets	$	2.8	$	4.6	Deferred income taxes and other liabilities	$	6.4	$	8.3

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    8

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows:

Derivative Instruments in Designated Cash Flow Hedging Relationships	Net Gain (Loss) Recognized in OCI		Location of Net Gain (Loss) Reclassified from AOCI to Income (Loss)	Net Gain (Loss) Reclassified from AOCI to Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Foreign currency contracts	$	177.1	Sales	$	(0.2)
			Cost of product sold	102.3
Pre-issuance hedge contracts	0.5		Interest expense	(0.4)
	$	177.6		$	101.7
For the Nine Months Ended November 30, 2022
Foreign currency contracts	$	146.6	Sales	$	(1.4)
			Cost of product sold	34.0
Pre-issuance hedge contracts	15.7		Interest expense	(0.8)
	$	162.3		$	31.8
For the Three Months Ended November 30, 2023
Foreign currency contracts	$	27.2	Sales	$	—
			Cost of product sold	36.6
Pre-issuance hedge contracts	(0.1)		Interest expense	(0.1)
	$	27.1		$	36.5
For the Three Months Ended November 30, 2022
Foreign currency contracts	$	75.3	Sales	$	(0.2)
			Cost of product sold	12.1
Pre-issuance hedge contracts	—		Interest expense	(0.2)
	$	75.3		$	11.7

We expect $130.2 million of net gains, net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months.

The effect of our undesignated derivative instruments on our results of operations is as follows:

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(28.9)
Foreign currency contracts	Selling, general, and administrative expenses	12.7
		$	(16.2)

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    9

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	25.3
Foreign currency contracts	Selling, general, and administrative expenses	(11.9)
		$	13.4
For the Three Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(13.3)
Foreign currency contracts	Selling, general, and administrative expenses	(9.8)
		$	(23.1)
For the Three Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	(7.8)
Foreign currency contracts	Selling, general, and administrative expenses	(9.3)
		$	(17.1)

4.    FAIR VALUE OF FINANCIAL INSTRUMENTS

Authoritative guidance establishes a framework for measuring fair value, including a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy includes three levels:

•Level 1 inputs are quoted prices in active markets for identical assets or liabilities;

•Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as volatility, interest rates, and yield curves that are observable for the asset or liability, either directly or indirectly; and

•Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

Fair value methodology

The following methods and assumptions are used to estimate the fair value of our financial instruments:

Foreign currency and commodity derivative contracts

The fair value is estimated using market-based inputs, obtained from independent pricing services, entered into valuation models. These valuation models require various inputs, including contractual terms, market foreign exchange prices, market commodity prices, interest-rate yield curves, and currency volatilities, as applicable (Level 2 fair value measurement).

Interest rate swap and Pre-issuance hedge contracts

The fair value is estimated based on quoted market prices from respective counterparties. Quotes are corroborated by using discounted cash flow calculations based upon forward interest-rate yield curves, which are obtained from independent pricing services (Level 2 fair value measurement).

Canopy investment

On November 1, 2023, the initial tranche of the November 2018 Canopy Warrants expired in accordance with its terms. The remaining tranches of the November 2018 Canopy Warrants were conditioned on the exercise, in full, of the expired warrants. As such, there are no longer any outstanding November 2018 Canopy Warrants. In

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    10

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

April 2023, we extended the maturity of the remaining C$100.0 million principal amount of our Canopy Debt Securities by exchanging them for the 2023 Canopy Promissory Note. As such, our investment in Canopy is currently comprised of (i) the Canopy Equity Method Investment and (ii) the 2023 Canopy Promissory Note. The 2023 Canopy Promissory Note is measured at fair value. Effective as of May 31, 2023, we determined that this instrument did not have future economic value given the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the maturity of the note. Accordingly, the fair value of the remaining balance for this instrument was determined to be zero. This reduction in fair value is included in income (loss) from unconsolidated investments within our consolidated results of operations for the nine months ended November 30, 2023. If the Canopy Amendment is authorized by Canopy’s shareholders, we intend to negotiate an exchange of the 2023 Canopy Promissory Note for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so.

Short-term borrowings

Our short-term borrowings consist of our commercial paper program and the revolving credit facility under our senior credit facility. The revolving credit facility is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating (as defined in our senior credit facility). For these short-term borrowings, the carrying value approximates the fair value.

Long-term debt

The fair value of our fixed interest rate long-term debt is estimated by discounting cash flows using interest rates currently available for debt with similar terms and maturities (Level 2 fair value measurement). As of November 30, 2023, the carrying amount of long-term debt, including the current portion, was $11,239.6 million, compared with an estimated fair value of $10,320.7 million. As of February 28, 2023, the carrying amount of long-term debt, including the current portion, was $11,296.0 million, compared with an estimated fair value of $10,236.0 million.

The carrying amounts of certain of our financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value as of November 30, 2023, and February 28, 2023, due to the relatively short maturity of these instruments.

Recurring basis measurements

The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
November 30, 2023
Assets:
Foreign currency contracts	$	—	$	326.9	$	—	$	326.9
Commodity derivative contracts	$	—	$	9.5	$	—	$	9.5
Liabilities:
Foreign currency contracts	$	—	$	10.4	$	—	$	10.4
Commodity derivative contracts	$	—	$	31.3	$	—	$	31.3
Pre-issuance hedge contracts	$	—	$	0.1	$	—	$	0.1

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    11

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
February 28, 2023
Assets:
Foreign currency contracts	$	—	$	249.5	$	—	$	249.5
Commodity derivative contracts	$	—	$	25.8	$	—	$	25.8
November 2018 Canopy Warrants	$	—	$	0.2	$	—	$	0.2
Canopy Debt Securities	$	—	$	69.6	$	—	$	69.6
Liabilities:
Foreign currency contracts	$	—	$	17.2	$	—	$	17.2
Commodity derivative contracts	$	—	$	27.8	$	—	$	27.8

Nonrecurring basis measurements

The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses
(in millions)
For the Nine Months Ended November 30, 2023
Equity method investments	$	94.8	$	0.6	$	0.6	$	136.1
For the Nine Months Ended November 30, 2022
Equity method investments	$	621.4	$	—	$	—	$	1,060.3

Equity method investments

As of November 30, 2023, we evaluated a certain equity method investment, made through our corporate venture capital function within the Corporate Operations and Other segment, and determined there was an other-than-temporary impairment due to business underperformance. The estimated fair value was based largely on the cash flows expected to be generated by the investment using unobservable data points.

As of August 31, 2023, we evaluated certain equity method investments, made through our corporate venture capital function, and determined there were other-than-temporary impairments due to business underperformance. Investments with a carrying value of $14.9 million were written down to an estimated fair value of $2.6 million, resulting in an impairment of $12.3 million. These investments are part of the Corporate Operations and Other segment. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2023. The estimated fair value was based largely on observable prices for similar assets. In October 2023, we exited one of these equity method investments in exchange for a note receivable.

We evaluated the Canopy Equity Method Investment as of May 31, 2023, and determined there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the fair value being less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    12

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

near-term, (ii) Canopy recorded significant costs in its fourth quarter of fiscal 2023 results designed to align its Canadian cannabis operations and resources in response to continued unfavorable market trends, (iii) the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, and (iv) Canopy’s identification of material misstatements in certain of its previously reported financial results related to sales in its BioSteel reporting unit that were accounted for incorrectly, including the recording of a goodwill impairment during its restated second quarter of fiscal 2023. As a result, the Canopy Equity Method Investment with a carrying value of $266.2 million was written down to its estimated fair value of $142.7 million, resulting in an impairment of $123.5 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2023. The estimated fair value was determined based on the closing price of the underlying equity security as of May 31, 2023.

We evaluated the Canopy Equity Method Investment as of August 31, 2022, and determined there was an other-than-temporary impairment based on several contributing factors, including: (i) the period of time for which the fair value had been less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recording a significant impairment of goodwill related to its cannabis operations during its first quarter of fiscal 2023, and (iii) the uncertainty of U.S. federal cannabis permissibility. As a result, the Canopy Equity Method Investment with a carrying value of $1,695.1 million was written down to its estimated fair value of $634.8 million, resulting in an impairment of $1,060.3 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2022. The estimated fair value was determined based on the closing price of the underlying equity security as of August 31, 2022.

5.    GOODWILL

The changes in the carrying amount of goodwill are as follows:

	Beer		Wine and Spirits		Consolidated
(in millions)
Balance, February 28, 2022	$	5,120.7	$	2,741.7	$	7,862.4
Purchase accounting allocations (1)	—		26.3		26.3
Wine Divestiture	—		(24.5)		(24.5)
Foreign currency translation adjustments	68.2		(7.0)		61.2
Balance, February 28, 2023	5,188.9		2,736.5		7,925.4
Purchase accounting allocations (2)	—		6.5		6.5
Foreign currency translation adjustments	46.3		—		46.3
Balance, November 30, 2023	$	5,235.2	$	2,743.0	$	7,978.2

(1)Purchase accounting allocations associated with the acquisitions of Austin Cocktails, Lingua Franca, and My Favorite Neighbor, LLC.

(2)Preliminary purchase accounting allocation associated with the June 2023 acquisition of the Domaine Curry wine business.

Divestitures

Craft Beer Divestitures

In June 2023, we completed the Craft Beer Divestitures. Prior to the Craft Beer Divestitures, we recorded the results of operations of such craft beer brands in the Beer segment.

Wine Divestiture

On October 6, 2022, we sold certain of our mainstream and premium wine brands and related inventory. The net cash proceeds from the Wine Divestiture were utilized primarily to reduce outstanding borrowings. Prior to the Wine Divestiture, we recorded the results of operations of these brands in the Wine and Spirits segment.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    13

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

The following table summarizes the net gain recognized in connection with this divestiture for the nine months and three months ended November 30, 2022:

(in millions)
Cash received from buyer	$	96.7
Net assets sold	(68.1)
Direct costs to sell (1)	(14.8)
Gain on sale of business (2)	$	13.8

(1)Includes certain contract termination costs.

(2)Included in selling, general, and administrative expenses within our consolidated results of operations.

Acquisitions

Austin Cocktails

In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. In addition, the purchase price for Austin Cocktails includes an earn-out over five years based on performance. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Lingua Franca

In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also included the acquisition of a trademark and inventory. In addition, the purchase price for Lingua Franca includes an earn-out over seven years based on performance. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

6.    INTANGIBLE ASSETS

The major components of intangible assets are as follows:

	November 30, 2023				February 28, 2023
	Gross Carrying Amount		Net Carrying Amount		Gross Carrying Amount		Net Carrying Amount
(in millions)
Amortizable intangible assets
Customer relationships	$	85.4	$	16.5	$	85.7	$	17.7
Other	20.8		0.3		20.8		—
Total	$	106.2	16.8		$	106.5	17.7
Nonamortizable intangible assets
Trademarks			2,715.4				2,710.4
Total intangible assets			$	2,732.2			$	2,728.1

We did not incur costs to renew or extend the term of acquired intangible assets for the nine months and three months ended November 30, 2023, and November 30, 2022. Net carrying amount represents the gross carrying value net of accumulated amortization.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    14

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

7.    EQUITY METHOD INVESTMENTS

Our equity method investments are as follows:

	November 30, 2023				February 28, 2023
	Carrying Value		Ownership Percentage		Carrying Value		Ownership Percentage
(in millions)
Canopy Equity Method Investment (1)	$	73.6	20.7	%	$	485.8	34.7	%
Other equity method investments	159.7		20%-50%		177.5		20%-50%
	$	233.3			$	663.3

(1)The fair value based on the closing price of the underlying equity security as of November 30, 2023, and February 28, 2023, was $94.8 million and $398.4 million, respectively.

Canopy Equity Method Investment

We have an investment in Canopy, a provider of medical and adult-use cannabis products. The Canopy Equity Method Investment consisted of 171.5 million Canopy common shares as of November 30, 2023. In December 2023, Canopy effected a reverse stock split at a ratio of one-for-ten. As a result, our Canopy Equity Method Investment consists of 17.1 million Canopy common shares. Equity in earnings (losses) from the Canopy Equity Method Investment and related activities is determined by recording the effect of basis differences. Amounts included in our consolidated results of operations for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Equity in earnings (losses) from Canopy and related activities	$	(288.3)	$	(876.5)	$	(56.5)	$	(60.8)

Plan to convert Canopy common stock ownership

In October 2022, we entered into a Consent Agreement with Canopy pursuant to which we have provided our consent, subject to certain conditions, to the Canopy Transaction. Canopy only holds non-voting and non-participating exchangeable shares of Canopy USA which are convertible into Class B shares of Canopy USA. A third-party investor holds 100% of the common shares of Canopy USA.

In connection with the Canopy Transaction, Canopy has proposed to amend its share capital to (i) create Exchangeable Shares and (ii) restate the rights of Canopy common shares to provide for their conversion into Exchangeable Shares through the Canopy Amendment. Canopy has stated its intention to hold a special meeting of its shareholders to consider the Canopy Amendment. We have entered into a voting support agreement with Canopy to vote in favor of the Canopy Amendment.

If the Canopy Transaction is completed and the Canopy Amendment is authorized by Canopy’s shareholders and adopted by Canopy, we intend, subject to a final decision in our sole discretion, to exercise our right to convert our Canopy common shares into Exchangeable Shares.

Assuming the completion of the Canopy Transaction and the transactions contemplated by the Consent Agreement and that we elect to convert our Canopy common shares into Exchangeable Shares:

•we will only have an interest in Exchangeable Shares, which are non-voting and non-participating securities, and our 2023 Canopy Promissory Note (for which we intend to negotiate an exchange of the principal amount for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so);

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    15

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

•we intend to terminate all legacy agreements and commercial arrangements between ourselves and Canopy, including the investor rights agreement but excluding the Consent Agreement and certain termination agreements;

•we will have no further governance rights in relation to Canopy, including rights to nominate members to the board of directors of Canopy, or consulting rights related to certain transactions;

•all of our nominees will resign from the board of directors of Canopy; and

•as our investment in Canopy common shares makes up our Canopy Equity Method Investment, we expect to no longer apply the equity method to our investment in Canopy, which we expect to instead be accounted for at fair value with changes reported in income (loss) from unconsolidated investments within our consolidated results.

If we do not convert our Canopy common shares into Exchangeable Shares:

•Canopy and its subsidiaries will not be permitted to exercise any rights to acquire shares and interests in entities carrying on cannabis-related business in the U.S.;

•Canopy USA will be required to exercise its repurchase rights to acquire the interests in Canopy USA held by its third-party investors; and

•we will continue to have all existing rights under our agreements with Canopy that predate the Consent Agreement, including governance rights in respect of Canopy (such as board nomination rights and consulting rights in respect of certain transactions).

8.    BORROWINGS

Borrowings consist of the following:

	November 30, 2023						February 28, 2023
	Current		Long-term		Total		Total
(in millions)
Short-term borrowings
Commercial paper	$	458.9					$	1,165.3
	$	458.9					$	1,165.3
Long-term debt
Term loan credit facilities	$	—	$	—	$	—	$	799.2
Senior notes	948.8		10,270.8		11,219.6		10,470.6
Other	8.5		11.5		20.0		26.2
	$	957.3	$	10,282.3	$	11,239.6	$	11,296.0

Bank facilities

The Company, CB International, the Administrative Agent, and certain other lenders are parties to the 2022 Credit Agreement. The Company, the Administrative Agent, and certain lenders were also parties to two term credit agreements. In May 2023, we repaid the outstanding three-year term loan facility borrowings under our August 2022 Term Credit Agreement with proceeds from the May 2023 Senior Notes (see “Senior notes” below). In August 2023, we repaid the outstanding five-year term loan facility borrowings under our April 2022 Term Credit Agreement with proceeds from commercial paper borrowings.

In October 2022, the Company, CB International, the Administrative Agent, and certain other lenders agreed to amend the 2022 Credit Agreement. The October 2022 Credit Agreement Amendment revises certain defined terms and covenants and will become effective upon (i) the amendment by Canopy of its Articles of Incorporation, (ii) the conversion of our Canopy common shares into Exchangeable Shares, and (iii) the resignation of our nominees from the board of directors of Canopy.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    16

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

As of November 30, 2023, information with respect to borrowings under the 2022 Credit Agreement is as follows:

	Outstanding borrowings		Interest rate		SOFR margin		Outstanding letters of credit		Remaining borrowing capacity (1)
(in millions)
2022 Credit Agreement
Revolving credit facility (2) (3)	$	—	—	%	—	%	$	11.5	$	1,779.0

(1)Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $459.5 million (excluding unamortized discount) (see “Commercial paper program” below).

(2)Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin.

(3)We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million.

We and our subsidiaries are subject to covenants that are contained in the 2022 Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio.

Commercial paper program

We have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.25 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility. As of November 30, 2023, we had $458.9 million of outstanding borrowings, net of unamortized discount, under our commercial paper program with a weighted average annual interest rate of 5.8% and a weighted average remaining term of nine days.

Pre-issuance hedge contracts

In November 2023, we entered into Pre-issuance hedge contracts, which were designated as cash flow hedges. As of November 30, 2023, we had hedged the interest rate volatility on $125.0 million of future debt issuances. In December 2023, we entered into additional cash flow designated, Pre-issuance hedge contracts for $150.0 million of future debt issuances. As a result of additional Pre-issuance hedge contracts, we have hedged the interest rate volatility on $275.0 million of future debt issuances.

Senior notes

In May 2023, we issued $750.0 million aggregate principal amount of 4.90% senior notes due May 2033. Proceeds from this offering, net of discount and debt issuance costs, were $739.8 million. Interest on the 4.90% May 2023 Senior Notes is payable semiannually on May 1 and November 1 of each year, beginning November 1, 2023. The 4.90% May 2023 Senior Notes are redeemable, in whole or in part, at our option at any time prior to February 1, 2033, at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the adjusted treasury rate, as defined in the applicable indenture, plus 25 basis points. On or after February 1, 2033, we may redeem the 4.90% May 2023 Senior Notes, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest. The 4.90% May 2023 Senior Notes are senior unsecured obligations which rank equally in right of payment to all of our existing and future senior unsecured indebtedness.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    17

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

Debt payments

As of November 30, 2023, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $56.6 million and $23.8 million, respectively) for the remaining three months of Fiscal 2024 and for each of the five succeeding fiscal years and thereafter are as follows:

(in millions)
Fiscal 2024	$	2.2
Fiscal 2025	957.5
Fiscal 2026	1,404.9
Fiscal 2027	603.8
Fiscal 2028	1,801.5
Fiscal 2029	500.0
Thereafter	6,050.1
	$	11,320.0

9.    INCOME TAXES

Our effective tax rate for the nine months ended November 30, 2023, and November 30, 2022, was 21.3% and 305.7%, respectively. Our effective tax rate for the three months ended November 30, 2023, and November 30, 2022, was 20.0% and 21.5%, respectively.

For the nine months and three months ended November 30, 2023, and three months ended November 30, 2022, our effective tax rate approximated the federal statutory rate of 21% as the increase in the valuation allowance related to our investment in Canopy was largely offset by the benefit of lower effective tax rates applicable to our foreign businesses.

For the nine months ended November 30, 2022, our effective tax rate did not approximate the federal statutory rate of 21% primarily due an increase in the valuation allowance related to our investment in Canopy, partially offset by a net income tax benefit recognized from the realization of tax losses related to a prior period divestiture.

10.    STOCKHOLDERS’ EQUITY

Common stock

The number of shares of common stock issued and treasury stock, and associated share activity, are as follows:

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Balance at February 28, 2023	212,697,428	—	22,705	29,498,426	—
Share repurchases	—	—	—	153,937	—
Conversion of shares	80	—	(80)	—	—
Exercise of stock options	—	—	800	(129,595)	—
Vesting of restricted stock units (2)	—	—	—	(71,189)	—
Vesting of performance share units (2)	—	—	—	(13,113)	—
Balance at May 31, 2023	212,697,508	—	23,425	29,438,466	—

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    18

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Conversion of shares	220	—	(220)	—	—
Exercise of stock options	—	—	606	(364,530)	—
Employee stock purchases	—	—	—	(30,172)	—
Vesting of restricted stock units (2)	—	—	—	(5,172)	—
Balance at August 31, 2023	212,697,728	—	23,811	29,038,592	—
Share repurchases	—	—	—	889,429	—
Conversion of shares	570	—	(570)	—	—
Exercise of stock options	—	—	—	(22,587)	—
Vesting of restricted stock units (2)	—	—	—	(68)	—
Balance at November 30, 2023	212,698,298	—	23,241	29,905,366	—
Balance at February 28, 2022	187,263,859	28,212,340	2,248,679	22,824,607	5,005,800
Share repurchases	—	—	—	4,065,508	—
Conversion of shares	655	(655)	—	—	—
Exercise of stock options	—	—	35	(108,228)	—
Vesting of restricted stock units (2)	—	—	—	(71,064)	—
Vesting of performance share units (2)	—	—	—	(16,326)	—
Balance at May 31, 2022	187,264,514	28,211,685	2,248,714	26,694,497	5,005,800
Share repurchases	—	—	—	1,652,445	—
Conversion of shares	2,196,749	—	(2,196,749)	—	—
Exercise of stock options	—	—	—	(75,482)	—
Employee stock purchases	—	—	—	(27,514)	—
Vesting of restricted stock units (2)	—	—	—	(4,851)	—
Balance at August 31, 2022	189,461,263	28,211,685	51,965	28,239,095	5,005,800
Retirement of treasury shares	—	(5,005,800)	—	—	(5,005,800)
Conversion of shares	23,205,885	(23,205,885)	—	—	—
Exercise of stock options	—	—	470	(63,529)	—
Balance at November 30, 2022	212,667,148	—	52,435	28,175,566	—

(1)Prior to the Reclassification, we had an additional class of common stock with a material number of shares outstanding: Class B Stock. Shares of Class B Stock were convertible into shares of Class A Stock on a one-to-one basis at any time at the option of the holder. For additional information, refer to “Reclassification” below.

(2)Net of the following shares withheld to satisfy tax withholding requirements:

	For the Three Months Ended May 31,	For the Three Months Ended August 31,	For the Three Months Ended November 30,	For the Nine Months Ended November 30,
2023
Restricted Stock Units	39,839	170	—	40,009
Performance Share Units	8,735	—	—	8,735
2022
Restricted Stock Units	37,308	186	—	37,494
Performance Share Units	4,919	—	—	4,919

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    19

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

Stock repurchases

In January 2021, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which the 2021 Authorization would expire. Shares repurchased under the 2021 Authorization become treasury shares.

Additionally, in November 2023, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which the 2023 Authorization would expire. Shares repurchased under the 2023 Authorization will become treasury shares.

For the nine months ended November 30, 2023, we repurchased 1,043,366 shares of Class A Stock pursuant to the 2021 Authorization through open market transactions at an aggregate cost of $249.7 million.

As of November 30, 2023, total shares repurchased under the 2021 Authorization and the 2023 Authorization are as follows:

			Class A Stock
	Repurchase Authorization		Dollar Value of Shares Repurchased		Number of Shares Repurchased
(in millions, except share data)
2021 Authorization	$	2,000.0	$	1,386.3	5,875,276
2023 Authorization	$	2,000.0	$	—	—

Reclassification

In November 2022, we completed the Reclassification at the Effective Time as contemplated by the Reclassification Agreement. Pursuant to the Reclassification, each share of Class B Stock issued and outstanding immediately prior to the Effective Time was reclassified, exchanged, and converted into one share of Class A Stock and the right to receive $64.64 in cash, without interest. The aggregate cash payment to holders of Class B Stock at the Effective Time was $1,500.0 million. We utilized our $1.0 billion delayed draw three-year term loan facility under the August 2022 Term Credit Agreement and borrowings under our commercial paper program to fund the aggregate cash payment to holders of Class B Stock.

11.    NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI

For the nine months and three months ended November 30, 2023, net income (loss) per common share – basic for Class A Stock has been computed based on the weighted average shares of common stock outstanding during the period. Net income (loss) per common share – diluted for Class A Stock reflects the weighted average shares of common stock plus the effect of dilutive securities outstanding during the period using the treasury stock method. The effect of dilutive securities includes the impact of outstanding stock-based awards. The dilutive computation does not assume conversion, exercise, or contingent issuance of securities that would have an anti-dilutive effect on the net income (loss) per common share attributable to CBI. The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows:

	For the Nine Months Ended November 30, 2023		For the Three Months Ended November 30, 2023
(in millions, except per share data)
Net income (loss) attributable to CBI	$	1,335.0	$	509.1
Weighted average common shares outstanding – basic	183.431		183.525
Stock-based awards, primarily stock options	0.665		0.645
Weighted average common shares outstanding – diluted	184.096		184.170
Net income (loss) per common share attributable to CBI – basic	$	7.28	$	2.77
Net income (loss) per common share attributable to CBI – diluted	$	7.25	$	2.76

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    20

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

For the nine months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock and Class B Stock has been computed using the two-class method. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock has been computed using the if-converted method and assumes the exercise of stock options using the treasury stock method and the conversion of Class B Stock as this method is more dilutive than the two-class method, until such conversion took place pursuant to the Reclassification. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class B Stock has been computed using the two-class method and does not assume conversion of Class B Stock into shares of Class A Stock. The computation of basic and diluted net income (loss) per common share are as follows:

	For the Nine Months Ended November 30, 2022				For the Three Months Ended November 30, 2022
	Class A Stock		Class B Stock (1)		Class A Stock		Class B Stock (1)
(in millions, except per share data)
Net income (loss) attributable to CBI allocated – basic	$	(247.3)	$	(46.7)	$	426.3	$	41.4
Conversion of Class B common shares into Class A common shares	—		—		41.4		—
Effect of stock-based awards on allocated net income (loss)	—		—		—		(0.1)
Net income (loss) attributable to CBI allocated – diluted	$	(247.3)	$	(46.7)	$	467.7	$	41.3
Weighted average common shares outstanding – basic	164.573		23.206		166.677		23.206
Conversion of Class B common shares into Class A common shares	—		—		17.850		—
Stock-based awards, primarily stock options (2)	—		—		0.764		—
Weighted average common shares outstanding – diluted	164.573		23.206		185.291		23.206
Net income (loss) per common share attributable to CBI – basic	$	(1.48)	$	(2.01)	$	2.58	$	1.78
Net income (loss) per common share attributable to CBI – diluted	$	(1.48)	$	(2.01)	$	2.52	$	1.78

(1)	Net income (loss) per common share attributable to CBI for Class B Stock was determined for the relevant periods through November 10, 2022, the date the Reclassification was completed.
(2)	We have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share for the nine months ended November 30, 2022, as the effect of including these would have been anti-dilutive:
		(in millions)
		Class B Stock	21.434
		Stock-based awards, primarily stock options	0.786

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    21

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

12.    COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI

Comprehensive income (loss) consists of net income (loss), foreign currency translation adjustments, unrealized net gain (loss) on derivative instruments, pension/postretirement adjustments, and our share of OCI of equity method investments. The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows:

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
For the Nine Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	1,335.0
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	264.2	$	—	264.2
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	264.2		—		264.2
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	192.1		(22.9)		169.2
Amounts reclassified	(108.8)		12.6		(96.2)
Net gain (loss) recognized in other comprehensive income (loss)	83.3		(10.3)		73.0
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)
Share of OCI of equity method investments
Net gain (loss)	(0.9)		(0.1)		(1.0)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.9)		(0.1)		(1.0)
Other comprehensive income (loss) attributable to CBI	$	346.2	$	(10.3)	335.9
Comprehensive income (loss) attributable to CBI					$	1,670.9
For the Nine Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	(294.0)
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	85.8	$	—	85.8
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	85.8		—		85.8
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	178.1		(23.4)		154.7
Amounts reclassified	(32.6)		3.2		(29.4)
Net gain (loss) recognized in other comprehensive income (loss)	145.5		(20.2)		125.3
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    22

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(2.4)		3.4		1.0
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(2.4)		3.4		1.0
Other comprehensive income (loss) attributable to CBI	$	228.5	$	(16.7)	211.8
Comprehensive income (loss) attributable to CBI					$	(82.2)
For the Three Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	509.1
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	(59.4)	$	—	(59.4)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(59.4)		—		(59.4)
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	29.3		(3.4)		25.9
Amounts reclassified	(39.3)		4.6		(34.7)
Net gain (loss) recognized in other comprehensive income (loss)	(10.0)		1.2		(8.8)
Pension/postretirement adjustments:
Net actuarial gain (loss)	0.1		—		0.1
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	0.1		—		0.1
Share of OCI of equity method investments
Net gain (loss)	(1.7)		(0.2)		(1.9)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(1.7)		(0.2)		(1.9)
Other comprehensive income (loss) attributable to CBI	$	(71.0)	$	1.0	(70.0)
Comprehensive income (loss) attributable to CBI					$	439.1
For the Three Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	467.7
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	96.9	$	—	96.9
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	96.9		—		96.9
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	82.4		(10.3)		72.1
Amounts reclassified	(12.3)		1.3		(11.0)
Net gain (loss) recognized in other comprehensive income (loss)	70.1		(9.0)		61.1
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.2)		—		(0.2)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.2)		—		(0.2)

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    23

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(3.3)		—		(3.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(3.3)		—		(3.3)
Other comprehensive income (loss) attributable to CBI	$	163.5	$	(9.0)	154.5
Comprehensive income (loss) attributable to CBI					$	622.2

Accumulated other comprehensive income (loss), net of income tax effect, includes the following components:

	Foreign Currency Translation Adjustments		Unrealized Net Gain (Loss) on Derivative Instruments		Pension/ Postretirement Adjustments		Share of OCI of Equity Method Investments		Accumulated Other Comprehensive Income (Loss)
(in millions)
Balance, February 28, 2023	$	(176.4)	$	198.5	$	(3.9)	$	10.3	$	28.5
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	264.2		169.2		(0.3)		(1.0)		432.1
Amounts reclassified from accumulated other comprehensive income (loss)	—		(96.2)		—		—		(96.2)
Other comprehensive income (loss)	264.2		73.0		(0.3)		(1.0)		335.9
Balance, November 30, 2023	$	87.8	$	271.5	$	(4.2)	$	9.3	$	364.4

13.    BUSINESS SEGMENT INFORMATION

Prior to May 31, 2023, our internal management financial reporting consisted of three business divisions: (i) Beer, (ii) Wine and Spirits, and (iii) Canopy and we reported our operating results in four segments: (i) Beer, (ii) Wine and Spirits, (iii) Corporate Operations and Other, and (iv) Canopy. Due to several factors occurring as of May 31, 2023, including those which led to the additional Canopy Equity Method Investment impairment combined with Canopy’s financial results no longer being provided to, or reviewed by, our CODM, and no longer being used to make strategic decisions, allocate resources, or assess performance, we have removed Canopy as a reportable segment. Accordingly, effective May 31, 2023, our internal management financial reporting consists of two business divisions: (i) Beer and (ii) Wine and Spirits and we report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other.

In the Beer segment, our portfolio consists of high-end imported beer brands and ABAs. We have an exclusive perpetual brand license to produce our Mexican beer portfolio and to import, market, and sell such portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of executive management, corporate development, corporate finance, corporate growth and strategy, human resources, internal audit, investor relations, IT, legal, and public relations, as well as our Canopy investment and investments made through our corporate venture capital function. All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by, our CODM as it is not used to make strategic decisions, allocate resources, or assess performance.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    24

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

In addition, management excludes Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments.

We evaluate segment operating performance based on operating income (loss) of the respective business units. Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$	(28.9)	$	25.3	$	(13.3)	$	(7.8)
Flow through of inventory step-up	(2.7)		(4.0)		(1.2)		(2.1)
Settlements of undesignated commodity derivative contracts	8.5		(68.8)		2.3		(14.2)
Strategic business development costs	—		(1.1)		—		(1.1)
Net flow through of reserved inventory	—		1.2		—		—
Recovery of (loss on) inventory write-down	—		0.2		—		—
Comparable Adjustments, Cost of product sold	(23.1)		(47.2)		(12.2)		(25.2)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(23.6)		(2.8)		(5.3)		(0.2)
Transition services agreements activity	(17.9)		(11.4)		(5.2)		(3.5)
Gain (loss) on sale of business	(15.1)		13.8		(0.2)		13.8
Transaction, integration, and other acquisition-related costs	(0.6)		(1.2)		—		(0.5)
Costs associated with the Reclassification	0.2		(31.5)		—		(10.2)
Other gains (losses) (1)	5.6		11.6		—		2.8
Comparable Adjustments, Selling, general, and administrative expenses	(51.4)		(21.5)		(10.7)		2.2
Comparable Adjustments, Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)

(1)	Primarily includes the following:
		For the Nine Months Ended November 30,				For the Three Months Ended November 30,
		2023		2022		2023		2022
	(in millions)
	Recognition of a previously deferred gain upon release of a related indemnity	$	5.6	$	—	$	—	$	—
	Gain from remeasurement of previously held equity method investments	$	—	$	5.2	$	—	$	—
	Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions	$	—	$	5.9	$	—	$	1.5

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    25

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

The accounting policies of the segments are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2023 Annual Report. Segment information is as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Beer
Net sales	$	6,459.8	$	5,929.4	$	1,968.5	$	1,891.9
Segment operating income (loss)	$	2,509.0	$	2,338.4	$	757.3	$	710.0
Capital expenditures	$	704.4	$	539.3	$	264.1	$	181.5
Depreciation and amortization	$	242.2	$	206.2	$	82.0	$	71.0
Wine and Spirits
Net sales:
Wine	$	1,180.7	$	1,316.6	$	435.8	$	470.5
Spirits	182.1		208.8		66.6		74.1
Net sales	$	1,362.8	$	1,525.4	$	502.4	$	544.6
Segment operating income (loss)	$	287.6	$	325.2	$	127.6	$	134.8
Income (loss) from unconsolidated investments	$	38.1	$	40.3	$	27.5	$	35.4
Equity method investments	$	130.5	$	134.7	$	130.5	$	134.7
Capital expenditures	$	107.1	$	83.2	$	29.6	$	31.6
Depreciation and amortization	$	68.1	$	63.3	$	22.5	$	20.0
Corporate Operations and Other
Segment operating income (loss)	$	(181.8)	$	(218.7)	$	(65.1)	$	(75.1)
Income (loss) from unconsolidated investments	$	(62.7)	$	(132.1)	$	(8.3)	$	(41.1)
Equity method investments	$	102.8	$	636.7	$	102.8	$	636.7
Capital expenditures	$	100.4	$	61.3	$	36.2	$	35.7
Depreciation and amortization	$	12.5	$	11.7	$	3.9	$	4.8
Comparable Adjustments
Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)
Income (loss) from unconsolidated investments	$	(452.8)	$	(1,852.4)	$	(61.0)	$	(31.5)
Consolidated
Net sales	$	7,822.6	$	7,454.8	$	2,470.9	$	2,436.5
Operating income (loss)	$	2,540.3	$	2,376.2	$	796.9	$	746.7
Income (loss) from unconsolidated investments (1)	$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)
Equity method investments	$	233.3	$	771.4	$	233.3	$	771.4
Capital expenditures	$	911.9	$	683.8	$	329.9	$	248.8
Depreciation and amortization	$	322.8	$	281.2	$	108.4	$	95.8

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    26

FINANCIAL STATEMENTS NOTES TO CONSOLIDATED FINANCIAL STATEMENTS Table of Contents

(1)	Income (loss) from unconsolidated investments consists of:
			For the Nine Months Ended November 30,				For the Three Months Ended November 30,
			2023		2022		2023		2022
		(in millions)
		Impairment of equity method investments	$	(136.1)	$	(1,060.3)	$	(0.3)	$	—
		Unrealized net gain (loss) on securities measured at fair value	(85.4)		(39.1)		(11.0)		(7.4)
		Equity in earnings (losses) from Canopy and related activities	(288.3)		(876.5)		(56.5)		(60.8)
		Equity in earnings (losses) from other equity method investees and related activities	32.1		31.7		25.7		31.0
		Net gain (loss) on sale of unconsolidated investment	0.3		—		0.3		—
			$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)

14.    SUBSEQUENT EVENT

Insurance recoveries

In December 2023, we recorded $37 million of business interruption and other recoveries from our insurance carrier. We are pursuing additional reimbursement from another insurance carrier, however there can be no assurance there will be any incremental recoveries. These recoveries related to an outage at our Nava Brewery due to severe winter weather events in early 2021. These proceeds will be included in our consolidated results of operations for the year ending February 29, 2024.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    27

MD&A Table of Contents

Item 2.    Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Introduction

This MD&A provides additional information on our businesses, current developments, financial condition, cash flows, and results of operations. It should be read in conjunction with our Financial Statements and with our consolidated financial statements and notes included in our 2023 Annual Report. This MD&A is organized as follows:

Overview.    This section provides a general description of our business, which we believe is important in understanding the results of our operations, financial condition, and potential future trends.

Strategy.    This section provides a description of our strategy and a discussion of a recent development and significant divestitures, acquisitions, and investments.

Results of operations.    This section provides an analysis of our results of operations presented on a business segment basis for the three months ended November 30, 2023, and November 30, 2022, and nine months ended November 30, 2023, and November 30, 2022. In addition, a brief description of significant transactions and other items that affect the comparability of the results is provided.

Liquidity and capital resources.    This section provides an analysis of our cash flows, outstanding debt, and liquidity position. Included in the analysis of outstanding debt is a discussion of the financial capacity available to fund our on-going operations and future commitments, as well as a discussion of other financing arrangements.

Overview

We are an international producer and marketer of beer, wine, and spirits with operations in the U.S., Mexico, New Zealand, and Italy with powerful, consumer-connected, high-quality brands like Corona Extra, Modelo Especial, the Robert Mondavi Brand Family, Kim Crawford, Meiomi, The Prisoner Wine Company, High West, Casa Noble, and Mi CAMPO. In the U.S., we are one of the top growth contributors at retail among beverage alcohol suppliers. We are the third-largest beer company in the U.S. and continue to strengthen our leadership position as the #1 high-end beer supplier and the #1 share gainer across the U.S. beer market. Within wine and spirits, we have reshaped our brand portfolio to a higher-end focused business aimed to deliver net sales growth and margin expansion. The strength of our brands makes us a supplier of choice to many of our consumers and our customers, which include wholesale distributors, retailers, and on-premise locations. We conduct our business through entities we wholly own as well as through a variety of joint ventures and other entities.

Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    28

MD&A Table of Contents

segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. For additional information, refer to Note 13.

In the Beer segment, our portfolio consists of high-end imported beer brands and ABAs. We have an exclusive perpetual brand license to produce our Mexican beer portfolio and to import, market, and sell such portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of executive management, corporate development, corporate finance, corporate growth and strategy, human resources, internal audit, investor relations, IT, legal, and public relations, as well as our Canopy investment and investments made through our corporate venture capital function. All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting.

Strategy

Business strategy

Our overall strategic vision is to consistently deliver industry-leading total stockholder returns over the long-term through a focus on these key pillars:

•continue building strong brands people love with advantaged routes to market;

•build a culture that is consumer-obsessed and leverages robust innovation capabilities to stay on the forefront of consumer trends;

•deploy capital in line with disciplined and balanced priorities; and

•deliver on impactful ESG initiatives that we believe are not only good business, but also good for the world.

We will continue to strive for success by ensuring consumer-led decision making drives all aspects of our business; building a diverse talent pipeline with best-in-class people development; investing in infrastructure that supports and enables our business, including data systems and architecture; and exemplifying intentional and proactive fiscal management. We place focus on positioning our portfolio on higher-margin, higher-growth categories of the beverage alcohol industry to align with consumer-led premiumization trends, which we believe will continue to drive faster growth rates across beer, wine, and spirits. To continue capitalizing on consumer-led premiumization trends, become more competitive, and grow our business, we have employed a strategy dedicated to organic growth and supplemented by targeted investments and acquisitions. We also believe a key component to driving faster growth rates is to invest and strengthen our leadership position within the DTC and 3-tier eCommerce channels. We have launched a multi-year Digital Business Acceleration initiative, which we believe will enable us to drive results by enhancing our technology capabilities in key areas. In Fiscal 2024, we continue to focus our Digital Business Acceleration initiative efforts on procurement, end-to-end supply chain planning, and marketing optimization, as well as introducing a new focus area, logistics. Additionally, we believe our continued focus on maintaining a strong balance sheet provides a solid financial foundation to support our broader strategic initiatives.

Our business strategy for the Beer segment focuses on strengthening our leadership position in the high-end segment of the U.S. beer market and continuing to grow our high-end imported beer brands through maintenance of leading margins, enhancements to our results of operations and operating cash flow, and exploring new avenues for growth. This includes continued focus on growing our beer portfolio in the U.S. through expanding distribution for key brands, including within the 3-tier eCommerce channel, as well as continued expansion, optimization, and/or construction activities at our breweries in Mexico. Additionally, in an effort to compete more fully in growing sectors of the high-end segment of the U.S. beer market, we have leveraged our

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    29

MD&A Table of Contents

innovation capabilities to create new line extensions behind celebrated, trusted brands and package formats that are intended to meet emerging needs.

Expansion, optimization, and/or construction activities continue under our Mexico Beer Projects to align with our anticipated future growth expectations and we now expect to spend approximately $4 billion between Fiscal 2024 and Fiscal 2028 on capital expenditures for our Beer segment. Additionally, we are pursuing the sale of the remaining assets at the canceled Mexicali Brewery after exploring various options; however, we may not be successful in completing any such sale or obtaining other forms of recovery.

Our business strategy for the Wine and Spirits segment focuses on higher-end brands, improving margins, and creating operating efficiencies. We have reshaped our portfolio primarily through an enhanced focus on higher-margin, higher-growth wine and spirits brands. Our business is organized into two distinct commercial teams, one focused on our fine wine and craft spirits brands and the other focused on our mainstream and premium brands. While each team has its own distinct strategy, both remain aligned to the goal of accelerating performance by growing organic net sales and expanding margins. In addition, we are advancing our aim to become a global, omni-channel competitor in line with consumer preferences. Our business continues to progressively expand into DTC channels (including hospitality), 3-tier eCommerce, and international markets, while continuing to grow in U.S. 3-tier brick-and-mortar distribution. In markets where it is feasible, we entered into a contractual arrangement with Southern Glazer’s Wine and Spirits to consolidate our U.S. distribution in order to obtain dedicated distributor selling resources which focus on our U.S. wine and spirits portfolio to drive organic growth.

Marketing, sales, and distribution of our products are primarily managed on a geographic basis allowing us to leverage leading market positions. In addition, market dynamics and consumer trends vary across each of our markets. Within our primary market in the U.S., we offer a range of beverage alcohol products across the imported beer, ABA, and branded wine and spirits categories, with generally separate distribution networks utilized for (i) our beer portfolio and (ii) our wine and spirits portfolio. The environment for our products is competitive in each of our markets.

We remain committed to our long-term financial model of: growing sales, expanding margins, and increasing cash flow in order to achieve earnings per share growth as well as our target net leverage ratio and dividend payout ratio; investing to support the growth of our business; and delivering additional returns to stockholders through periodic share repurchases. Our results of operations and financial condition have been affected by inflation, changing prices, reductions in discretionary income of consumers available to purchase our products, and shifting consumer behaviors, as well as other unfavorable global and regional economic conditions, global supply chain disruptions and constraints, and geopolitical events. We expect some or all of these impacts to continue during the remainder of Fiscal 2024 which could have a material impact on our results of operations. We intend to continue to monitor the inflationary environment and the impact on the consumer when we consider passing along rising costs through further selling price increases, subject to normal competitive conditions. In addition, we continue to identify on-going cost savings initiatives, including our commodity and foreign exchange hedging programs. However, there can be no assurance that we will be able to fully mitigate rising costs through increased selling prices and/or cost savings initiatives. Furthermore, to the extent climate-related severe weather events, such as droughts, floods, wildfires, extreme heat, and/or late frosts, continue to occur or accelerate in future periods, it could have a material impact on our results of operations and financial condition.

ESG strategy

During the course of our history, we have been committed to safeguarding our environment, making a positive difference in our communities, and advocating for responsible consumption of beverage alcohol products. We believe our ESG strategy enables us to better meet stakeholder expectations, reflects our Company values, and directly address pressing environmental and societal needs that are important to our stockholders, communities, consumers, and employees.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    30

MD&A Table of Contents

Specifically, we have focused on areas where we believe we have the greatest opportunities to make meaningful, positive impacts for people and the planet, and we dedicate our resources towards:

Serving as good stewards of our environment and natural resources

Improve water availability and resilience for our communities where we operate; reducing GHG emissions through energy conservation and renewable energy initiatives; and reducing operational waste and enhancing our use of returnable, recyclable, or renewable packaging

Enhancing social equity within our industry and communities

Championing the professional development and advancement of women in the beverage alcohol industry and our communities; enhancing economic development and prosperity in disadvantaged communities; and championing an inclusive workplace culture characterized by diversity in background and thought, which reflects our consumers and the communities where we live and work

Promoting responsible beverage alcohol consumption

Ensuring the responsible promotion and marketing of our products; and empowering adults to make responsible choices in their alcohol (substance) consumption by supporting fact-based education, engagement programs, and policies

During Third Quarter 2024 we published our 2023 ESG Impact Report and took the following steps to advance our ESG strategy by key area:

Serving as good stewards of our environment and natural resources

•surpassed our initial target and now aim to restore a total of 5 billion gallons of water withdrawals from local watersheds near our production facilities between Fiscal 2023 and Fiscal 2025

•invested in a project in Nogales, Arizona to address river borne trash that is generated both locally and across the border from Mexico to help improve the quality of water for communities near where we operate. We estimate approximately 25,000 people will be positively impacted by this project

Enhancing social equity within our industry and communities

•our team members attended a national conference and career exposition focused on empowering and enabling Hispanic/Latinx professionals to achieve their educational, economic, and social potential. Our employees participated in panel discussions and workshops, networked with peer corporate leadership in the areas of talent acquisition and DEI, and continued efforts to build a diverse talent pipeline

Promoting responsible beverage alcohol consumption

•in collaboration with Responsibility.org, a not-for-profit that aims to empower adults to make a lifetime of responsible alcohol choices, we shared responsible consumption messaging around seasonal activities, such as the beginning of football season, as well as, holidays including Halloween, Día de los Muertos, and Thanksgiving, with employees and external audiences

•we partnered with Uber to provide ride vouchers for U.S. employees celebrating Thanksgiving as part of our Safe Ride Home program

Recent Development

Insurance recoveries

In December 2023, we recorded $37 million of business interruption and other recoveries from our insurance carrier. We are pursuing additional reimbursement from another insurance carrier, however there can be no assurance there will be any incremental recoveries. These recoveries related to an outage at our Nava Brewery due to severe winter weather events in early 2021. For additional information, refer to Note 14.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    31

MD&A Table of Contents

Divestitures, acquisitions, and investments

Beer segment

Craft Beer Divestitures

In June 2023, we completed the Craft Beer Divestitures. Accordingly, our consolidated results of operations include the results of operations of such craft beer brands through the dates of these divestitures. The Craft Beer Divestitures are consistent with our strategic focus on continuing to grow our high-end imported beer brands through maintenance of leading margins and enhancements to our results of operations.

Daleville Facility

In May 2023, we sold the Daleville Facility in connection with management’s decision to exit the craft beer business. The net cash proceeds from the transaction were used primarily for general corporate purposes.

Wine and Spirits segment

Wine Divestiture

In October 2022, we sold certain of our mainstream and premium wine brands and related inventory. Accordingly, our consolidated results of operations include the results of operations of such mainstream and premium wine brands through the date of divestiture. We received cash proceeds of $96.7 million from the Wine Divestiture that were utilized primarily to reduce outstanding borrowings. We recognized a $13.8 million net gain on the sale of business for the Third Quarter 2023 and Nine Months 2023. This gain was included in selling, general, and administrative expenses within our consolidated results.

Austin Cocktails acquisition

In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Lingua Franca acquisition

In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also included the acquisition of a trademark and inventory. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Our Wine and Spirits segment divestiture and acquisitions support our strategic focus on consumer-led premiumization trends and meeting the evolving needs of our consumers.

Corporate Operations and Other segment

Corporate ventures

As of November 30, 2023, we evaluated a certain equity method investment, made through our corporate venture capital function, and determined there was an other-than-temporary impairment due to business underperformance.

As of August 31, 2023, we evaluated certain equity method investments, made through our corporate venture capital function, and determined there were other-than-temporary impairments due to business underperformance. Investments with a carrying value of $14.9 million were written down to an estimated fair value of $2.6 million, resulting in an impairment of $12.3 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for Nine Months 2024. In October 2023, we exited one of these equity method investments in exchange for a note receivable.

Canopy investment

We have an investment in Canopy, a North American cannabis and CPG company providing medical and adult-use cannabis products, which expands our portfolio into adjacent categories. We expect to convert our Canopy common shares into Exchangeable Shares following the completion of the Canopy Transaction.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    32

MD&A Table of Contents

Canopy Equity Method Investment —

We evaluated the Canopy Equity Method Investment as of May 31, 2023, and determined there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the fair value being less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recorded significant costs in its fourth quarter of fiscal 2023 results designed to align its Canadian cannabis operations and resources in response to continued unfavorable market trends, (iii) the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, and (iv) Canopy’s identification of material misstatements in certain of its previously reported financial results related to sales in its BioSteel reporting unit that were accounted for incorrectly, including the recording of a goodwill impairment during its restated second quarter of fiscal 2023. As a result, the Canopy Equity Method Investment with a carrying value of $266.2 million was written down to its estimated fair value of $142.7 million, resulting in an impairment of $123.5 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for Nine Months 2024.

Additionally, we evaluated the Canopy Equity Method Investment as of August 31, 2022, and determined that there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the period of time for which the fair value had been less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recording a significant impairment of goodwill related to its cannabis operations during its first quarter of fiscal 2023, and (iii) the uncertainty of U.S. federal cannabis permissibility. As a result, the Canopy Equity Method Investment with a carrying value of $1,695.1 million was written down to its estimated fair value of $634.8 million, resulting in an impairment of $1,060.3 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for Nine Months 2023.

Other Canopy investments —

In July 2022, we received 29.2 million common shares of Canopy following the exchange of C$100.0 million principal amount of our Canopy Debt Securities. In April 2023, we extended the maturity of the remaining C$100.0 million principal amount of our Canopy Debt Securities by exchanging them for the 2023 Canopy Promissory Note. The fair value of the Canopy Debt Securities was $69.6 million as of February 28, 2023. As of May 31, 2023, we determined that the 2023 Canopy Promissory Note did not have future economic value and, accordingly, the fair value was reduced to zero. On November 1, 2023, the initial tranche of the November 2018 Canopy Warrants expired in accordance with its terms. The remaining tranches of the November 2018 Canopy Warrants were conditioned on the exercise, in full, of the expired warrants. As such, there are no longer any outstanding November 2018 Canopy Warrants.

Plan to convert Canopy common stock ownership —

In October 2022, we entered into a Consent Agreement with Canopy pursuant to which we have provided our consent, subject to certain conditions, to the Canopy Transaction. Assuming the completion of the Canopy Transaction and the transactions contemplated by the Consent Agreement and that we elect to convert our Canopy common shares into Exchangeable Shares:

•we will only have an interest in Exchangeable Shares, which are non-voting and non-participating securities, and our 2023 Canopy Promissory Note (for which we intend to negotiate an exchange of the principal amount for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so);

•we intend to terminate all legacy agreements and commercial arrangements between ourselves and Canopy, including the investor rights agreement but excluding the Consent Agreement and certain termination agreements;

•we will have no further governance rights in relation to Canopy, including rights to nominate members to the board of directors of Canopy, or consulting rights related to certain transactions;

•all of our nominees will resign from the board of directors of Canopy; and

•as our investment in Canopy common shares makes up our Canopy Equity Method Investment, we expect to no longer apply the equity method to our investment in Canopy, which we expect to instead

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    33

MD&A Table of Contents

be accounted for at fair value with changes reported in income (loss) from unconsolidated investments within our consolidated results.

For additional information on these divestitures, acquisitions, and investments refer to Notes 4, 5, and 7.

Results of Operations

Financial Highlights

References to organic throughout the following discussion exclude the impact of the Wine Divestiture, as appropriate.

Third Quarter 2024 compared with Third Quarter 2023

•Our results of operations were positively impacted by improvements within the Beer segment driven by a successful execution of cost savings initiatives and 3.4% shipment volume growth.

•Net sales increased 1% largely due to an increase in Beer net sales driven primarily by shipment volume growth and favorable impact from pricing, partially offset by a decline in Wine and Spirits net sales driven primarily by a decrease in organic branded shipment volume.

•Operating income increased 7% largely due to the improvements within (i) the Beer segment as shipment volume growth and lower marketing spend outpaced the growth of cost of product sold, driven by the successful execution of cost savings initiatives, and (ii) the Corporate Operations and Other segment from lower Digital Business Acceleration investments as compared to Third Quarter 2023, partially offset by a decline in the Wine and Spirits segment driven by the decrease in organic branded shipment volume.

•Net income attributable to CBI and diluted net income per common share attributable to CBI increased 9% and 10%, respectively, largely due to the items discussed above.

Nine Months 2024 compared to Nine Months 2023

•Our results of operations were impacted by (i) lower impairment and other losses related to our investment in Canopy as compared with Nine Months 2023 and (ii) improvements within the Beer segment driven by 6.6% shipment volume growth and a successful execution of cost savings initiatives, partially offset by a decline in performance in the Wine and Spirits segment.

•Net sales increased 5% largely due to an increase in Beer net sales driven primarily by shipment volume growth and favorable impact from pricing, partially offset by a decline in Wine and Spirits net sales driven primarily by a decrease in branded shipment volume.

•Operating income increased 7% largely due to the improvements within (i) the Beer segment as shipment volume outpaced the growth of cost of product sold, driven by the successful execution of cost savings initiatives, (ii) the Corporate Operations and Other segment from lower Digital Business Acceleration investments as compared to Nine Months 2023, and (iii) lower cost of product sold and marketing spend within the Wine and Spirits segment, partially offset by a decline in branded wine and spirits shipment volume and impacts from the Wine Divestiture.

•Net income (loss) attributable to CBI and diluted net income (loss) per common share attributable to CBI increased largely due to the items discussed above.

Comparable Adjustments

Management excludes items that affect comparability from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    34

MD&A Table of Contents

As more fully described herein and in the related Notes, the Comparable Adjustments that impacted comparability in our segment results for each period are as follows:

	Third Quarter 2024		Third Quarter 2023		Nine Months 2024		Nine Months 2023
(in millions)
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$	(13.3)	$	(7.8)	$	(28.9)	$	25.3
Flow through of inventory step-up	(1.2)		(2.1)		(2.7)		(4.0)
Settlements of undesignated commodity derivative contracts	2.3		(14.2)		8.5		(68.8)
Strategic business development costs	—		(1.1)		—		(1.1)
Net flow through of reserved inventory	—		—		—		1.2
Recovery of (loss on) inventory write-down	—		—		—		0.2
Comparable Adjustments, Cost of product sold	(12.2)		(25.2)		(23.1)		(47.2)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(5.3)		(0.2)		(23.6)		(2.8)
Transition services agreements activity	(5.2)		(3.5)		(17.9)		(11.4)
Gain (loss) on sale of business	(0.2)		13.8		(15.1)		13.8
Transaction, integration, and other acquisition-related costs	—		(0.5)		(0.6)		(1.2)
Costs associated with the Reclassification	—		(10.2)		0.2		(31.5)
Other gains (losses)	—		2.8		5.6		11.6
Comparable Adjustments, Selling, general, and administrative expenses	(10.7)		2.2		(51.4)		(21.5)
Comparable Adjustments, Operating income (loss)	$	(22.9)	$	(23.0)	$	(74.5)	$	(68.7)
Comparable Adjustments, Income (loss) from unconsolidated investments	$	(61.0)	$	(31.5)	$	(452.8)	$	(1,852.4)

Cost of product sold

Undesignated commodity derivative contracts

Net gain (loss) on undesignated commodity derivative contracts represents a net gain (loss) from the changes in fair value of undesignated commodity derivative contracts. The net gain (loss) is reported outside of segment operating results until such time that the underlying exposure is recognized in the segment operating results. At settlement, the net gain (loss) from the changes in fair value of the undesignated commodity derivative contracts is reported in the appropriate operating segment, allowing the results of our operating segments to reflect the economic effects of the commodity derivative contracts without the resulting unrealized mark to fair value volatility.

Flow through of inventory step-up

In connection with acquisitions, the allocation of purchase price in excess of book value for certain inventories on hand at the date of acquisition is referred to as inventory step-up. Inventory step-up represents an assumed manufacturing profit attributable to the acquired business prior to acquisition.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    35

MD&A Table of Contents

Strategic business development costs

We recognized costs in connection with certain activities which are intended to streamline, increase efficiencies, and reduce our cost structure within the Wine and Spirits segment.

Net flow through of reserved inventory

We sold reserved inventory previously written down following the 2020 U.S. West Coast wildfires.

Recovery of (loss on) inventory write-down

We recognized a gain from a change in estimate on reserved bulk wine inventory and certain grapes as a result of smoke damage sustained during the 2020 U.S. West Coast wildfires.

Selling, general, and administrative expenses

Restructuring and other strategic business development costs

We recognized costs in connection with certain activities which are intended to streamline, increase efficiencies, and reduce our cost structure.

Transition services agreements activity

We recognized costs in connection with transition services agreements related to the previous sale of a portion of our wine and spirits business.

Gain (loss) on sale of business

We recognized a net gain (loss) primarily from (i) the sale of the Daleville Facility and the Craft Beer Divestitures (Nine Months 2024) and (ii) the completion of the Wine Divestiture (Third Quarter 2023, Nine Months 2023).

Transaction, integration, and other acquisition-related costs

We recognized transaction, integration, and other acquisition-related costs in connection with our investments, acquisitions, and divestitures.

Costs associated with the Reclassification

We recognized costs primarily related to professional and consulting fees, printing and mailing the associated proxy statement/prospectus, and all filing and other fees paid to the SEC in connection with the Reclassification.

Other gains (losses)

We recognized other gains (losses) primarily from (i) recognition of a previously deferred gain upon release of a related indemnity (Nine Months 2024), (ii) a gain recognized on the remeasurement of our previously held equity interests to the acquisition-date fair value (Nine Months 2023), and (iii) decreases in estimated fair values of a contingent liabilities associated with prior period acquisitions (Third Quarter 2023, Nine Months 2023).

Income (loss) from unconsolidated investments

We recognized income (loss) primarily from (i) comparable adjustments to equity in losses from Canopy’s results, (ii) an impairment of our Canopy Equity Method Investment (Nine Months 2024, Nine Months 2023), (iii) unrealized net losses from the changes in fair value of our securities measured at fair value, and (iv) impairments of certain other equity method investments (Third Quarter 2024, Nine Months 2024). For additional information, refer to Notes 4 and 7.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    36

MD&A Table of Contents

Business Segments

Third Quarter 2024 compared to Third Quarter 2023

Net sales

	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions)
Beer	$	1,968.5	$	1,891.9	$	76.6	4	%
Wine and Spirits:
Wine	435.8		470.5		(34.7)		(7	%)
Spirits	66.6		74.1		(7.5)		(10	%)
Total Wine and Spirits	502.4		544.6		(42.2)		(8	%)
Consolidated net sales	$	2,470.9	$	2,436.5	$	34.4	1	%

	Beer segment	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions, branded product, 24-pack, 12-ounce case equivalents)
Net sales		$	1,968.5	$	1,891.9	$	76.6	4	%
Shipments		101.1		97.8				3.4	%
Depletions								8.2	%

The increase in Beer net sales is largely due to (i) $67.6 million of shipment volume growth within our Mexican beer portfolio, which benefited from continued consumer demand, and (ii) $22.6 million of favorable impact from pricing in select markets within our Mexican beer portfolio, partially offset by $9.7 million of unfavorable product mix primarily from a shift in package types.

	Wine and Spirits segment	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions, branded product, 9-liter case equivalents)
Net sales		$	502.4	$	544.6	$	(42.2)	(8	%)
Shipments
Total		6.1		6.9				(11.6	%)
Organic (1)		6.1		6.8				(10.3	%)
U.S. Domestic		5.3		6.0				(11.7	%)
Organic U.S. Domestic (1)		5.3		5.9				(10.2	%)
Depletions (1)								(10.0	%)

(1)Includes an adjustment to remove volume associated with the Wine Divestiture for the period September 1, 2022, through October 5, 2022.

The decrease in Wine and Spirits net sales is due to a $38.5 million decrease in organic net sales and $3.7 million from the Wine Divestiture. The decrease in organic net sales is driven by (i) a $56.2 million decrease in branded wine and spirits shipment volume and (ii) $0.2 million of unfavorable impact from pricing, partially offset by (i) an $11.1 million increase in non-branded net sales primarily due to higher bulk sales as compared to Third

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    37

MD&A Table of Contents

Quarter 2023 and (ii) $6.8 million of favorable product mix, driven by consumer-led premiumization. The decrease in branded wine and spirits shipment volume is attributable to our U.S. wholesale market, primarily driven by declines in both the overall wine market and in our lower-end brands. Additionally, the impact from pricing remained relatively flat as lower contractual distributor payments as compared to Third Quarter 2023 were largely offset by favorable pricing actions.

Gross profit

	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions)
Beer	$	1,039.1	$	989.5	$	49.6	5	%
Wine and Spirits	243.7		262.6		(18.9)		(7	%)
Comparable Adjustments	(12.2)		(25.2)		13.0		NM
Consolidated gross profit	$	1,270.6	$	1,226.9	$	43.7	4	%

The increase in Beer gross profit is primarily due to (i) $36.7 million of shipment volume growth and (ii) the $22.6 million favorable impact from pricing, partially offset by (i) $8.3 million of unfavorable product mix and (ii) $2.0 million of higher cost of product sold. Cost of product sold was impacted by (i) $18.2 million of higher material costs, including malt, starch, glass, and other packaging, driven by inflation, (ii) $10.9 million of higher depreciation resulting from the Mexico Beer Projects, and (iii) $9.3 million of other brewery costs including fixed cost absorption which were offset by (i) $32.7 million of decreased transportation costs and (ii) $4.0 million of lower inventory obsolescence as compared to Third Quarter 2023. To partially offset the increases in cost of product sold we are executing initiatives that have resulted in over $55 million of net cost savings for Third Quarter 2024.

The decrease in Wine and Spirits gross profit is due to a $16.7 million decrease in organic gross profit and $2.2 million from the Wine Divestiture. The decrease in organic gross profit is attributable to (i) a $25.8 million decrease in branded wine and spirits shipment volume and (ii) $4.8 million of unfavorable product mix led by lower-margin, non-branded net sales, partially offset by $13.6 million of lower cost of product sold. The decrease in cost of product sold was largely attributable to (i) $8.4 million of decreased transportation and warehousing costs, including ocean freight shipping, and (ii) $4.9 million of cost savings initiatives, primarily resulting in lower grape costs, as well as lower materials and packaging costs, driven by our sustainable packaging projects.

Gross profit as a percent of net sales increased to 51.4% for Third Quarter 2024 compared with 50.4% for Third Quarter 2023. This increase was largely due to (i) 55 basis points of rate growth from lower cost of product sold within the Wine and Spirits segment, (ii) a favorable change of approximately 55 basis points in Comparable Adjustments, and (iii) 45 basis points of favorable impact from Beer pricing in select markets, partially offset by approximately 55 basis points of rate decline resulting from unfavorable product mix and lower-margin, non-branded net sales within the Wine and Spirits segment.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    38

MD&A Table of Contents

Selling, general, and administrative expenses

	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions)
Beer	$	281.8	$	279.5	$	2.3	1	%
Wine and Spirits	116.1		127.8		(11.7)		(9	%)
Corporate Operations and Other	65.1		75.1		(10.0)		(13	%)
Comparable Adjustments	10.7		(2.2)		12.9		NM
Consolidated selling, general, and administrative expenses	$	473.7	$	480.2	$	(6.5)	(1	%)

Beer selling, general, and administrative expenses remained relatively flat as $12.8 million of increased general and administrative expenses were offset by $10.5 million of decreased marketing spend as compared to Third Quarter 2023, due to a timing shift. We continue to expect marketing spend to approximate 9% of net sales for Fiscal 2024. The increase in general and administrative expenses was driven largely by unfavorable foreign currency impact and higher compensation and benefits, partially offset by lower legal fees as compared to Third Quarter 2023.

The decrease in Wine and Spirits selling, general, and administrative expenses is largely due to $8.3 million and $4.1 million of decreased general and administrative expenses and marketing spend, respectively. The decrease in general and administrative expenses is driven by lower compensation and benefits. The decrease in marketing spend is driven by less planned media investments for our lower-end brands as compared to Third Quarter 2023.

The decrease in Corporate Operations and Other selling, general, and administrative expenses is largely due to a $14 million reduction in third-party services, driven by lower Digital Business Acceleration investments, partially offset by a $3 million increase in compensation and benefits due to higher headcount and increased costs associated with merit and the short-term incentive accrual as compared to Third Quarter 2023. The increase in compensation and benefits was offset by favorability from the November 2022 Reclassification.

Selling, general, and administrative expenses as a percent of net sales decreased to 19.2% for Third Quarter 2024 as compared to 19.7% for Third Quarter 2023. The decrease is largely driven by (i) approximately 50 basis points of rate decline as the increase in Beer net sales exceeded the increase in selling, general, and administrative expenses, (ii) approximately 40 basis points of rate decline from the decrease in Corporate Operations and Other selling, general, and administrative expenses, and (iii) 15 basis points of rate decline from the decrease in Wine and Spirits’ selling, general, and administrative expenses, partially offset by an unfavorable change in Comparable Adjustments, contributing 55 basis points of rate growth.

Operating income (loss)

	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions)
Beer	$	757.3	$	710.0	$	47.3	7	%
Wine and Spirits	127.6		134.8		(7.2)		(5	%)
Corporate Operations and Other	(65.1)		(75.1)		10.0		13	%
Comparable Adjustments	(22.9)		(23.0)		0.1		NM
Consolidated operating income (loss)	$	796.9	$	746.7	$	50.2	7	%

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    39

MD&A Table of Contents

The increase in Beer operating income is largely attributable to the cost savings initiatives, shipment volume growth within our Mexican beer portfolio, and the favorable pricing impact, partially offset by higher material costs.

The decrease in Wine and Spirits operating income is largely attributable to the decline in branded wine and spirits shipment volume and unfavorable product mix, partially offset by the lower cost of product sold and general and administrative expenses.

As previously discussed, the Corporate Operations and Other decrease in operating loss is largely due to the lower Digital Business Acceleration investments, partially offset by increased compensation and benefits.

Income (loss) from unconsolidated investments

	Third Quarter 2024		Third Quarter 2023		Dollar Change		Percent Change
(in millions)
Impairment of equity method investments	$	(0.3)	$	—	$	(0.3)	NM
Unrealized net gain (loss) on securities measured at fair value	(11.0)		(7.4)		(3.6)		(49	%)
Equity in earnings (losses) from Canopy and related activities	(56.5)		(60.8)		4.3		7	%
Equity in earnings (losses) from other equity method investees and related activities	25.7		31.0		(5.3)		(17	%)
Net gain (loss) on sale of unconsolidated investment	0.3		0.0		0.3		NM
	$	(41.8)	$	(37.2)	$	(4.6)	(12	%)

Interest expense

Interest expense increased to $104.2 million for Third Quarter 2024 as compared to $98.7 million for Third Quarter 2023. This increase of $5.5 million, or 6%, is due to approximately $480 million of higher average borrowings and approximately 15 basis points of higher weighted average interest rates, partially offset by an increase in capitalized interest in connection with the Mexico Beer Projects. The higher average borrowings and weighted average interest rates are largely attributable to funding the aggregate cash payment to holders of Class B Stock in connection with the Reclassification. For additional information, refer to Note 8.

(Provision for) benefit from income taxes

The provision for income taxes decreased to $130.0 million for Third Quarter 2024 from $131.1 million for Third Quarter 2023. Our effective tax rate for Third Quarter 2024 was 20.0% as compared with 21.5% for Third Quarter 2023. In comparison to prior year, our income taxes were impacted primarily by the effective tax rates applicable to our foreign businesses.

For additional information, refer to Note 9.

Net income (loss) attributable to CBI

Net income attributable to CBI increased to $509.1 million for Third Quarter 2024 from $467.7 million for Third Quarter 2023. This increase of $41.4 million, or 9%, is largely attributable to (i) the Third Quarter 2024 improvements within the Beer segment driven by shipment volume growth and lower marketing spend outpacing the growth of cost of product sold, driven by the successful execution of cost savings initiatives and (ii) the lower Digital Business Acceleration investments within the Corporate Operations and Other segment. This favorability was partially offset by the performance decline in the Wine and Spirits segment.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    40

MD&A Table of Contents

Nine Months 2024 compared to Nine Months 2023

Net sales

	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions)
Beer	$	6,459.8	$	5,929.4	$	530.4	9	%
Wine and Spirits:
Wine	1,180.7		1,316.6		(135.9)		(10	%)
Spirits	182.1		208.8		(26.7)		(13	%)
Total Wine and Spirits	1,362.8		1,525.4		(162.6)		(11	%)
Consolidated net sales	$	7,822.6	$	7,454.8	$	367.8	5	%

	Beer segment	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions, branded product, 24-pack, 12-ounce case equivalents)
Net sales		$	6,459.8	$	5,929.4	$	530.4	9	%
Shipments		331.1		310.5				6.6	%
Depletions								7.2	%

The increase in Beer net sales is largely due to (i) $400.9 million of shipment volume growth within our Mexican beer portfolio, which benefited from continued consumer demand, and (ii) $139.9 million of favorable impact from pricing in select markets within our Mexican beer portfolio, partially offset by a $7.2 million decline from the Craft Beer Divestitures.

	Wine and Spirits segment	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions, branded product, 9-liter case equivalents)
Net sales		$	1,362.8	$	1,525.4	$	(162.6)	(11	%)
Shipments
Total		18.1		21.1				(14.2	%)
Organic (1)		18.1		20.5				(11.7	%)
U.S. Domestic		15.9		18.2				(12.6	%)
Organic U.S. Domestic (1)		15.9		17.8				(10.7	%)
Depletions (1)								(8.1	%)

(1)Includes an adjustment to remove volume associated with the Wine Divestiture for the period March 1, 2022, through October 5, 2022.

The decrease in Wine and Spirits net sales is due to a $124.1 million decrease in organic net sales and $38.5 million from the Wine Divestiture. The decrease in organic net sales is driven by a $165.9 million decrease in branded wine and spirits shipment volume, partially offset by (i) $26.2 million of favorable product mix, driven by consumer-led premiumization, and (ii) $16.4 million of favorable impact from pricing. The decrease in branded

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    41

MD&A Table of Contents

wine and spirits shipment volume is attributable to our U.S. wholesale market, primarily driven by declines in both the overall wine market and in our lower-end brands. The favorable impact from pricing was driven by price increases, partially offset by lower contractual distributor payments as compared to Nine Months 2023.

Gross profit

	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions)
Beer	$	3,366.5	$	3,156.6	$	209.9	7	%
Wine and Spirits	634.9		698.4		(63.5)		(9	%)
Comparable Adjustments	(23.1)		(47.2)		24.1		NM
Consolidated gross profit	$	3,978.3	$	3,807.8	$	170.5	4	%

The increase in Beer gross profit is primarily due to (i) $215.9 million of shipment volume growth and (ii) the $139.9 million favorable impact from pricing, partially offset by (i) $136.1 million of higher cost of product sold and (ii) $13.1 million of unfavorable product mix. The higher cost of product sold is primarily due to (i) $100.5 million of higher material costs, including malt, glass, aluminum, and starch, driven by inflation and global supply chain constraints, (ii) $32.2 million of higher depreciation resulting from the Mexico Beer Projects, (iii) $13.7 million of costs related to a voluntary product recall of select kegs for quality assurance, and (iv) a $15.0 million increase in brewery costs, including compensation and benefits and IT expenses, partially offset by (i) $23.9 million of decreased transportation costs and (ii) $6.5 million of lower inventory obsolescence as compared to Nine Months 2023. To partially offset the increases in cost of product sold we are executing initiatives that have resulted in approximately $105 million of net cost savings for Nine Months 2024.

The decrease in Wine and Spirits gross profit is due to a $40.8 million decrease in organic gross profit and $22.7 million from the Wine Divestiture. The decrease in organic gross profit is attributable to (i) an $80.0 million decrease in branded wine and spirits shipment volume and (ii) a $9.7 million decrease in non-branded gross profit on net sales, partially offset by (i) $35.1 million of lower cost of product sold and (ii) the $16.4 million favorable impact from pricing. The decrease in cost of product sold was largely attributable to (i) $23.1 million of decreased transportation and warehousing costs, including ocean freight shipping, and (ii) $12.0 million of cost savings initiatives, primarily resulting in lower grape costs, as well as lower materials and packaging costs, driven by our sustainable packaging projects.

Gross profit as a percent of net sales decreased to 50.9% for Nine Months 2024 compared with 51.1% for Nine Months 2023. This decrease was largely due to (i) approximately 160 basis points of rate decline from higher cost of product sold within the Beer segment, driven by the increase in material costs, and (ii) approximately 30 basis points of rate decline resulting from unfavorable product mix and lower-margin, non-branded net sales within the Wine and Spirits segment, partially offset by (i) approximately 80 basis points of favorable impact from Beer pricing in select markets, (ii) approximately 40 basis points of rate growth from lower cost of product sold within the Wine and Spirits segment, and (iii) a favorable change of approximately 30 basis points in Comparable Adjustments.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    42

MD&A Table of Contents

Selling, general, and administrative expenses

	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions)
Beer	$	857.5	$	818.2	$	39.3	5	%
Wine and Spirits	347.3		373.2		(25.9)		(7	%)
Corporate Operations and Other	181.8		218.7		(36.9)		(17	%)
Comparable Adjustments	51.4		21.5		29.9		NM
Consolidated selling, general, and administrative expenses	$	1,438.0	$	1,431.6	$	6.4	—	%

The increase in Beer selling, general, and administrative expenses is driven largely by $24.7 million and $14.6 million of increased general and administrative expenses and marketing spend, respectively. The increase in general and administrative expenses was driven primarily by (i) unfavorable foreign currency impact, (ii) higher compensation and benefits, primarily related to incremental headcount to support the growth of our Mexican beer portfolio, and (iii) increased legal expenses, partially offset by (i) decreased costs associated with the short-term incentive accrual as compared to Nine Months 2023, (ii) favorability from strategic asset relocation in Nine Months 2023, and (iii) the Craft Beer Divestitures. The increase in marketing spend is primarily driven by ongoing media investments to build awareness of our high-end imported beer brands, partially offset by the Craft Beer Divestitures.

The decrease in Wine and Spirits selling, general, and administrative expenses is largely due to a $20.5 million decrease in marketing spend driven by less planned media investments for our lower-end brands as compared to Nine Months 2023. General and administrative expenses also decreased driven by lower compensation and benefits and consulting services, partially offset by higher litigation expenses.

The decrease in Corporate Operations and Other selling, general, and administrative expenses is largely due to a $42 million reduction in third-party services, driven by lower Digital Business Acceleration investments, and a $3 million decrease in compensation and benefits, partially offset by a $5 million increase in IT project expenses as compared to Nine Months 2023. The decrease in compensation and benefits was led by favorability from the November 2022 Reclassification.

Selling, general, and administrative expenses as a percent of net sales decreased to 18.4% for Nine Months 2024 as compared with 19.2% for Nine Months 2023. The decrease is largely driven by (i) 80 basis points of rate decline as the increase in Beer net sales exceeded the increase in selling, general, and administrative expenses and (ii) approximately 55 basis points of rate decline from a decrease in the Corporate Operations and Other segment’s selling, general, and administrative expenses, partially offset by an unfavorable change in Comparable Adjustments, contributing approximately 45 basis points of rate growth.

Operating income (loss)

	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions)
Beer	$	2,509.0	$	2,338.4	$	170.6	7	%
Wine and Spirits	287.6		325.2		(37.6)		(12	%)
Corporate Operations and Other	(181.8)		(218.7)		36.9		17	%
Comparable Adjustments	(74.5)		(68.7)		(5.8)		NM
Consolidated operating income (loss)	$	2,540.3	$	2,376.2	$	164.1	7	%

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    43

MD&A Table of Contents

The increase in Beer operating income is largely attributable to the shipment volume growth within our Mexican beer portfolio, the favorable pricing impact, and the cost savings initiatives, partially offset by higher material costs.

The decrease in Wine and Spirits operating income is largely attributable to the decline in branded wine and spirits shipment volume and the Wine Divestiture, partially offset by the lower cost of product sold and marketing spend and the favorable pricing impact.

As previously discussed, the Corporate Operations and Other decrease in operating loss is largely due to the lower Digital Business Acceleration investments.

Income (loss) from unconsolidated investments

	Nine Months 2024		Nine Months 2023		Dollar Change		Percent Change
(in millions)
Impairment of equity method investments	$	(136.1)	$	(1,060.3)	$	924.2	87	%
Unrealized net gain (loss) on securities measured at fair value	(85.4)		(39.1)		(46.3)		(118	%)
Equity in earnings (losses) from Canopy and related activities	(288.3)		(876.5)		588.2		67	%
Equity in earnings (losses) from other equity method investees	32.1		31.7		0.4		1	%
Net gain (loss) on sale of unconsolidated investment	0.3		0.0		0.3		NM
	$	(477.4)	$	(1,944.2)	$	1,466.8	75	%

Interest expense

Interest expense increased to $333.0 million for Nine Months 2024 as compared to $281.5 million for Nine Months 2023. This increase of $51.5 million, or 18%, is due to $1.1 billion of higher average borrowings and approximately 35 basis points of higher weighted average interest rates, partially offset by an increase in capitalized interest in connection with the Mexico Beer Projects. The higher average borrowings and weighted average interest rates are largely attributable to funding the aggregate cash payment to holders of Class B Stock in connection with the Reclassification. For additional information, refer to Note 8.

Loss on extinguishment of debt

Loss on extinguishment of debt primarily consists of a premium payment and the write-off of debt issuance costs in connection with the tender offers of our 3.20% February 2018 Senior Notes and 4.25% May 2013 Senior Notes and make-whole payments in connection with the early redemption of those notes (Nine Months 2023).

(Provision for) benefit from income taxes

The provision for income taxes decreased to $368.4 million for Nine Months 2024 from $388.9 million for Nine Months 2023. Our effective tax rate for Nine Months 2024 was 21.3% as compared with 305.7% for Nine Months 2023. In comparison to prior year, our income taxes were impacted primarily by:

•an increase in the valuation allowance related to our investment in Canopy, driven by the Canopy Equity Method Investment impairment recognized in the Nine Months 2023; offset by

•a net income tax benefit from the realization of tax losses related to a prior period divestiture recognized in the Nine Months 2023; and

•the effective tax rates applicable to our foreign businesses.

For additional information, refer to Note 9.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    44

MD&A Table of Contents

We continue to expect our reported effective tax rate for Fiscal 2024 to be in the range of 19% to 21%. This range does not reflect any future equity in earnings (losses) from the Canopy Equity Method Investment and related activities.

Net income (loss) attributable to CBI

Net income (loss) attributable to CBI increased to $1,335.0 million for Nine Months 2024 from $(294.0) million for Nine Months 2023. This increase of $1,629.0 million is primarily attributable to (i) lower impairment and other losses related to our investment in Canopy and (ii) the Nine Months 2024 improvements within the Beer segment as shipment volume growth exceeded the growth of cost of product sold, driven by the successful execution of cost savings initiatives.

Liquidity and Capital Resources

General

Our primary source of liquidity has been cash flow from operating activities. Our ability to consistently generate robust cash flow from our operations is one of our most significant financial strengths; it enables us to invest in our people and our brands, make capital investments and strategic acquisitions, provide a cash dividend program, and from time-to-time, repurchase shares of our common stock. Our largest use of cash in our operations is for purchasing and carrying inventories and carrying seasonal accounts receivable. Historically, we have used this cash flow to repay our short-term borrowings and fund capital expenditures. Additionally, our commercial paper program is used to fund our short-term borrowing requirements and to maintain our access to the capital markets. We use our short-term borrowings, including our commercial paper program, to support our working capital requirements and capital expenditures, among other things.

We seek to maintain adequate liquidity to meet working capital requirements, fund capital expenditures, and repay scheduled principal and interest payments on debt. Absent deterioration of market conditions, we believe that cash flows from operating and financing activities will provide adequate resources to satisfy our working capital, scheduled principal and interest payments on debt, anticipated dividend payments, periodic share repurchases, and anticipated capital expenditure requirements for both our short-term and long-term capital needs.

We have an agreement with a financial institution for payment services and began to facilitate a voluntary supply chain finance program through this participating financial institution during Fiscal 2023. The program is available to certain of our suppliers allowing them the option to manage their cash flow. We are not a party to the agreements between the participating financial institution and the suppliers in connection with the program. Our rights and obligations to our suppliers, including amounts due and scheduled payment terms, are not impacted. As of November 30, 2023, the amount payable to this participating financial institution for suppliers who voluntarily participate in the supply chain finance program was $5.6 million and was included in accounts payable within our consolidated balance sheet. We account for payments made under the supply chain finance program the same as our other accounts payable, as a reduction to our cash flow from operating activities.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    45

MD&A Table of Contents

Cash Flows

	Nine Months 2024		Nine Months 2023		Dollar Change
(in millions)
Net cash provided by (used in):
Operating activities	$	2,346.8	$	2,280.6	$	66.2
Investing activities	(929.9)		(646.6)		(283.3)
Financing activities	(1,472.4)		(1,645.9)		173.5
Effect of exchange rate changes on cash and cash equivalents	0.7		(2.5)		3.2
Net increase (decrease) in cash and cash equivalents	$	(54.8)	$	(14.4)	$	(40.4)

Operating activities

The increase in net cash provided by (used in) operating activities consists of:

	Nine Months 2024		Nine Months 2023		Dollar Change
(in millions)
Net income (loss)	$	1,360.8	$	(261.7)	$	1,622.5
Unrealized net (gain) loss on securities measured at fair value	85.4		39.1		46.3
Deferred tax provision (benefit)	28.2		218.4		(190.2)
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	257.3		845.4		(588.1)
Impairment of equity method investments	136.1		1,060.3		(924.2)
Other non-cash adjustments	550.0		518.6		31.4
Change in operating assets and liabilities, net of effects from purchase and sale of business	(71.0)		(139.5)		68.5
Net cash provided by (used in) operating activities	$	2,346.8	$	2,280.6	$	66.2

The $68.5 million net change in operating assets and liabilities was largely driven by an increase in inventory levels for the Beer segment. These changes were partially offset by the timing of collections for (i) recoverable value-added taxes for the Beer segment and (ii) accounts payable for both the Beer and Wine and Spirits segments.

Investing activities

Net cash used in investing activities increased to $929.9 million for Nine Months 2024 from $646.6 million for Nine Months 2023. This increase of $283.3 million, or 44%, was primarily due to (i) $228.1 million of additional capital expenditures for Nine Months 2024 largely related to the Mexico Beer Projects and (ii) $91.3 million of reduced proceeds from the sale of business, driven by the 2022 Wine Divestiture. These increases were partially offset by a $29.6 million decrease in business acquisitions for Nine Months 2024. The Nine Months 2023 business acquisitions consisted of Lingua Franca and Austin Cocktails.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    46

MD&A Table of Contents

Financing activities

The decrease in net cash provided by (used in) financing activities consists of:

	Nine Months 2024		Nine Months 2023		Dollar Change
(in millions)
Net proceeds from (payments of) debt, current and long-term, and related activities	$	(774.4)	$	1,707.0	$	(2,481.4)
Dividends paid	(491.1)		(441.1)		(50.0)
Purchases of treasury stock	(249.7)		(1,400.5)		1,150.8
Net cash provided by stock-based compensation activities	77.8		26.2		51.6
Distributions to noncontrolling interests	(35.0)		(37.5)		2.5
Payment to holders of Class B Stock in connection with the Reclassification	—		(1,500.0)		1,500.0
Net cash provided by (used in) financing activities	$	(1,472.4)	$	(1,645.9)	$	173.5

Debt

Total debt outstanding as of November 30, 2023, amounted to $11,698.5 million, a decrease of $762.8 million, or 6%, from February 28, 2023. This decrease consisted of:

Debt repayment Debt issuance

Bank facilities

In May 2023, we repaid the outstanding three-year term loan facility borrowings under our August 2022 Term Credit Agreement with proceeds from the May 2023 Senior Notes (see “Senior notes” below). In August 2023, we repaid the outstanding five-year term loan facility borrowings under our April 2022 Term Credit Agreement with proceeds from commercial paper borrowings.

Senior notes

In May 2023, we issued the May 2023 Senior Notes. Proceeds from this offering, net of discount and debt issuance costs, of $739.8 million were used for general corporate purposes, including the repayment of outstanding borrowings under the August 2022 Term Credit Agreement and to reduce outstanding commercial paper borrowings.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    47

MD&A Table of Contents

General

The majority of our outstanding borrowings as of November 30, 2023, consisted of fixed-rate senior unsecured notes, with maturities ranging from calendar 2024 to calendar 2050.

Additionally, we have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.25 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility.

We do not have purchase commitments from buyers for our commercial paper and, therefore, our ability to issue commercial paper is subject to market demand. If the commercial paper market is not available to us for any reason when commercial paper borrowings mature, we will utilize unused commitments under our revolving credit facility under our 2022 Credit Agreement to repay commercial paper borrowings. We do not expect that fluctuations in demand for commercial paper will affect our liquidity given our borrowing capacity available under our revolving credit facility.

We had the following remaining borrowing capacity available under our 2022 Credit Agreement:

	November 30, 2023		December 31, 2023
(in millions)
Revolving credit facility (1)	$	1,779.0	$	1,915.5

(1)Net of outstanding revolving credit facility borrowings and outstanding letters of credit under our 2022 Credit Agreement and outstanding borrowings under our commercial paper program (excluding unamortized discount) of $459.5 million and $323.0 million as of November 30, 2023, and December 31, 2023, respectively.

The financial institutions participating in our 2022 Credit Agreement have complied with prior funding requests and we believe they will comply with any future funding requests. However, there can be no assurances that any particular financial institution will continue to do so.

As of November 30, 2023, we and our subsidiaries were subject to covenants that are contained in our 2022 Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio, both as defined in our 2022 Credit Agreement. As of November 30, 2023, under our 2022 Credit Agreement, the minimum interest coverage ratio was 2.5x and the maximum net leverage ratio was 4.0x.

Our indentures relating to our outstanding senior notes contain certain covenants, including, but not limited to: (i) a limitation on liens on certain assets, (ii) a limitation on certain sale and leaseback transactions, and (iii) restrictions on mergers, consolidations, and the transfer of all or substantially all of our assets to another person.

As of November 30, 2023, we were in compliance with our covenants under our 2022 Credit Agreement and our indentures, and have met all debt payment obligations.

For further discussion and presentation of our borrowings and available sources of borrowing, refer to Note 12 of our consolidated financial statements included in our 2023 Annual Report and Note 8.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    48

MD&A Table of Contents

Common Stock Dividends

On January 4, 2024, our Board of Directors declared a quarterly cash dividend of $0.89 per share of Class A Stock and $0.80 per share of Class 1 Stock payable on February 22, 2024, to stockholders of record of each class as of the close of business on February 8, 2024.

We currently expect to continue to pay a regular quarterly cash dividend to stockholders of our common stock in the future, but such payments are subject to approval of our Board of Directors and are dependent upon our financial condition, results of operations, capital requirements, and other factors, including those set forth under Item 1A. “Risk Factors” of our 2023 Annual Report as supplemented by the additional factors set forth under Item 1A. “Risk Factors” included in this Form 10-Q.

Share Repurchase Program

Our Board of Directors authorized the repurchase of our publicly traded common stock of up to $2.0 billion under the 2021 Authorization and an additional repurchase of up to $2.0 billion under the 2023 Authorization.

As of November 30, 2023, total shares repurchased under the 2021 Authorization and the 2023 Authorization are as follows:

			Class A Stock
	Repurchase Authorization		Dollar Value of Shares Repurchased		Number of Shares Repurchased
(in millions, except share data)
2021 Authorization	$	2,000.0	$	1,386.3	5,875,276
2023 Authorization	$	2,000.0	$	—	—

Share repurchases under the 2021 Authorization and 2023 Authorization may be accomplished at management’s discretion from time to time based on market conditions, our cash and debt position, and other factors as determined by management. Shares may be repurchased through open market or privately negotiated transactions. We may fund future share repurchases with cash generated from operations and/or proceeds from borrowings. Any repurchased shares will become treasury shares, including shares previously repurchased under the 2021 Authorization.

We currently expect to continue to repurchase shares in the future, but such repurchases are dependent upon our financial condition, results of operations, capital requirements, and other factors, including those set forth under Item 1A. “Risk Factors” of our 2023 Annual Report as supplemented by the additional factors set forth under Item 1A. “Risk Factors” included in this Form 10-Q.

For additional information, refer to Note 17 of our consolidated financial statements included in our 2023 Annual Report and Note 10.

Accounting Guidance

Accounting guidance adopted for Nine Months 2024 did not have a material impact on our Financial Statements.

Information Regarding Forward-Looking Statements

This Form 10-Q contains “forward-looking statements” within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act. These forward-looking statements are subject to a number of risks and

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    49

MD&A Table of Contents

uncertainties, many of which are beyond our control, which could cause actual results to differ materially from those set forth in, or implied by, such forward-looking statements. All statements other than statements of historical fact included in this Form 10-Q are forward-looking statements, including without limitation:

•The statements under MD&A regarding:

◦our business strategy, growth plans, innovation, and Digital Business Acceleration initiatives, new products, future operations, financial position, net sales, expenses, cost savings initiatives, capital expenditures, effective tax rates and anticipated tax liabilities, expected volume, inventory, supply, and demand levels, balance, and trends, long-term financial model, access to capital markets, liquidity and capital resources, and prospects, plans, and objectives of management;

◦our beer expansion, optimization, and/or construction activities, including anticipated scope, capacity, costs, capital expenditures, and timeframes for completion;

◦the potential sale of the remaining assets at the Mexicali Brewery;

◦our ESG strategy, sustainability initiatives, and environmental stewardship targets;

◦anticipated inflationary pressures, changing prices, and reductions in consumer discretionary income as well as other unfavorable global and regional economic conditions, and geopolitical events, and our responses thereto;

◦the potential impact to supply, production levels, and costs due to global supply chain disruptions and constraints and shifting consumer behaviors;

◦expected or potential actions of third parties, including possible changes to laws, rules, and regulations;

◦the availability of a supply chain finance program;

◦the manner, timing, and duration of the share repurchase program and source of funds for share repurchases; and

◦the amount and timing of future dividends.

•The statements regarding:

◦the potential completion of the Canopy Transaction, including the Canopy Amendment, and the transactions contemplated by the Consent Agreement, including conversion of our Canopy common shares for Exchangeable Shares, and related results and impacts of such transactions;

◦the potential exchange of our 2023 Canopy Promissory Note for Exchangeable Shares;

◦our activities surrounding our investment in Canopy;

◦a potential future impairment of our Canopy Equity Method Investment; and

◦our future ownership level in Canopy and our future share of Canopy’s reported earnings and losses.

•The statements regarding the future reclassification of net gains from AOCI.

When used in this Form 10-Q, the words “anticipate,” “intend,” “expect,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. All forward-looking statements speak only as of the date of this Form 10-Q. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct. In addition to the risks and uncertainties of ordinary business operations and conditions in the general economy and markets in which we compete, our forward-looking statements contained in this Form 10-Q are also subject to the risk, uncertainty, and possible variance from our current expectations regarding:

•water, agricultural and other raw material, and packaging material supply, production, and/or shipment difficulties which could adversely affect our ability to supply our customers;

•the ability to respond to anticipated inflationary pressures, including reductions in consumer discretionary income and our ability to pass along rising costs through increased selling prices;

•the actual impact to supply, production levels, and costs from global supply chain disruptions and constraints, transportation challenges (including from labor strikes or other labor activities), shifting consumer behaviors, wildfires, and severe weather events, due to, among other reasons, actual supply chain and transportation performance, actual consumer behaviors, and the actual severity and geographical reach of wildfires and severe weather events;

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    50

MD&A Table of Contents

•reliance on complex information systems and third‐party global networks;

•the actual balance of supply and demand for our products, the actual performance of our distributors and the actual demand, net sales, channel proportions, and volume trends for our products due to, among other reasons, actual shipments to distributors and actual consumer demand;

•beer operations expansion, optimization, and/or construction activities, scope, capacity, supply, costs (including impairments), capital expenditures, and timing due to, among other reasons, market conditions, our cash and debt position, receipt of required regulatory approvals by the expected dates and on the expected terms, and other factors as determined by management;

•results of the potential sale of the remaining assets at the Mexicali Brewery or obtaining other forms of recovery;

•the impact of the military conflicts in Ukraine and in Israel and surrounding areas, geopolitical tensions, and responses, including on inflation, supply chains, commodities, energy, and cybersecurity;

•contamination and degradation of product quality from diseases, pests, weather, and other conditions;

•communicable disease outbreaks, pandemics, or other widespread public health crises, such as the COVID-19 pandemic, and associated governmental containment actions, which may include the closure of non-essential businesses (including our manufacturing facilities);

•the amount, timing, and source of funds for any share repurchases, which may vary due to market conditions, our cash and debt position, the impact of the beer operations expansion, optimization, and/or construction activities, and other factors as determined by management from time to time;

•the amount and timing of future dividends which are subject to the determination and discretion of our Board of Directors and may be impacted if our ability to use cash flow to fund dividends is affected by unanticipated increases in total net debt, we are unable to generate cash flow at anticipated levels, or we fail to generate expected earnings;

•the accuracy of management’s projections relating to the Canopy investment due to Canopy’s actual results and market and economic conditions, and the impact of our investment in Canopy, including recording our proportional share of Canopy’s estimated pre-tax losses;

•the timeframe and amount of any potential future impairment of our Canopy Equity Method Investment;

•Canopy’s failure to receive the requisite approval of its shareholders necessary to approve the Canopy Transaction, any other delays with respect to, or the failure to complete, the Canopy Transaction, the ability to recognize the anticipated benefits of the Canopy Transaction and the impact of the Canopy Transaction on the market price of Canopy’s common stock;

•completion of the Canopy Transaction, the exchange of our 2023 Canopy Promissory Note for Exchangeable Shares, and the impact from converting our Canopy common shares for Exchangeable Shares on our relationship with and investment in Canopy;

•any impact of U.S. federal laws on Canopy Strategic Transactions or upon the implementation of such Canopy Strategic Transactions, or the impact of any Canopy Strategic Transaction upon our future ownership level in Canopy or our future share of Canopy’s reported earnings and losses;

•the expected impacts and results of our wine and spirits portfolio reshaping and leadership transition as well as of our efforts for our wine and spirits business to become a global, omni-channel competitor;

•purchase accounting with respect to any transaction, or the assumptions used regarding the assets purchased and liabilities assumed to determine their fair value;

•general economic, geopolitical, domestic, international, and regulatory conditions, world financial market and banking sector instability, including economic slowdown or recession, and any potential U.S. federal government shutdown;

•the ability to continue to recognize anticipated benefits of the Reclassification; and

•our targeted net leverage ratio due to market conditions, our ability to generate cash flow at expected levels, and our ability to generate expected earnings.

For additional information about risks and uncertainties that could cause actual results to differ materially from those set forth in or implied by our forward-looking statements, please refer to Item 1A. “Risk Factors” of our 2023 Annual Report as supplemented by the additional factors set forth under Item 1A. “Risk Factors” included in this Form 10-Q.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    51

OTHER KEY INFORMATION Table of Contents

Item 3.    Quantitative and Qualitative Disclosures About Market Risk.

As a result of our global operating, investment, acquisition, divestiture, and financing activities, we are exposed to market risk associated with changes in foreign currency exchange rates, commodity prices, and interest rates. To manage the volatility relating to these risks, we periodically purchase and/or sell derivative instruments including foreign currency forward and option contracts, commodity swap contracts, interest rate swap contracts, and Pre-issuance hedge contracts. We use derivative instruments to reduce earnings and cash flow volatility resulting from shifts in market rates, as well as to hedge economic exposures. We do not enter into derivative instruments for trading or speculative purposes.

Foreign currency and commodity price risk

Foreign currency derivative instruments are or may be used to hedge existing foreign currency denominated assets and liabilities, forecasted foreign currency denominated sales/purchases to/from third parties as well as intercompany sales/purchases, intercompany principal and interest payments, and in connection with investments, acquisitions, or divestitures outside the U.S. As of November 30, 2023, we had exposures to foreign currency risk primarily related to the Mexican peso, Canadian dollar, New Zealand dollar, and euro. Approximately 100% of our balance sheet exposures and 87% of our forecasted transactional exposures for the remaining three months of Fiscal 2024 were hedged as of November 30, 2023.

Commodity derivative instruments are or may be used to hedge forecasted commodity purchases from third parties as either economic hedges or accounting hedges. As of November 30, 2023, exposures to commodity price risk which we are currently hedging include aluminum, corn, diesel fuel, and natural gas prices. Approximately 84% of our forecasted transactional exposures for the remaining three months of Fiscal 2024 were hedged as of November 30, 2023.

We have performed a sensitivity analysis to estimate our exposure to market risk of foreign exchange rates and commodity prices reflecting the impact of a hypothetical 10% adverse change in the applicable market. The volatility of the applicable rates and prices is dependent on many factors which cannot be forecasted with reliable accuracy. Gains or losses from the revaluation or settlement of the related underlying positions would substantially offset such gains or losses on the derivative instruments. The aggregate notional value, estimated fair value, and sensitivity analysis for our open foreign currency and commodity derivative instruments are summarized as follows:

	Aggregate Notional Value				Fair Value, Net Asset (Liability)				Increase (Decrease) in Fair Value – Hypothetical 10% Adverse Change
	November 30, 2023		November 30, 2022		November 30, 2023		November 30, 2022		November 30, 2023		November 30, 2022
(in millions)
Foreign currency contracts	$	2,812.2	$	2,766.3	$	316.5	$	172.1	$	(185.1)	$	(191.3)
Commodity derivative contracts	$	383.9	$	341.1	$	(21.8)	$	45.0	$	31.4	$	(34.3)

Interest rate risk

The estimated fair value of our fixed interest rate debt is subject to interest rate risk, credit risk, and foreign currency risk. In addition, we also have variable interest rate debt outstanding (primarily SOFR-based), certain of which includes a fixed margin subject to the same risks identified for our fixed interest rate debt.

As of November 30, 2023, we had $125.0 million outstanding cash flow designated, Pre-issuance hedge contracts which fixed our three-year interest rates to minimize interest rate volatility on our future debt issuances. There were no other cash flow designated or undesignated interest rate swap contracts or Pre-issuance hedge contracts outstanding as of November 30, 2023, or November 30, 2022. Subsequently, in December 2023, we entered into additional cash flow designated, Pre-issuance hedge contracts, for $150.0 million of future debt issuances.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    52

OTHER KEY INFORMATION Table of Contents

We have performed a sensitivity analysis to estimate our exposure to market risk of interest rates reflecting the impact of a hypothetical 1% increase in the prevailing interest rates. The volatility of the applicable rates is dependent on many factors which cannot be forecasted with reliable accuracy.

The aggregate notional value, estimated fair value, and sensitivity analysis for our outstanding fixed-rate debt, including current maturities, are summarized as follows:

	Aggregate Notional Value				Fair Value, Net Asset (Liability)				Increase (Decrease) in Fair Value – Hypothetical 1% Rate Increase
	November 30, 2023		November 30, 2022		November 30, 2023		November 30, 2022		November 30, 2023		November 30, 2022
(in millions)
Fixed interest rate debt	$	11,320.0	$	10,077.8	$	(10,320.7)	$	(9,205.0)	$	(599.2)	$	(620.2)
Pre-issuance hedge contracts	$	125.0	$	—	$	(0.1)	$	—	$	(3.2)	$	—

A 1% hypothetical change in the prevailing interest rates would have increased interest expense on our variable interest rate debt by $6.7 million and $6.6 million for the nine months ended November 30, 2023, and November 30, 2022, respectively.

For additional discussion on our market risk, refer to Notes 3 and 4.

Item 4.    Controls and Procedures.

Disclosure controls and procedures

Our Chief Executive Officer and our Chief Financial Officer have concluded, based on their evaluation as of the end of the period covered by this report, that the Company’s “disclosure controls and procedures” (as defined in the Exchange Act Rules 13a-15(e) and 15d-15(e)) are effective to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act (i) is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and (ii) is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Internal control over financial reporting

In connection with the foregoing evaluation by our Chief Executive Officer and our Chief Financial Officer, no changes were identified in the Company’s “internal control over financial reporting” (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during our fiscal quarter ended November 30, 2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    53

OTHER KEY INFORMATION Table of Contents

PART II – OTHER INFORMATION

Item 1. Legal Proceedings.

For additional information regarding Legal Proceedings, see Item 1A. “Risk Factors.”

Item 1A. Risk Factors.

In addition to information discussed elsewhere in this Form 10-Q, you should carefully consider the risk factors disclosed in the 2023 Annual Report. The risk factors associated with our business have not materially changed compared to the risk factors disclosed in the 2023 Annual Report except for the updated risk factor below. The risk factor described below and the additional risks described in the 2023 Annual Report are not the only risks we face. Additional factors not presently known to us or that we currently deem to be immaterial could materially affect our business, liquidity, financial condition, and/or results of operations in future periods. The following risk factor is organized under a relevant heading; however, it may be relevant to other headings as well.

Strategic Risks

Dependence upon trademarks and proprietary rights, failure to protect our intellectual property rights

Our future success depends significantly on our ability to protect our current and future brands and products and to defend our intellectual property rights. We have been granted numerous trademark registrations and use certain trademarks under license covering our brands and products, and we have filed, and expect to continue to file or have filed on our behalf, trademark applications seeking to protect newly developed brands and products. We cannot be sure that trademark registrations will be issued with respect to any of such trademark applications. We could also, by omission, fail to timely renew or protect a trademark and our competitors could challenge, invalidate, or circumvent any existing or future trademarks issued to, or licensed by, us.

Our subsidiaries CB Brand Strategies, LLC, Crown Imports LLC, and Compañía Cervecera de Coahuila, S. de R.L. de C.V. were named as defendants in a lawsuit originally filed in U.S. District Court for the Southern District of New York on February 15, 2021, and most recently amended on March 16, 2022, by Cervecería Modelo de México, S. de R.L. de C.V. and Trademarks Grupo Modelo, S. de R.L. de C.V. captioned Cervecería Modelo de México, S. de R.L. de C.V., et al. v. CB Brand Strategies, LLC, et al., Case No. 21 Civ. 01317-LAK (S.D.N.Y.). The plaintiffs alleged, among other things, that our sub-license of the trademarks for our Mexican beer brands should not permit us to use the Corona brand name on our Corona Hard Seltzer or the Modelo brand name on our Modelo Ranch Water. On August 5, 2022, both the plaintiffs and the defendants filed motions for summary judgment. On November 3, 2022, the court denied our motion for summary judgment. On December 13, 2022, the court denied plaintiffs’ motion for summary judgment. At a trial in March 2023, the jury returned a unanimous verdict in our favor on all counts in the plaintiffs’ complaint, and the court entered judgment dismissing the complaint on March 15, 2023. On April 12, 2023, the plaintiffs filed a motion for judgment as a matter of law or, in the alternative, for a new trial with the court, which motion was denied on April 14, 2023.

On May 12, 2023, the plaintiffs filed a notice of appeal to the U.S. Court of Appeals for the Second Circuit from the final judgment entered in the above-captioned case, rulings and orders incorporated in, antecedent to, or ancillary to that final judgment, and the court’s order denying the plaintiffs’ motion for judgment as a matter of law or, in the alternative, for a new trial in that action. The appeal is captioned Cervecería Modelo de México, S. de R.L. de C.V., et al. v. CB Brand Strategies, LLC, et al., Case No. 23-810 (2d Cir.). The plaintiffs’ principal brief was filed on August 22, 2023, our response brief was filed on November 21, 2023, and plaintiffs’ reply brief was filed on December 12, 2023. The appeal remains pending.

While we continue to believe this lawsuit is without merit, litigation is inherently unpredictable and subject to substantial uncertainties and unfavorable developments and resolutions could occur. In addition, our cost of defending this litigation has been and could continue to be substantial. If we are not successful, we may not be able to market Corona Hard Seltzer in its current formulation under the Corona brand name or Modelo Ranch Water product in its current formulation under the Modelo brand name and we may be required to pay

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    54

OTHER KEY INFORMATION Table of Contents

damage awards, each of which may have an adverse effect on our business, liquidity, financial condition and/or results of operations.

We have been and may continue to be subject to other litigation related to our trademarks and intellectual property rights. A substantial adverse judgment or other unfavorable resolution of these matters or our failure to otherwise protect our intellectual property rights as well as the costs associated with such activities could have a material adverse effect on our business, liquidity, financial condition, and/or results of operations.

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds.

Issuer Purchases of Equity Securities

Period	Total Number of Shares Purchased	Average Price Paid Per Share		Total Number of Shares Purchased as Part of a Publicly Announced Program	Approximate Dollar Value of Shares that May Yet Be Purchased Under the Program (1)(2)
(in millions, except share and per share data)
September 1 – 30, 2023	—	$	—	—	$	828.4
October 1 – 31, 2023	—	$	—	—	$	828.4
November 1 – 30, 2023	889,429	$	241.42	889,429	$	2,613.7
Total	889,429	$	241.42	889,429

(1)In January 2021, we announced that our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock under the 2021 Authorization. The Board of Directors did not specify a date upon which the 2021 Authorization would expire. Share repurchases for the periods included herein were effected through open market transactions and exclude the impact of Federal excise tax owed pursuant to the IRA.

(2)In November 2023, we announced that our Board of Directors authorized an additional repurchase of up to $2.0 billion of our publicly traded common stock under the 2023 Authorization. The Board of Directors did not specify a date upon which the 2023 Authorization would expire. No shares have been repurchased under the 2023 Authorization.

Item 5.    Other Information.

During the three months ended November 30, 2023, none of our directors or officers (as defined in Exchange Act Rule 16a-1(f)) adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408 of Regulation S-K.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    55

OTHER KEY INFORMATION Table of Contents

Item 6.    Exhibits.

		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date
2.1	Subscription Agreement, dated as of August 14, 2018, by and between CBG Holdings LLC and Canopy, including, among other things, a form of the Amended and Restated Investor Rights Agreement. †	8-K	2.1	August 16, 2018
2.2	Foreign Exchange Rate Agreement dated October 26, 2018, between CBG Holdings LLC and Canopy.	10-Q	2.2	January 9, 2019
3.1	Amended and Restated Certificate of Incorporation of the Company.	8-K	3.1	November 10, 2022
3.2	Amended and Restated By-Laws of the Company.	8-K	3.2	November 10, 2022
4.1	Indenture, dated as of April 17, 2012, by and among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.1	April 23, 2012
4.2	Supplemental Indenture No. 5, dated as of June 7, 2013, among the Company, Constellation Brands Beach Holdings, Inc., Crown Imports LLC, and M&T, as Trustee.	8-K	4.4	June 11, 2013
4.3	Supplemental Indenture No. 6, dated as of May 28, 2014, among the Company, Constellation Marketing Services, Inc., and M&T, as Trustee.	10-Q	4.21	July 10, 2014
4.4	Supplemental Indenture No. 8, with respect to 4.750% Senior Notes due 2024, dated as of November 3, 2014, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.2	November 7, 2014
4.5	Supplemental Indenture No. 9, with respect to 4.750% Senior Notes due 2025, dated as of December 4, 2015, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.1	December 8, 2015
4.6	Supplemental Indenture No. 10, dated as of January 15, 2016, among the Company, Home Brew Mart, Inc., and M&T, as Trustee.	10-K	4.26	April 25, 2016
4.7	Supplemental Indenture No. 11 with respect to 3.700% Senior Notes due 2026, dated as of December 6, 2016, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.1	December 6, 2016
4.8	Supplemental Indenture No. 13 with respect to 3.500% Senior Notes due 2027, dated as of May 9, 2017, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.2	May 9, 2017
4.9	Supplemental Indenture No. 14 with respect to 4.500% Senior Notes due 2047, dated as of May 9, 2017, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.3	May 9, 2017
4.10	Supplemental Indenture No. 19 with respect to 3.600% Senior Notes due 2028, dated as of February 7, 2018, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.2	February 7, 2018
4.11	Supplemental Indenture No. 20 with respect to 4.100% Senior Notes due 2048, dated as of February 7, 2018, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.3	February 7, 2018
4.12	Supplemental Indenture No. 22 with respect to 4.400% Senior Notes due 2025, dated as of October 29, 2018, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.2	October 29, 2018

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    56

OTHER KEY INFORMATION Table of Contents

		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date
4.13	Supplemental Indenture No. 23 with respect to 4.650% Senior Notes due 2028, dated as of October 29, 2018, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.3	October 29, 2018
4.14	Supplemental Indenture No. 24 with respect to 5.250% Senior Notes due 2048, dated as of October 29, 2018, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.4	October 29, 2018
4.15	Supplemental Indenture No. 25 with respect to 3.150% Senior Notes due 2029, dated as of July 29, 2019, among the Company, as Issuer, certain subsidiaries, as Guarantors, and M&T, as Trustee.	8-K	4.1	July 29, 2019
4.16	Supplemental Indenture No. 26 with respect to 2.875% Senior Notes due 2030, dated as of April 27, 2020, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.1	April 27, 2020
4.17	Supplemental Indenture No. 27 with respect to 3.750% Senior Notes due 2050, dated as of April 27, 2020, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.2	April 27, 2020
4.18	Supplemental Indenture No. 28 with respect to 2.250% Senior Notes due 2031, dated as of July 26, 2021, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.1	July 26, 2021
4.19	Supplemental Indenture No. 29 with respect to 3.600% Senior Notes due 2024, dated as of May 9, 2022, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.1	May 9, 2022
4.20	Supplemental Indenture No. 30 with respect to 4.350% Senior Notes due 2027, dated as of May 9, 2022, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.2	May 9, 2022
4.21	Supplemental Indenture No. 31 with respect to 4.750% Senior Notes due 2032, dated as of May 9, 2022, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.3	May 9, 2022
4.22	Supplemental Indenture No. 32 with respect to 5.000% Senior Notes due 2026, dated as of February 2, 2023, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.1	February 2, 2023
4.23	Supplemental Indenture No. 33 with respect to 4.900% Senior Notes due 2033, dated as of May 1, 2023, among the Company, as Issuer, and M&T, as Trustee.	8-K	4.1	May 1, 2023
4.24	Restatement Agreement, dated as of April 14, 2022, by and among the Company, CB International, Bank of America, N.A., as Administrative Agent, and the Lenders party thereto, including the Tenth Amended and Restated Credit Agreement dated as of April 14, 2022, by and among the Company, CB International, Bank of America, N.A., as Administrative Agent, and the Lenders party thereto. †	8-K	4.1	April 15, 2022
4.25	Amendment No. 1, dated as of October 18, 2022, to Tenth Amended and Restated Credit Agreement, dated as of April 14, 2022, by and among the Company, CB International Finance S.à r.l., Bank of America, N.A., as Administrative Agent, and the Lenders party thereto. †	8-K	4.2	October 26, 2022
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act (filed herewith).

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    57

OTHER KEY INFORMATION Table of Contents

		Incorporated by Reference
Exhibit No.	Exhibit Description	Form	Exhibit	Filing Date
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Exchange Act (filed herewith).
32.1	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350 (furnished herewith).
32.2	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350 (furnished herewith).
99.1	Consent Agreement, dated April 18, 2019, by and between CBG Holdings LLC and Canopy (Form 6-K filed by Canopy).	6-K	99.4	April 30, 2019
99.2	Second Amended and Restated Investor Rights Agreement, dated April 18, 2019, by and among Greenstar Canada Investment Limited Partnership, CBG Holdings LLC and Canopy (Form 6-K filed by Canopy).	6-K	99.3	April 30, 2019
99.3	Consent Agreement, dated October 24, 2022, by and between CBG Holdings LLC, Greenstar Canada Investment Limited Partnership and Canopy. †	8-K	99.2	October 26, 2022
101.INS	XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document (filed herewith).
101.SCH	XBRL Taxonomy Extension Schema Document (filed herewith).
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document (filed herewith).
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document (filed herewith).
101.LAB	XBRL Taxonomy Extension Labels Linkbase Document (filed herewith).
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document (filed herewith).
104	Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

† The exhibits, disclosure schedules, and other schedules, as applicable, have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The Company agrees to furnish supplementally a copy of such exhibits, disclosure schedules, and other schedules, as applicable, or any section thereof, to the SEC upon request.

The Company agrees, upon request of the SEC, to furnish copies of each instrument that defines the rights of holders of long-term debt of the Company or its subsidiaries that is not filed herewith pursuant to Item 601(b)(4)(iii)(A) because the total amount of long-term debt authorized under such instrument does not exceed 10% of the total assets of the Company and its subsidiaries on a consolidated basis.

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    58

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

		CONSTELLATION BRANDS, INC.
Date:	January 5, 2024	By:	/s/ Darrell Hearne
			Darrell Hearne, Senior Vice President and Controller
Date:	January 5, 2024	By:	/s/ Garth Hankinson
			Garth Hankinson, Executive Vice President and Chief Financial Officer (principal financial officer and principal accounting officer)

Constellation Brands, Inc. Q3 FY 2024 Form 10-Q #WORTHREACHINGFOR    I    59

EX-31.1

Exhibit 31.1

RULE 13a-14(a)/15d-14(a) CERTIFICATION

OF CHIEF EXECUTIVE OFFICER

Constellation Brands, Inc.

Form 10-Q for Fiscal Quarter Ended November 30, 2023

I, William A. Newlands, certify that:

1. I have reviewed this report on Form 10-Q of Constellation Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 5, 2024

/s/ William A. Newlands

William A. Newlands

President and
Chief Executive Officer

EX-31.2

Exhibit 31.2

RULE 13a-14(a)/15d-14(a) CERTIFICATION

OF CHIEF FINANCIAL OFFICER

Constellation Brands, Inc.

Form 10-Q for Fiscal Quarter Ended November 30, 2023

I, Garth Hankinson, certify that:

1. I have reviewed this report on Form 10-Q of Constellation Brands, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: January 5, 2024

/s/ Garth Hankinson

Garth Hankinson

Executive Vice President and
Chief Financial Officer

EX-32.1

Exhibit 32.1

SECTION 1350 CERTIFICATION

OF CHIEF EXECUTIVE OFFICER

Constellation Brands, Inc.

Form 10-Q for Fiscal Quarter Ended November 30, 2023

In connection with the Constellation Brands, Inc. Quarterly Report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023, I, William A. Newlands, certify pursuant to 18 U.S.C. Section 1350 that, to the best of my knowledge:

1.    The Quarterly Report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023 of Constellation Brands, Inc. fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.    The information contained in the periodic report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023 of Constellation Brands, Inc. fairly presents, in all material respects, the financial condition and results of operations of Constellation Brands, Inc.

Dated:	January 5, 2024	/s/ William A. Newlands
		William A. Newlands President and Chief Executive Officer

EX-32.2

Exhibit 32.2

SECTION 1350 CERTIFICATION

OF CHIEF FINANCIAL OFFICER

Constellation Brands, Inc.

Form 10-Q for Fiscal Quarter Ended November 30, 2023

In connection with the Constellation Brands, Inc. Quarterly Report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023, I, Garth Hankinson, certify pursuant to 18 U.S.C. Section 1350 that, to the best of my knowledge:

1.    The Quarterly Report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023 of Constellation Brands, Inc. fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.    The information contained in the periodic report on Form 10-Q for the Fiscal Quarter Ended November 30, 2023 of Constellation Brands, Inc. fairly presents, in all material respects, the financial condition and results of operations of Constellation Brands, Inc.

Dated:	January 5, 2024	/s/ Garth Hankinson
		Garth Hankinson Executive Vice President and Chief Financial Officer

XML

Cover Page - shares	9 Months Ended
	Nov. 30, 2023	Dec. 31, 2023
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Nov. 30, 2023
Document Transition Report	false
Entity File Number	001-08495
Entity Registrant Name	CONSTELLATION BRANDS, INC.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	16-0716709
Entity Address, Address Line One	207 High Point Drive
Entity Address, Address Line Two	Building 100
Entity Address, City or Town	Victor
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	14564
City Area Code	585
Local Phone Number	678-7100
Title of 12(b) Security	Class A Common Stock
Trading Symbol	STZ
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000016918
Amendment Flag	false
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--02-29
Class A Stock
Entity Common Stock, Shares Outstanding		182,796,408
Class 1 Common Stock
Entity Common Stock, Shares Outstanding		23,661

XML

Consolidated Balance Sheets - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Current assets:
Cash and cash equivalents	$ 78.7	$ 133.5
Accounts receivable	897.3	901.6
Inventories	1,988.0	1,898.7
Prepaid expenses and other	587.4	562.3
Total current assets	3,551.4	3,496.1
Property, plant, and equipment	7,713.5	6,865.2
Goodwill	7,978.2	7,925.4
Intangible assets	2,732.2	2,728.1
Equity method investments	233.3	663.3
Deferred income taxes	2,086.1	2,193.3
Other assets	762.7	790.9
Total assets	25,057.4	24,662.3
Current liabilities:
Short-term borrowings	458.9	1,165.3
Current maturities of long-term debt	957.3	9.5
Accounts payable	1,028.8	941.5
Other accrued expenses and liabilities	934.9	852.0
Total current liabilities	3,379.9	2,968.3
Long-term debt, less current maturities	10,282.3	11,286.5
Deferred income taxes and other liabilities	1,596.8	1,673.6
Total liabilities	15,259.0	15,928.4
Commitments and contingencies
CBI stockholders’ equity:
Additional paid-in capital	2,019.2	1,903.0
Retained earnings	13,187.6	12,343.9
Accumulated other comprehensive income (loss)	364.4	28.5
Total stockholders’ equity before treasury stock adjustments	15,573.3	14,277.5
Total CBI stockholders’ equity	9,471.0	8,413.6
Noncontrolling interests	327.4	320.3
Total stockholders’ equity	9,798.4	8,733.9
Total liabilities and stockholders’ equity	25,057.4	24,662.3
Class A Stock
CBI stockholders’ equity:
Common stock, value	2.1	2.1
Less: Treasury stock –	$ (6,102.3)	$ (5,863.9)

XML

Consolidated Balance Sheets (Parenthetical) - Class A Stock - $ / shares	Nov. 30, 2023	Feb. 28, 2023
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	322,000,000	322,000,000
Common stock, shares issued (in shares)	212,698,298	212,697,428
Treasury stock, at cost (in shares)	29,905,366	29,498,426

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Sales	$ 2,658.2	$ 2,624.6	$ 8,410.7	$ 8,029.6
Excise taxes	(187.3)	(188.1)	(588.1)	(574.8)
Net sales	2,470.9	2,436.5	7,822.6	7,454.8
Cost of product sold	(1,200.3)	(1,209.6)	(3,844.3)	(3,647.0)
Gross profit	1,270.6	1,226.9	3,978.3	3,807.8
Selling, general, and administrative expenses	(473.7)	(480.2)	(1,438.0)	(1,431.6)
Operating income (loss)	796.9	746.7	2,540.3	2,376.2
Income (loss) from unconsolidated investments	(41.8)	(37.2)	(477.4)	(1,944.2)
Interest expense	(104.2)	(98.7)	(333.0)	(281.5)
Loss on extinguishment of debt	0.0	0.0	(0.7)	(23.3)
Income (loss) before income taxes	650.9	610.8	1,729.2	127.2
(Provision for) benefit from income taxes	(130.0)	(131.1)	(368.4)	(388.9)
Net income (loss)	520.9	479.7	1,360.8	(261.7)
Net (income) loss attributable to noncontrolling interests	(11.8)	(12.0)	(25.8)	(32.3)
Net income (loss) attributable to CBI	509.1	467.7	1,335.0	(294.0)
Comprehensive income (loss)	447.0	643.1	1,713.0	(32.8)
Comprehensive (income) loss attributable to noncontrolling interests	(7.9)	(20.9)	(42.1)	(49.4)
Comprehensive income (loss) attributable to CBI	439.1	622.2	1,670.9	(82.2)
Class A Stock
Net income (loss) attributable to CBI	$ 509.1	$ 426.3	$ 1,335.0	$ (247.3)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 2.77	$ 2.58	$ 7.28	$ (1.48)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 2.76	$ 2.52	$ 7.25	$ (1.48)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)	183,525	166,677	183,431	164,573
Weighted average common shares outstanding - diluted (in shares)	184,170	185,291	184,096	164,573
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)	$ 0.89	$ 0.80	$ 2.67	$ 2.40
Class B Stock
Net income (loss) attributable to CBI		$ 41.4		$ (46.7)
Net income (loss) per common share attributable to CBI:
Net income (loss) per common share attributable to CBI - basic (in dollars per share)		$ 1.78		$ (2.01)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)		$ 1.78		$ (2.01)
Weighted average common shares outstanding:
Weighted average common shares outstanding - basic (in shares)		23,206		23,206
Weighted average common shares outstanding - diluted (in shares)		23,206		23,206
Cash dividends declared per common share:
Cash dividends declared per common share (in dollars per share)		$ 0.72		$ 2.16

XML

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Total	Class A Stock	Common Stock Class A Stock	Common Stock Class B Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Treasury Stock	Non-controlling Interests
Stockholders' equity, beginning of period at Feb. 28, 2022	$ 12,047.8		$ 1.9	$ 0.3	$ 1,808.9	$ 14,505.4	$ (412.7)	$ (4,171.9)	$ 315.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	399.3					389.5			9.8
Other comprehensive income (loss), net of income tax effect	259.0						246.4		12.6
Comprehensive income (loss)	658.3
Repurchase of shares	(1,007.6)							(1,007.6)
Dividends declared	(148.7)					(148.7)
Noncontrolling interest distributions	(11.2)								(11.2)
Shares issued under equity compensation plans	3.2				(0.6)			3.8
Stock-based compensation	16.7				16.7
Stockholders' equity, end of period at May. 31, 2022	11,558.5		1.9	0.3	1,825.0	14,746.2	(166.3)	(5,175.7)	327.1
Stockholders' equity, beginning of period at Feb. 28, 2022	12,047.8		1.9	0.3	1,808.9	14,505.4	(412.7)	(4,171.9)	315.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(261.7)
Other comprehensive income (loss), net of income tax effect							211.8
Comprehensive income (loss)	(32.8)
Stockholders' equity, end of period at Nov. 30, 2022	8,716.7		2.1	0.0	1,883.6	12,267.8	(200.9)	(5,563.1)	327.2
Stockholders' equity, beginning of period at May. 31, 2022	11,558.5		1.9	0.3	1,825.0	14,746.2	(166.3)	(5,175.7)	327.1
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	(1,140.7)					(1,151.2)			10.5
Other comprehensive income (loss), net of income tax effect	(193.5)						(189.1)		(4.4)
Comprehensive income (loss)	(1,334.2)
Repurchase of shares	(392.9)							(392.9)
Dividends declared	(146.6)					(146.6)
Noncontrolling interest distributions	(11.3)								(11.3)
Shares issued under equity compensation plans	16.5				14.5			2.0
Stock-based compensation	20.9				20.9
Stockholders' equity, end of period at Aug. 31, 2022	9,710.9		1.9	0.3	1,860.4	13,448.4	(355.4)	(5,566.6)	321.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	479.7					467.7			12.0
Other comprehensive income (loss), net of income tax effect	163.4						154.5		8.9
Comprehensive income (loss)	643.1
Reclassification payment	(1,500.0)					(1,500.0)
Retirement of treasury shares	0.0			(0.1)		(2.2)		2.3
Conversion of common shares			0.2	(0.2)
Dividends declared	(146.1)					(146.1)
Noncontrolling interest distributions	(15.6)								(15.6)
Shares issued under equity compensation plans	6.1				4.9			1.2
Stock-based compensation	18.3				18.3
Stockholders' equity, end of period at Nov. 30, 2022	8,716.7		2.1	$ 0.0	1,883.6	12,267.8	(200.9)	(5,563.1)	327.2
Stockholders' equity, beginning of period at Feb. 28, 2023	8,733.9		2.1		1,903.0	12,343.9	28.5	(5,863.9)	320.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	139.2					135.9			3.3
Other comprehensive income (loss), net of income tax effect	225.3						214.4		10.9
Comprehensive income (loss)	364.5
Repurchase of shares	(35.0)							(35.0)
Dividends declared	(163.1)					(163.1)
Noncontrolling interest distributions	(11.3)								(11.3)
Shares issued under equity compensation plans	4.7				0.6			4.1
Stock-based compensation	14.5				14.5
Stockholders' equity, end of period at May. 31, 2023	8,908.2		2.1		1,918.1	12,316.7	242.9	(5,894.8)	323.2
Stockholders' equity, beginning of period at Feb. 28, 2023	8,733.9		2.1		1,903.0	12,343.9	28.5	(5,863.9)	320.3
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	1,360.8
Other comprehensive income (loss), net of income tax effect							335.9
Comprehensive income (loss)	1,713.0
Repurchase of shares		$ (249.7)
Stockholders' equity, end of period at Nov. 30, 2023	9,798.4		2.1		2,019.2	13,187.6	364.4	(6,102.3)	327.4
Stockholders' equity, beginning of period at May. 31, 2023	8,908.2		2.1		1,918.1	12,316.7	242.9	(5,894.8)	323.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	700.7					690.0			10.7
Other comprehensive income (loss), net of income tax effect	200.8						191.5		9.3
Comprehensive income (loss)	901.5
Dividends declared	(164.0)					(164.0)
Noncontrolling interest distributions	(10.0)								(10.0)
Shares issued under equity compensation plans	70.2				62.6			7.6
Stock-based compensation	18.1				18.1
Stockholders' equity, end of period at Aug. 31, 2023	9,724.0		2.1		1,998.8	12,842.7	434.4	(5,887.2)	333.2
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (loss)	520.9					509.1			11.8
Other comprehensive income (loss), net of income tax effect	(73.9)						(70.0)		(3.9)
Comprehensive income (loss)	447.0
Repurchase of shares	(214.7)							(214.7)
Dividends declared	(164.2)					(164.2)
Noncontrolling interest distributions	(13.7)								(13.7)
Shares issued under equity compensation plans	3.0				3.4			(0.4)
Stock-based compensation	17.0				17.0
Stockholders' equity, end of period at Nov. 30, 2023	$ 9,798.4		$ 2.1		$ 2,019.2	$ 13,187.6	$ 364.4	$ (6,102.3)	$ 327.4

XML

Consolidated Statements of Cash Flows - USD ($) $ in Millions	9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES
Net income (loss)	$ 1,360.8	$ (261.7)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
Unrealized net (gain) loss on securities measured at fair value	85.4	39.1
Deferred tax provision (benefit)	28.2	218.4
Depreciation	321.8	278.4
Stock-based compensation	49.5	56.1
Equity in (earnings) losses of equity method investees and related activities, net of distributed earnings	257.3	845.4
Noncash lease expense	62.9	66.7
Amortization of debt issuance costs and loss on extinguishment of debt	8.9	31.1
Impairment of equity method investments	136.1	1,060.3
(Gain) loss on sale of business	15.1	(13.8)
Gain (loss) on settlement of Pre-issuance hedge contracts	1.4	20.7
Change in operating assets and liabilities, net of effects from purchase and sale of business:
Accounts receivable	6.9	(25.3)
Inventories	(90.4)	(259.3)
Prepaid expenses and other current assets	(49.1)	204.7
Accounts payable	24.5	187.4
Other accrued expenses and liabilities	37.1	(247.0)
Other	90.4	79.4
Total adjustments	986.0	2,542.3
Net cash provided by (used in) operating activities	2,346.8	2,280.6
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of property, plant, and equipment	(911.9)	(683.8)
Purchase of business, net of cash acquired	(7.5)	(37.1)
Investments in equity method investees and securities	(34.6)	(29.5)
Proceeds from sale of assets	21.8	6.6
Proceeds from sale of business	5.4	96.7
Other investing activities	(3.1)	0.5
Net cash provided by (used in) investing activities	(929.9)	(646.6)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from issuance of long-term debt	744.8	2,845.8
Principal payments of long-term debt	(807.5)	(1,657.3)
Net proceeds from (repayments of) short-term borrowings	(706.4)	552.6
Dividends paid	(491.1)	(441.1)
Purchases of treasury stock	(249.7)	(1,400.5)
Proceeds from shares issued under equity compensation plans	89.0	36.7
Payments of minimum tax withholdings on stock-based payment awards	(11.2)	(10.5)
Payments of debt issuance, debt extinguishment, and other financing costs	(5.3)	(34.1)
Distributions to noncontrolling interests	(35.0)	(37.5)
Payment to holders of Class B Stock in connection with the Reclassification	0.0	(1,500.0)
Net cash provided by (used in) financing activities	(1,472.4)	(1,645.9)
Effect of exchange rate changes on cash and cash equivalents	0.7	(2.5)
Net increase (decrease) in cash and cash equivalents	(54.8)	(14.4)
Cash and cash equivalents, beginning of period	133.5	199.4
Cash and cash equivalents, end of period	78.7	185.0
Supplemental disclosures of noncash investing and financing activities
Additions to property, plant, and equipment	$ 178.1	$ 174.6

XML

Basis of Presentation

9 Months Ended

Nov. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

BASIS OF PRESENTATION

BASIS OF PRESENTATION

We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2023 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. All financial information for the nine months and three months ended November 30, 2022, has been restated to conform to the new segment presentation. For additional information, refer to Note 13.

XML

Inventories

9 Months Ended

Nov. 30, 2023

Inventory Disclosure [Abstract]

INVENTORIES

INVENTORIES

Inventories are stated at the lower of cost (primarily computed in accordance with the first-in, first-out method) or net realizable value. Elements of cost include materials, labor, and overhead and consist of the following:

	November 30, 2023		February 28, 2023
(in millions)
Raw materials and supplies	$	244.0	$	245.5
In-process inventories	1,098.9		967.8
Finished case goods	645.1		685.4
	$	1,988.0	$	1,898.7

XML

Derivative Instruments

9 Months Ended

Nov. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

DERIVATIVE INSTRUMENTS

DERIVATIVE INSTRUMENTS

Overview

Our risk management and derivative accounting policies are presented in Notes 1 and 6 of our consolidated financial statements included in our 2023 Annual Report and have not changed significantly for the nine months and three months ended November 30, 2023.

The aggregate notional value of outstanding derivative instruments is as follows:

	November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts	$	2,233.3	$	1,969.5
Pre-issuance hedge contracts	$	125.0	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts	$	578.9	$	831.7
Commodity derivative contracts	$	383.9	$	416.5

Credit risk

We are exposed to credit-related losses if the counterparties to our derivative contracts default. This credit risk is limited to the fair value of the derivative contracts. To manage this risk, we contract only with major financial institutions that have earned investment-grade credit ratings and with whom we have standard International Swaps and Derivatives Association agreements which allow for net settlement of the derivative contracts. We have also established counterparty credit guidelines that are regularly monitored. Because of these safeguards, we believe the risk of loss from counterparty default to be immaterial.

In addition, our derivative instruments are not subject to credit rating contingencies or collateral requirements. As of November 30, 2023, the estimated fair value of derivative instruments in a net liability position due to counterparties was $1.5 million. If we were required to settle the net liability position under these derivative instruments on November 30, 2023, we would have had sufficient available liquidity on hand to satisfy this obligation.

Results of period derivative activity

The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4):

Assets					Liabilities
	November 30, 2023		February 28, 2023			November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	152.6	$	109.1	Other accrued expenses and liabilities	$	4.3	$	9.8
Other assets	$	166.2	$	134.5	Deferred income taxes and other liabilities	$	0.4	$	3.5
Pre-issuance hedge contracts:
Prepaid expenses and other	$	—	$	—	Other accrued expenses and liabilities	$	0.1	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	8.1	$	5.9	Other accrued expenses and liabilities	$	5.7	$	3.9
Commodity derivative contracts:
Prepaid expenses and other	$	6.7	$	21.2	Other accrued expenses and liabilities	$	24.9	$	19.5
Other assets	$	2.8	$	4.6	Deferred income taxes and other liabilities	$	6.4	$	8.3

The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows:

Derivative Instruments in Designated Cash Flow Hedging Relationships	Net Gain (Loss) Recognized in OCI		Location of Net Gain (Loss) Reclassified from AOCI to Income (Loss)	Net Gain (Loss) Reclassified from AOCI to Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Foreign currency contracts	$	177.1	Sales	$	(0.2)
			Cost of product sold	102.3
Pre-issuance hedge contracts	0.5		Interest expense	(0.4)
	$	177.6		$	101.7
For the Nine Months Ended November 30, 2022
Foreign currency contracts	$	146.6	Sales	$	(1.4)
			Cost of product sold	34.0
Pre-issuance hedge contracts	15.7		Interest expense	(0.8)
	$	162.3		$	31.8
For the Three Months Ended November 30, 2023
Foreign currency contracts	$	27.2	Sales	$	—
			Cost of product sold	36.6
Pre-issuance hedge contracts	(0.1)		Interest expense	(0.1)
	$	27.1		$	36.5
For the Three Months Ended November 30, 2022
Foreign currency contracts	$	75.3	Sales	$	(0.2)
			Cost of product sold	12.1
Pre-issuance hedge contracts	—		Interest expense	(0.2)
	$	75.3		$	11.7

We expect $130.2 million of net gains, net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months.

The effect of our undesignated derivative instruments on our results of operations is as follows:

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(28.9)
Foreign currency contracts	Selling, general, and administrative expenses	12.7
		$	(16.2)

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	25.3
Foreign currency contracts	Selling, general, and administrative expenses	(11.9)
		$	13.4
For the Three Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(13.3)
Foreign currency contracts	Selling, general, and administrative expenses	(9.8)
		$	(23.1)
For the Three Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	(7.8)
Foreign currency contracts	Selling, general, and administrative expenses	(9.3)
		$	(17.1)

XML

Fair Value of Financial Instruments

9 Months Ended

Nov. 30, 2023

Fair Value Disclosures [Abstract]

FAIR VALUE OF FINANCIAL INSTRUMENTS

FAIR VALUE OF FINANCIAL INSTRUMENTS

Authoritative guidance establishes a framework for measuring fair value, including a hierarchy for inputs used in measuring fair value that maximizes the use of observable inputs and minimizes the use of unobservable inputs by requiring that the most observable inputs be used when available. The hierarchy includes three levels:

•Level 1 inputs are quoted prices in active markets for identical assets or liabilities;

•Level 2 inputs include data points that are observable such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical assets or similar assets or liabilities in markets that are not active, and inputs (other than quoted prices) such as volatility, interest rates, and yield curves that are observable for the asset or liability, either directly or indirectly; and

•Level 3 inputs are unobservable data points for the asset or liability, and include situations where there is little, if any, market activity for the asset or liability.

Fair value methodology

The following methods and assumptions are used to estimate the fair value of our financial instruments:

Foreign currency and commodity derivative contracts

The fair value is estimated using market-based inputs, obtained from independent pricing services, entered into valuation models. These valuation models require various inputs, including contractual terms, market foreign exchange prices, market commodity prices, interest-rate yield curves, and currency volatilities, as applicable (Level 2 fair value measurement).

Interest rate swap and Pre-issuance hedge contracts

The fair value is estimated based on quoted market prices from respective counterparties. Quotes are corroborated by using discounted cash flow calculations based upon forward interest-rate yield curves, which are obtained from independent pricing services (Level 2 fair value measurement).

Canopy investment

On November 1, 2023, the initial tranche of the November 2018 Canopy Warrants expired in accordance with its terms. The remaining tranches of the November 2018 Canopy Warrants were conditioned on the exercise, in full, of the expired warrants. As such, there are no longer any outstanding November 2018 Canopy Warrants. In

April 2023, we extended the maturity of the remaining C$100.0 million principal amount of our Canopy Debt Securities by exchanging them for the 2023 Canopy Promissory Note. As such, our investment in Canopy is currently comprised of (i) the Canopy Equity Method Investment and (ii) the 2023 Canopy Promissory Note. The 2023 Canopy Promissory Note is measured at fair value. Effective as of May 31, 2023, we determined that this instrument did not have future economic value given the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, prior to the maturity of the note. Accordingly, the fair value of the remaining balance for this instrument was determined to be zero. This reduction in fair value is included in income (loss) from unconsolidated investments within our consolidated results of operations for the nine months ended November 30, 2023. If the Canopy Amendment is authorized by Canopy’s shareholders, we intend to negotiate an exchange of the 2023 Canopy Promissory Note for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so.

Short-term borrowings

Our short-term borrowings consist of our commercial paper program and the revolving credit facility under our senior credit facility. The revolving credit facility is a variable interest rate bearing note with a fixed margin, adjustable based upon our debt rating (as defined in our senior credit facility). For these short-term borrowings, the carrying value approximates the fair value.

Long-term debt

The fair value of our fixed interest rate long-term debt is estimated by discounting cash flows using interest rates currently available for debt with similar terms and maturities (Level 2 fair value measurement). As of November 30, 2023, the carrying amount of long-term debt, including the current portion, was $11,239.6 million, compared with an estimated fair value of $10,320.7 million. As of February 28, 2023, the carrying amount of long-term debt, including the current portion, was $11,296.0 million, compared with an estimated fair value of $10,236.0 million.

The carrying amounts of certain of our financial instruments, including cash and cash equivalents, accounts receivable, and accounts payable, approximate fair value as of November 30, 2023, and February 28, 2023, due to the relatively short maturity of these instruments.

Recurring basis measurements

The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
November 30, 2023
Assets:
Foreign currency contracts	$	—	$	326.9	$	—	$	326.9
Commodity derivative contracts	$	—	$	9.5	$	—	$	9.5
Liabilities:
Foreign currency contracts	$	—	$	10.4	$	—	$	10.4
Commodity derivative contracts	$	—	$	31.3	$	—	$	31.3
Pre-issuance hedge contracts	$	—	$	0.1	$	—	$	0.1

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
February 28, 2023
Assets:
Foreign currency contracts	$	—	$	249.5	$	—	$	249.5
Commodity derivative contracts	$	—	$	25.8	$	—	$	25.8
November 2018 Canopy Warrants	$	—	$	0.2	$	—	$	0.2
Canopy Debt Securities	$	—	$	69.6	$	—	$	69.6
Liabilities:
Foreign currency contracts	$	—	$	17.2	$	—	$	17.2
Commodity derivative contracts	$	—	$	27.8	$	—	$	27.8

Nonrecurring basis measurements

The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses
(in millions)
For the Nine Months Ended November 30, 2023
Equity method investments	$	94.8	$	0.6	$	0.6	$	136.1
For the Nine Months Ended November 30, 2022
Equity method investments	$	621.4	$	—	$	—	$	1,060.3

Equity method investments

As of November 30, 2023, we evaluated a certain equity method investment, made through our corporate venture capital function within the Corporate Operations and Other segment, and determined there was an other-than-temporary impairment due to business underperformance. The estimated fair value was based largely on the cash flows expected to be generated by the investment using unobservable data points.

As of August 31, 2023, we evaluated certain equity method investments, made through our corporate venture capital function, and determined there were other-than-temporary impairments due to business underperformance. Investments with a carrying value of $14.9 million were written down to an estimated fair value of $2.6 million, resulting in an impairment of $12.3 million. These investments are part of the Corporate Operations and Other segment. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2023. The estimated fair value was based largely on observable prices for similar assets. In October 2023, we exited one of these equity method investments in exchange for a note receivable.

We evaluated the Canopy Equity Method Investment as of May 31, 2023, and determined there was an other-than-temporary impairment. Our conclusion was based on several contributing factors, including: (i) the fair value being less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the

near-term, (ii) Canopy recorded significant costs in its fourth quarter of fiscal 2023 results designed to align its Canadian cannabis operations and resources in response to continued unfavorable market trends, (iii) the substantial doubt about Canopy’s ability to continue as a going concern, as disclosed by Canopy, and (iv) Canopy’s identification of material misstatements in certain of its previously reported financial results related to sales in its BioSteel reporting unit that were accounted for incorrectly, including the recording of a goodwill impairment during its restated second quarter of fiscal 2023. As a result, the Canopy Equity Method Investment with a carrying value of $266.2 million was written down to its estimated fair value of $142.7 million, resulting in an impairment of $123.5 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2023. The estimated fair value was determined based on the closing price of the underlying equity security as of May 31, 2023.

We evaluated the Canopy Equity Method Investment as of August 31, 2022, and determined there was an other-than-temporary impairment based on several contributing factors, including: (i) the period of time for which the fair value had been less than the carrying value and the uncertainty surrounding Canopy’s stock price recovering in the near-term, (ii) Canopy recording a significant impairment of goodwill related to its cannabis operations during its first quarter of fiscal 2023, and (iii) the uncertainty of U.S. federal cannabis permissibility. As a result, the Canopy Equity Method Investment with a carrying value of $1,695.1 million was written down to its estimated fair value of $634.8 million, resulting in an impairment of $1,060.3 million. This loss from impairment was included in income (loss) from unconsolidated investments within our consolidated results for the nine months ended November 30, 2022. The estimated fair value was determined based on the closing price of the underlying equity security as of August 31, 2022.

XML

Goodwill

9 Months Ended

Nov. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

GOODWILL

GOODWILL

The changes in the carrying amount of goodwill are as follows:

	Beer		Wine and Spirits		Consolidated
(in millions)
Balance, February 28, 2022	$	5,120.7	$	2,741.7	$	7,862.4
Purchase accounting allocations (1)	—		26.3		26.3
Wine Divestiture	—		(24.5)		(24.5)
Foreign currency translation adjustments	68.2		(7.0)		61.2
Balance, February 28, 2023	5,188.9		2,736.5		7,925.4
Purchase accounting allocations (2)	—		6.5		6.5
Foreign currency translation adjustments	46.3		—		46.3
Balance, November 30, 2023	$	5,235.2	$	2,743.0	$	7,978.2

(1)Purchase accounting allocations associated with the acquisitions of Austin Cocktails, Lingua Franca, and My Favorite Neighbor, LLC.

(2)Preliminary purchase accounting allocation associated with the June 2023 acquisition of the Domaine Curry wine business.

Divestitures

Craft Beer Divestitures

In June 2023, we completed the Craft Beer Divestitures. Prior to the Craft Beer Divestitures, we recorded the results of operations of such craft beer brands in the Beer segment.

Wine Divestiture

On October 6, 2022, we sold certain of our mainstream and premium wine brands and related inventory. The net cash proceeds from the Wine Divestiture were utilized primarily to reduce outstanding borrowings. Prior to the Wine Divestiture, we recorded the results of operations of these brands in the Wine and Spirits segment.

The following table summarizes the net gain recognized in connection with this divestiture for the nine months and three months ended November 30, 2022:

(in millions)
Cash received from buyer	$	96.7
Net assets sold	(68.1)
Direct costs to sell (1)	(14.8)
Gain on sale of business (2)	$	13.8

(1)Includes certain contract termination costs.

(2)Included in selling, general, and administrative expenses within our consolidated results of operations.

Acquisitions

Austin Cocktails

In April 2022, we acquired the remaining 73% ownership interest in Austin Cocktails, which included a portfolio of small batch, RTD cocktails. This transaction primarily included the acquisition of goodwill and a trademark. In addition, the purchase price for Austin Cocktails includes an earn-out over five years based on performance. The results of operations of Austin Cocktails are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

Lingua Franca

In March 2022, we acquired the Lingua Franca business, including a collection of Oregon-based luxury wines, a vineyard, and a production facility. This transaction also included the acquisition of a trademark and inventory. In addition, the purchase price for Lingua Franca includes an earn-out over seven years based on performance. The results of operations of Lingua Franca are reported in the Wine and Spirits segment and have been included in our consolidated results of operations from the date of acquisition.

XML

Intangible Assets

9 Months Ended

Nov. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

INTANGIBLE ASSETS

INTANGIBLE ASSETS

The major components of intangible assets are as follows:

	November 30, 2023				February 28, 2023
	Gross Carrying Amount		Net Carrying Amount		Gross Carrying Amount		Net Carrying Amount
(in millions)
Amortizable intangible assets
Customer relationships	$	85.4	$	16.5	$	85.7	$	17.7
Other	20.8		0.3		20.8		—
Total	$	106.2	16.8		$	106.5	17.7
Nonamortizable intangible assets
Trademarks			2,715.4				2,710.4
Total intangible assets			$	2,732.2			$	2,728.1

We did not incur costs to renew or extend the term of acquired intangible assets for the nine months and three months ended November 30, 2023, and November 30, 2022. Net carrying amount represents the gross carrying value net of accumulated amortization.

XML

Equity Method Investments

9 Months Ended

Nov. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

EQUITY METHOD INVESTMENTS

EQUITY METHOD INVESTMENTS

Our equity method investments are as follows:

	November 30, 2023				February 28, 2023
	Carrying Value		Ownership Percentage		Carrying Value		Ownership Percentage
(in millions)
Canopy Equity Method Investment (1)	$	73.6	20.7	%	$	485.8	34.7	%
Other equity method investments	159.7		20%-50%		177.5		20%-50%
	$	233.3			$	663.3

(1)The fair value based on the closing price of the underlying equity security as of November 30, 2023, and February 28, 2023, was $94.8 million and $398.4 million, respectively.

Canopy Equity Method Investment

We have an investment in Canopy, a provider of medical and adult-use cannabis products. The Canopy Equity Method Investment consisted of 171.5 million Canopy common shares as of November 30, 2023. In December 2023, Canopy effected a reverse stock split at a ratio of one-for-ten. As a result, our Canopy Equity Method Investment consists of 17.1 million Canopy common shares. Equity in earnings (losses) from the Canopy Equity Method Investment and related activities is determined by recording the effect of basis differences. Amounts included in our consolidated results of operations for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Equity in earnings (losses) from Canopy and related activities	$	(288.3)	$	(876.5)	$	(56.5)	$	(60.8)

Plan to convert Canopy common stock ownership

In October 2022, we entered into a Consent Agreement with Canopy pursuant to which we have provided our consent, subject to certain conditions, to the Canopy Transaction. Canopy only holds non-voting and non-participating exchangeable shares of Canopy USA which are convertible into Class B shares of Canopy USA. A third-party investor holds 100% of the common shares of Canopy USA.

In connection with the Canopy Transaction, Canopy has proposed to amend its share capital to (i) create Exchangeable Shares and (ii) restate the rights of Canopy common shares to provide for their conversion into Exchangeable Shares through the Canopy Amendment. Canopy has stated its intention to hold a special meeting of its shareholders to consider the Canopy Amendment. We have entered into a voting support agreement with Canopy to vote in favor of the Canopy Amendment.

If the Canopy Transaction is completed and the Canopy Amendment is authorized by Canopy’s shareholders and adopted by Canopy, we intend, subject to a final decision in our sole discretion, to exercise our right to convert our Canopy common shares into Exchangeable Shares.

Assuming the completion of the Canopy Transaction and the transactions contemplated by the Consent Agreement and that we elect to convert our Canopy common shares into Exchangeable Shares:

•we will only have an interest in Exchangeable Shares, which are non-voting and non-participating securities, and our 2023 Canopy Promissory Note (for which we intend to negotiate an exchange of the principal amount for Exchangeable Shares, although neither we nor Canopy has any binding obligation to do so);

•we intend to terminate all legacy agreements and commercial arrangements between ourselves and Canopy, including the investor rights agreement but excluding the Consent Agreement and certain termination agreements;

•we will have no further governance rights in relation to Canopy, including rights to nominate members to the board of directors of Canopy, or consulting rights related to certain transactions;

•all of our nominees will resign from the board of directors of Canopy; and

•as our investment in Canopy common shares makes up our Canopy Equity Method Investment, we expect to no longer apply the equity method to our investment in Canopy, which we expect to instead be accounted for at fair value with changes reported in income (loss) from unconsolidated investments within our consolidated results.

If we do not convert our Canopy common shares into Exchangeable Shares:

•Canopy and its subsidiaries will not be permitted to exercise any rights to acquire shares and interests in entities carrying on cannabis-related business in the U.S.;

•Canopy USA will be required to exercise its repurchase rights to acquire the interests in Canopy USA held by its third-party investors; and

•we will continue to have all existing rights under our agreements with Canopy that predate the Consent Agreement, including governance rights in respect of Canopy (such as board nomination rights and consulting rights in respect of certain transactions).

XML

Borrowings

9 Months Ended

Nov. 30, 2023

Debt Disclosure [Abstract]

BORROWINGS

BORROWINGS

Borrowings consist of the following:

	November 30, 2023						February 28, 2023
	Current		Long-term		Total		Total
(in millions)
Short-term borrowings
Commercial paper	$	458.9					$	1,165.3
	$	458.9					$	1,165.3
Long-term debt
Term loan credit facilities	$	—	$	—	$	—	$	799.2
Senior notes	948.8		10,270.8		11,219.6		10,470.6
Other	8.5		11.5		20.0		26.2
	$	957.3	$	10,282.3	$	11,239.6	$	11,296.0

Bank facilities

The Company, CB International, the Administrative Agent, and certain other lenders are parties to the 2022 Credit Agreement. The Company, the Administrative Agent, and certain lenders were also parties to two term credit agreements. In May 2023, we repaid the outstanding three-year term loan facility borrowings under our August 2022 Term Credit Agreement with proceeds from the May 2023 Senior Notes (see “Senior notes” below). In August 2023, we repaid the outstanding five-year term loan facility borrowings under our April 2022 Term Credit Agreement with proceeds from commercial paper borrowings.

In October 2022, the Company, CB International, the Administrative Agent, and certain other lenders agreed to amend the 2022 Credit Agreement. The October 2022 Credit Agreement Amendment revises certain defined terms and covenants and will become effective upon (i) the amendment by Canopy of its Articles of Incorporation, (ii) the conversion of our Canopy common shares into Exchangeable Shares, and (iii) the resignation of our nominees from the board of directors of Canopy.

As of November 30, 2023, information with respect to borrowings under the 2022 Credit Agreement is as follows:

	Outstanding borrowings		Interest rate		SOFR margin		Outstanding letters of credit		Remaining borrowing capacity (1)
(in millions)
2022 Credit Agreement
Revolving credit facility (2) (3)	$	—	—	%	—	%	$	11.5	$	1,779.0

(1)Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $459.5 million (excluding unamortized discount) (see “Commercial paper program” below).

(2)Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin.

(3)We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million.

We and our subsidiaries are subject to covenants that are contained in the 2022 Credit Agreement, including those restricting the incurrence of additional subsidiary indebtedness, additional liens, mergers and consolidations, transactions with affiliates, and sale and leaseback transactions, in each case subject to numerous conditions, exceptions, and thresholds. The financial covenants are limited to a minimum interest coverage ratio and a maximum net leverage ratio.

Commercial paper program

We have a commercial paper program which provides for the issuance of up to an aggregate principal amount of $2.25 billion of commercial paper. Our commercial paper program is backed by unused commitments under our revolving credit facility under our 2022 Credit Agreement. Accordingly, outstanding borrowings under our commercial paper program reduce the amount available under our revolving credit facility. As of November 30, 2023, we had $458.9 million of outstanding borrowings, net of unamortized discount, under our commercial paper program with a weighted average annual interest rate of 5.8% and a weighted average remaining term of nine days.

Pre-issuance hedge contracts

In November 2023, we entered into Pre-issuance hedge contracts, which were designated as cash flow hedges. As of November 30, 2023, we had hedged the interest rate volatility on $125.0 million of future debt issuances. In December 2023, we entered into additional cash flow designated, Pre-issuance hedge contracts for $150.0 million of future debt issuances. As a result of additional Pre-issuance hedge contracts, we have hedged the interest rate volatility on $275.0 million of future debt issuances.

Senior notes

In May 2023, we issued $750.0 million aggregate principal amount of 4.90% senior notes due May 2033. Proceeds from this offering, net of discount and debt issuance costs, were $739.8 million. Interest on the 4.90% May 2023 Senior Notes is payable semiannually on May 1 and November 1 of each year, beginning November 1, 2023. The 4.90% May 2023 Senior Notes are redeemable, in whole or in part, at our option at any time prior to February 1, 2033, at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest and a make-whole payment based on the present value of the future payments at the adjusted treasury rate, as defined in the applicable indenture, plus 25 basis points. On or after February 1, 2033, we may redeem the 4.90% May 2023 Senior Notes, in whole or in part, at our option at any time at a redemption price equal to 100% of the outstanding principal amount, plus accrued and unpaid interest. The 4.90% May 2023 Senior Notes are senior unsecured obligations which rank equally in right of payment to all of our existing and future senior unsecured indebtedness.

Debt payments

As of November 30, 2023, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $56.6 million and $23.8 million, respectively) for the remaining three months of Fiscal 2024 and for each of the five succeeding fiscal years and thereafter are as follows:

(in millions)
Fiscal 2024	$	2.2
Fiscal 2025	957.5
Fiscal 2026	1,404.9
Fiscal 2027	603.8
Fiscal 2028	1,801.5
Fiscal 2029	500.0
Thereafter	6,050.1
	$	11,320.0

XML

Income Taxes

9 Months Ended

Nov. 30, 2023

Income Tax Disclosure [Abstract]

INCOME TAXES

INCOME TAXES

Our effective tax rate for the nine months ended November 30, 2023, and November 30, 2022, was 21.3% and 305.7%, respectively. Our effective tax rate for the three months ended November 30, 2023, and November 30, 2022, was 20.0% and 21.5%, respectively.

For the nine months and three months ended November 30, 2023, and three months ended November 30, 2022, our effective tax rate approximated the federal statutory rate of 21% as the increase in the valuation allowance related to our investment in Canopy was largely offset by the benefit of lower effective tax rates applicable to our foreign businesses.

For the nine months ended November 30, 2022, our effective tax rate did not approximate the federal statutory rate of 21% primarily due an increase in the valuation allowance related to our investment in Canopy, partially offset by a net income tax benefit recognized from the realization of tax losses related to a prior period divestiture.

XML

Stockholders' Equity

9 Months Ended

Nov. 30, 2023

Equity [Abstract]

STOCKHOLDERS' EQUITY

STOCKHOLDERS’ EQUITY

Common stock

The number of shares of common stock issued and treasury stock, and associated share activity, are as follows:

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Balance at February 28, 2023	212,697,428	—	22,705	29,498,426	—
Share repurchases	—	—	—	153,937	—
Conversion of shares	80	—	(80)	—	—
Exercise of stock options	—	—	800	(129,595)	—
Vesting of restricted stock units (2)	—	—	—	(71,189)	—
Vesting of performance share units (2)	—	—	—	(13,113)	—
Balance at May 31, 2023	212,697,508	—	23,425	29,438,466	—

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Conversion of shares	220	—	(220)	—	—
Exercise of stock options	—	—	606	(364,530)	—
Employee stock purchases	—	—	—	(30,172)	—
Vesting of restricted stock units (2)	—	—	—	(5,172)	—
Balance at August 31, 2023	212,697,728	—	23,811	29,038,592	—
Share repurchases	—	—	—	889,429	—
Conversion of shares	570	—	(570)	—	—
Exercise of stock options	—	—	—	(22,587)	—
Vesting of restricted stock units (2)	—	—	—	(68)	—
Balance at November 30, 2023	212,698,298	—	23,241	29,905,366	—
Balance at February 28, 2022	187,263,859	28,212,340	2,248,679	22,824,607	5,005,800
Share repurchases	—	—	—	4,065,508	—
Conversion of shares	655	(655)	—	—	—
Exercise of stock options	—	—	35	(108,228)	—
Vesting of restricted stock units (2)	—	—	—	(71,064)	—
Vesting of performance share units (2)	—	—	—	(16,326)	—
Balance at May 31, 2022	187,264,514	28,211,685	2,248,714	26,694,497	5,005,800
Share repurchases	—	—	—	1,652,445	—
Conversion of shares	2,196,749	—	(2,196,749)	—	—
Exercise of stock options	—	—	—	(75,482)	—
Employee stock purchases	—	—	—	(27,514)	—
Vesting of restricted stock units (2)	—	—	—	(4,851)	—
Balance at August 31, 2022	189,461,263	28,211,685	51,965	28,239,095	5,005,800
Retirement of treasury shares	—	(5,005,800)	—	—	(5,005,800)
Conversion of shares	23,205,885	(23,205,885)	—	—	—
Exercise of stock options	—	—	470	(63,529)	—
Balance at November 30, 2022	212,667,148	—	52,435	28,175,566	—

(1)Prior to the Reclassification, we had an additional class of common stock with a material number of shares outstanding: Class B Stock. Shares of Class B Stock were convertible into shares of Class A Stock on a one-to-one basis at any time at the option of the holder. For additional information, refer to “Reclassification” below.

(2)Net of the following shares withheld to satisfy tax withholding requirements:

	For the Three Months Ended May 31,	For the Three Months Ended August 31,	For the Three Months Ended November 30,	For the Nine Months Ended November 30,
2023
Restricted Stock Units	39,839	170	—	40,009
Performance Share Units	8,735	—	—	8,735
2022
Restricted Stock Units	37,308	186	—	37,494
Performance Share Units	4,919	—	—	4,919

Stock repurchases

In January 2021, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which the 2021 Authorization would expire. Shares repurchased under the 2021 Authorization become treasury shares.

Additionally, in November 2023, our Board of Directors authorized the repurchase of up to $2.0 billion of our publicly traded common stock. The Board of Directors did not specify a date upon which the 2023 Authorization would expire. Shares repurchased under the 2023 Authorization will become treasury shares.

For the nine months ended November 30, 2023, we repurchased 1,043,366 shares of Class A Stock pursuant to the 2021 Authorization through open market transactions at an aggregate cost of $249.7 million.

As of November 30, 2023, total shares repurchased under the 2021 Authorization and the 2023 Authorization are as follows:

			Class A Stock
	Repurchase Authorization		Dollar Value of Shares Repurchased		Number of Shares Repurchased
(in millions, except share data)
2021 Authorization	$	2,000.0	$	1,386.3	5,875,276
2023 Authorization	$	2,000.0	$	—	—

Reclassification

In November 2022, we completed the Reclassification at the Effective Time as contemplated by the Reclassification Agreement. Pursuant to the Reclassification, each share of Class B Stock issued and outstanding immediately prior to the Effective Time was reclassified, exchanged, and converted into one share of Class A Stock and the right to receive $64.64 in cash, without interest. The aggregate cash payment to holders of Class B Stock at the Effective Time was $1,500.0 million. We utilized our $1.0 billion delayed draw three-year term loan facility under the August 2022 Term Credit Agreement and borrowings under our commercial paper program to fund the aggregate cash payment to holders of Class B Stock.

XML

Net Income (Loss) Per Common Share Attributable to CBI

9 Months Ended

Nov. 30, 2023

Earnings Per Share [Abstract]

NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI

NET INCOME (LOSS) PER COMMON SHARE ATTRIBUTABLE TO CBI

For the nine months and three months ended November 30, 2023, net income (loss) per common share – basic for Class A Stock has been computed based on the weighted average shares of common stock outstanding during the period. Net income (loss) per common share – diluted for Class A Stock reflects the weighted average shares of common stock plus the effect of dilutive securities outstanding during the period using the treasury stock method. The effect of dilutive securities includes the impact of outstanding stock-based awards. The dilutive computation does not assume conversion, exercise, or contingent issuance of securities that would have an anti-dilutive effect on the net income (loss) per common share attributable to CBI. The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows:

	For the Nine Months Ended November 30, 2023		For the Three Months Ended November 30, 2023
(in millions, except per share data)
Net income (loss) attributable to CBI	$	1,335.0	$	509.1
Weighted average common shares outstanding – basic	183.431		183.525
Stock-based awards, primarily stock options	0.665		0.645
Weighted average common shares outstanding – diluted	184.096		184.170
Net income (loss) per common share attributable to CBI – basic	$	7.28	$	2.77
Net income (loss) per common share attributable to CBI – diluted	$	7.25	$	2.76

For the nine months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock and Class B Stock has been computed using the two-class method. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock has been computed using the if-converted method and assumes the exercise of stock options using the treasury stock method and the conversion of Class B Stock as this method is more dilutive than the two-class method, until such conversion took place pursuant to the Reclassification. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class B Stock has been computed using the two-class method and does not assume conversion of Class B Stock into shares of Class A Stock. The computation of basic and diluted net income (loss) per common share are as follows:

	For the Nine Months Ended November 30, 2022				For the Three Months Ended November 30, 2022
	Class A Stock		Class B Stock (1)		Class A Stock		Class B Stock (1)
(in millions, except per share data)
Net income (loss) attributable to CBI allocated – basic	$	(247.3)	$	(46.7)	$	426.3	$	41.4
Conversion of Class B common shares into Class A common shares	—		—		41.4		—
Effect of stock-based awards on allocated net income (loss)	—		—		—		(0.1)
Net income (loss) attributable to CBI allocated – diluted	$	(247.3)	$	(46.7)	$	467.7	$	41.3
Weighted average common shares outstanding – basic	164.573		23.206		166.677		23.206
Conversion of Class B common shares into Class A common shares	—		—		17.850		—
Stock-based awards, primarily stock options (2)	—		—		0.764		—
Weighted average common shares outstanding – diluted	164.573		23.206		185.291		23.206
Net income (loss) per common share attributable to CBI – basic	$	(1.48)	$	(2.01)	$	2.58	$	1.78
Net income (loss) per common share attributable to CBI – diluted	$	(1.48)	$	(2.01)	$	2.52	$	1.78

(1)	Net income (loss) per common share attributable to CBI for Class B Stock was determined for the relevant periods through November 10, 2022, the date the Reclassification was completed.
(2)	We have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share for the nine months ended November 30, 2022, as the effect of including these would have been anti-dilutive:
		(in millions)
		Class B Stock	21.434
		Stock-based awards, primarily stock options	0.786

XML

Comprehensive Income (Loss) Attributable to CBI

9 Months Ended

Nov. 30, 2023

Equity [Abstract]

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI

COMPREHENSIVE INCOME (LOSS) ATTRIBUTABLE TO CBI

Comprehensive income (loss) consists of net income (loss), foreign currency translation adjustments, unrealized net gain (loss) on derivative instruments, pension/postretirement adjustments, and our share of OCI of equity method investments. The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows:

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
For the Nine Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	1,335.0
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	264.2	$	—	264.2
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	264.2		—		264.2
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	192.1		(22.9)		169.2
Amounts reclassified	(108.8)		12.6		(96.2)
Net gain (loss) recognized in other comprehensive income (loss)	83.3		(10.3)		73.0
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)
Share of OCI of equity method investments
Net gain (loss)	(0.9)		(0.1)		(1.0)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.9)		(0.1)		(1.0)
Other comprehensive income (loss) attributable to CBI	$	346.2	$	(10.3)	335.9
Comprehensive income (loss) attributable to CBI					$	1,670.9
For the Nine Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	(294.0)
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	85.8	$	—	85.8
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	85.8		—		85.8
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	178.1		(23.4)		154.7
Amounts reclassified	(32.6)		3.2		(29.4)
Net gain (loss) recognized in other comprehensive income (loss)	145.5		(20.2)		125.3
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(2.4)		3.4		1.0
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(2.4)		3.4		1.0
Other comprehensive income (loss) attributable to CBI	$	228.5	$	(16.7)	211.8
Comprehensive income (loss) attributable to CBI					$	(82.2)
For the Three Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	509.1
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	(59.4)	$	—	(59.4)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(59.4)		—		(59.4)
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	29.3		(3.4)		25.9
Amounts reclassified	(39.3)		4.6		(34.7)
Net gain (loss) recognized in other comprehensive income (loss)	(10.0)		1.2		(8.8)
Pension/postretirement adjustments:
Net actuarial gain (loss)	0.1		—		0.1
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	0.1		—		0.1
Share of OCI of equity method investments
Net gain (loss)	(1.7)		(0.2)		(1.9)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(1.7)		(0.2)		(1.9)
Other comprehensive income (loss) attributable to CBI	$	(71.0)	$	1.0	(70.0)
Comprehensive income (loss) attributable to CBI					$	439.1
For the Three Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	467.7
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	96.9	$	—	96.9
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	96.9		—		96.9
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	82.4		(10.3)		72.1
Amounts reclassified	(12.3)		1.3		(11.0)
Net gain (loss) recognized in other comprehensive income (loss)	70.1		(9.0)		61.1
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.2)		—		(0.2)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.2)		—		(0.2)

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(3.3)		—		(3.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(3.3)		—		(3.3)
Other comprehensive income (loss) attributable to CBI	$	163.5	$	(9.0)	154.5
Comprehensive income (loss) attributable to CBI					$	622.2

Accumulated other comprehensive income (loss), net of income tax effect, includes the following components:

	Foreign Currency Translation Adjustments		Unrealized Net Gain (Loss) on Derivative Instruments		Pension/ Postretirement Adjustments		Share of OCI of Equity Method Investments		Accumulated Other Comprehensive Income (Loss)
(in millions)
Balance, February 28, 2023	$	(176.4)	$	198.5	$	(3.9)	$	10.3	$	28.5
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	264.2		169.2		(0.3)		(1.0)		432.1
Amounts reclassified from accumulated other comprehensive income (loss)	—		(96.2)		—		—		(96.2)
Other comprehensive income (loss)	264.2		73.0		(0.3)		(1.0)		335.9
Balance, November 30, 2023	$	87.8	$	271.5	$	(4.2)	$	9.3	$	364.4

XML

Business Segment Information

9 Months Ended

Nov. 30, 2023

Segment Reporting [Abstract]

BUSINESS SEGMENT INFORMATION

BUSINESS SEGMENT INFORMATION

Prior to May 31, 2023, our internal management financial reporting consisted of three business divisions: (i) Beer, (ii) Wine and Spirits, and (iii) Canopy and we reported our operating results in four segments: (i) Beer, (ii) Wine and Spirits, (iii) Corporate Operations and Other, and (iv) Canopy. Due to several factors occurring as of May 31, 2023, including those which led to the additional Canopy Equity Method Investment impairment combined with Canopy’s financial results no longer being provided to, or reviewed by, our CODM, and no longer being used to make strategic decisions, allocate resources, or assess performance, we have removed Canopy as a reportable segment. Accordingly, effective May 31, 2023, our internal management financial reporting consists of two business divisions: (i) Beer and (ii) Wine and Spirits and we report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other.

In the Beer segment, our portfolio consists of high-end imported beer brands and ABAs. We have an exclusive perpetual brand license to produce our Mexican beer portfolio and to import, market, and sell such portfolio in the U.S. In the Wine and Spirits segment, we sell a portfolio that includes higher-end wine brands complemented by certain higher-end spirits brands. Amounts included in the Corporate Operations and Other segment consist of costs of executive management, corporate development, corporate finance, corporate growth and strategy, human resources, internal audit, investor relations, IT, legal, and public relations, as well as our Canopy investment and investments made through our corporate venture capital function. All costs included in the Corporate Operations and Other segment are general costs that are applicable to the consolidated group and are, therefore, not allocated to the other reportable segments. All costs reported within the Corporate Operations and Other segment are not included in our CODM’s evaluation of the operating income (loss) performance of the other reportable segments. The business segments reflect how our operations are managed, how resources are allocated, how operating performance is evaluated by senior management, and the structure of our internal financial reporting. Long-lived tangible assets and total asset information by segment is not provided to, or reviewed by, our CODM as it is not used to make strategic decisions, allocate resources, or assess performance.

In addition, management excludes Comparable Adjustments from its evaluation of the results of each operating segment as these Comparable Adjustments are not reflective of core operations of the segments. Segment operating performance and the incentive compensation of segment management are evaluated based on core segment operating income (loss) which does not include the impact of these Comparable Adjustments.

We evaluate segment operating performance based on operating income (loss) of the respective business units. Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$	(28.9)	$	25.3	$	(13.3)	$	(7.8)
Flow through of inventory step-up	(2.7)		(4.0)		(1.2)		(2.1)
Settlements of undesignated commodity derivative contracts	8.5		(68.8)		2.3		(14.2)
Strategic business development costs	—		(1.1)		—		(1.1)
Net flow through of reserved inventory	—		1.2		—		—
Recovery of (loss on) inventory write-down	—		0.2		—		—
Comparable Adjustments, Cost of product sold	(23.1)		(47.2)		(12.2)		(25.2)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(23.6)		(2.8)		(5.3)		(0.2)
Transition services agreements activity	(17.9)		(11.4)		(5.2)		(3.5)
Gain (loss) on sale of business	(15.1)		13.8		(0.2)		13.8
Transaction, integration, and other acquisition-related costs	(0.6)		(1.2)		—		(0.5)
Costs associated with the Reclassification	0.2		(31.5)		—		(10.2)
Other gains (losses) (1)	5.6		11.6		—		2.8
Comparable Adjustments, Selling, general, and administrative expenses	(51.4)		(21.5)		(10.7)		2.2
Comparable Adjustments, Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)

(1)	Primarily includes the following:
		For the Nine Months Ended November 30,				For the Three Months Ended November 30,
		2023		2022		2023		2022
	(in millions)
	Recognition of a previously deferred gain upon release of a related indemnity	$	5.6	$	—	$	—	$	—
	Gain from remeasurement of previously held equity method investments	$	—	$	5.2	$	—	$	—
	Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions	$	—	$	5.9	$	—	$	1.5

The accounting policies of the segments are the same as those described for the Company in Note 1 of our consolidated financial statements included in our 2023 Annual Report. Segment information is as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Beer
Net sales	$	6,459.8	$	5,929.4	$	1,968.5	$	1,891.9
Segment operating income (loss)	$	2,509.0	$	2,338.4	$	757.3	$	710.0
Capital expenditures	$	704.4	$	539.3	$	264.1	$	181.5
Depreciation and amortization	$	242.2	$	206.2	$	82.0	$	71.0
Wine and Spirits
Net sales:
Wine	$	1,180.7	$	1,316.6	$	435.8	$	470.5
Spirits	182.1		208.8		66.6		74.1
Net sales	$	1,362.8	$	1,525.4	$	502.4	$	544.6
Segment operating income (loss)	$	287.6	$	325.2	$	127.6	$	134.8
Income (loss) from unconsolidated investments	$	38.1	$	40.3	$	27.5	$	35.4
Equity method investments	$	130.5	$	134.7	$	130.5	$	134.7
Capital expenditures	$	107.1	$	83.2	$	29.6	$	31.6
Depreciation and amortization	$	68.1	$	63.3	$	22.5	$	20.0
Corporate Operations and Other
Segment operating income (loss)	$	(181.8)	$	(218.7)	$	(65.1)	$	(75.1)
Income (loss) from unconsolidated investments	$	(62.7)	$	(132.1)	$	(8.3)	$	(41.1)
Equity method investments	$	102.8	$	636.7	$	102.8	$	636.7
Capital expenditures	$	100.4	$	61.3	$	36.2	$	35.7
Depreciation and amortization	$	12.5	$	11.7	$	3.9	$	4.8
Comparable Adjustments
Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)
Income (loss) from unconsolidated investments	$	(452.8)	$	(1,852.4)	$	(61.0)	$	(31.5)
Consolidated
Net sales	$	7,822.6	$	7,454.8	$	2,470.9	$	2,436.5
Operating income (loss)	$	2,540.3	$	2,376.2	$	796.9	$	746.7
Income (loss) from unconsolidated investments (1)	$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)
Equity method investments	$	233.3	$	771.4	$	233.3	$	771.4
Capital expenditures	$	911.9	$	683.8	$	329.9	$	248.8
Depreciation and amortization	$	322.8	$	281.2	$	108.4	$	95.8

(1)	Income (loss) from unconsolidated investments consists of:
			For the Nine Months Ended November 30,				For the Three Months Ended November 30,
			2023		2022		2023		2022
		(in millions)
		Impairment of equity method investments	$	(136.1)	$	(1,060.3)	$	(0.3)	$	—
		Unrealized net gain (loss) on securities measured at fair value	(85.4)		(39.1)		(11.0)		(7.4)
		Equity in earnings (losses) from Canopy and related activities	(288.3)		(876.5)		(56.5)		(60.8)
		Equity in earnings (losses) from other equity method investees and related activities	32.1		31.7		25.7		31.0
		Net gain (loss) on sale of unconsolidated investment	0.3		—		0.3		—
			$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)

XML

Subsequent Event

9 Months Ended

Nov. 30, 2023

Subsequent Events [Abstract]

SUBSEQUENT EVENT

SUBSEQUENT EVENT

Insurance recoveries

In December 2023, we recorded $37 million of business interruption and other recoveries from our insurance carrier. We are pursuing additional reimbursement from another insurance carrier, however there can be no assurance there will be any incremental recoveries. These recoveries related to an outage at our Nava Brewery due to severe winter weather events in early 2021. These proceeds will be included in our consolidated results of operations for the year ending February 29, 2024.

XML

Pay vs Performance Disclosure - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Pay vs Performance Disclosure
Net income (loss) attributable to CBI	$ 509.1	$ 467.7	$ 1,335.0	$ (294.0)

XML

Insider Trading Arrangements	3 Months Ended
	Nov. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

XML

Basis of Presentation (Policies)

9 Months Ended

Nov. 30, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Basis of presentation

We have prepared the Financial Statements, without audit, pursuant to the rules and regulations of the SEC applicable to quarterly reporting on Form 10-Q and reflect, in our opinion, all adjustments necessary to present fairly our financial information. All such adjustments are of a normal recurring nature. Certain information and footnote disclosures normally included in financial statements, prepared in accordance with generally accepted accounting principles, have been condensed or omitted as permitted by such rules and regulations. These Financial Statements should be read in conjunction with the consolidated financial statements and related notes included in the 2023 Annual Report. Results of operations for interim periods are not necessarily indicative of annual results.

Effective May 31, 2023, we changed our internal management financial reporting to consist of two business divisions: (i) Beer and (ii) Wine and Spirits and we now report our operating results in three segments: (i) Beer, (ii) Wine and Spirits, and (iii) Corporate Operations and Other following the removal of the Canopy operating segment. All financial information for the nine months and three months ended November 30, 2022, has been restated to conform to the new segment presentation. For additional information, refer to Note 13.

XML

Inventories (Tables)

9 Months Ended

Nov. 30, 2023

Inventory Disclosure [Abstract]

Schedule of Components of Inventories

Elements of cost include materials, labor, and overhead and consist of the following:

	November 30, 2023		February 28, 2023
(in millions)
Raw materials and supplies	$	244.0	$	245.5
In-process inventories	1,098.9		967.8
Finished case goods	645.1		685.4
	$	1,988.0	$	1,898.7

XML

Derivative Instruments (Tables)

9 Months Ended

Nov. 30, 2023

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Aggregate notional value of outstanding derivative instruments

The aggregate notional value of outstanding derivative instruments is as follows:

	November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts	$	2,233.3	$	1,969.5
Pre-issuance hedge contracts	$	125.0	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts	$	578.9	$	831.7
Commodity derivative contracts	$	383.9	$	416.5

Fair value and location of derivative instruments on our balance sheets

The estimated fair value and location of our derivative instruments on our balance sheets are as follows (see Note 4):

Assets					Liabilities
	November 30, 2023		February 28, 2023			November 30, 2023		February 28, 2023
(in millions)
Derivative instruments designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	152.6	$	109.1	Other accrued expenses and liabilities	$	4.3	$	9.8
Other assets	$	166.2	$	134.5	Deferred income taxes and other liabilities	$	0.4	$	3.5
Pre-issuance hedge contracts:
Prepaid expenses and other	$	—	$	—	Other accrued expenses and liabilities	$	0.1	$	—
Derivative instruments not designated as hedging instruments
Foreign currency contracts:
Prepaid expenses and other	$	8.1	$	5.9	Other accrued expenses and liabilities	$	5.7	$	3.9
Commodity derivative contracts:
Prepaid expenses and other	$	6.7	$	21.2	Other accrued expenses and liabilities	$	24.9	$	19.5
Other assets	$	2.8	$	4.6	Deferred income taxes and other liabilities	$	6.4	$	8.3

Effect of derivative instruments on our results of operations and OCI

The principal effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, as well as OCI, net of income tax effect, is as follows:

Derivative Instruments in Designated Cash Flow Hedging Relationships	Net Gain (Loss) Recognized in OCI		Location of Net Gain (Loss) Reclassified from AOCI to Income (Loss)	Net Gain (Loss) Reclassified from AOCI to Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Foreign currency contracts	$	177.1	Sales	$	(0.2)
			Cost of product sold	102.3
Pre-issuance hedge contracts	0.5		Interest expense	(0.4)
	$	177.6		$	101.7
For the Nine Months Ended November 30, 2022
Foreign currency contracts	$	146.6	Sales	$	(1.4)
			Cost of product sold	34.0
Pre-issuance hedge contracts	15.7		Interest expense	(0.8)
	$	162.3		$	31.8
For the Three Months Ended November 30, 2023
Foreign currency contracts	$	27.2	Sales	$	—
			Cost of product sold	36.6
Pre-issuance hedge contracts	(0.1)		Interest expense	(0.1)
	$	27.1		$	36.5
For the Three Months Ended November 30, 2022
Foreign currency contracts	$	75.3	Sales	$	(0.2)
			Cost of product sold	12.1
Pre-issuance hedge contracts	—		Interest expense	(0.2)
	$	75.3		$	11.7

The effect of our undesignated derivative instruments on our results of operations is as follows:

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(28.9)
Foreign currency contracts	Selling, general, and administrative expenses	12.7
		$	(16.2)

Derivative Instruments Not Designated as Hedging Instruments	Location of Net Gain (Loss) Recognized in Income (Loss)	Net Gain (Loss) Recognized in Income (Loss)
(in millions)
For the Nine Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	25.3
Foreign currency contracts	Selling, general, and administrative expenses	(11.9)
		$	13.4
For the Three Months Ended November 30, 2023
Commodity derivative contracts	Cost of product sold	$	(13.3)
Foreign currency contracts	Selling, general, and administrative expenses	(9.8)
		$	(23.1)
For the Three Months Ended November 30, 2022
Commodity derivative contracts	Cost of product sold	$	(7.8)
Foreign currency contracts	Selling, general, and administrative expenses	(9.3)
		$	(17.1)

XML

Fair Value of Financial Instruments (Tables)

9 Months Ended

Nov. 30, 2023

Fair Value Disclosures [Abstract]

Financial assets and liabilities measured at estimated fair value on a recurring basis

The following table presents our financial assets and liabilities measured at estimated fair value on a recurring basis:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
November 30, 2023
Assets:
Foreign currency contracts	$	—	$	326.9	$	—	$	326.9
Commodity derivative contracts	$	—	$	9.5	$	—	$	9.5
Liabilities:
Foreign currency contracts	$	—	$	10.4	$	—	$	10.4
Commodity derivative contracts	$	—	$	31.3	$	—	$	31.3
Pre-issuance hedge contracts	$	—	$	0.1	$	—	$	0.1

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total
(in millions)
February 28, 2023
Assets:
Foreign currency contracts	$	—	$	249.5	$	—	$	249.5
Commodity derivative contracts	$	—	$	25.8	$	—	$	25.8
November 2018 Canopy Warrants	$	—	$	0.2	$	—	$	0.2
Canopy Debt Securities	$	—	$	69.6	$	—	$	69.6
Liabilities:
Foreign currency contracts	$	—	$	17.2	$	—	$	17.2
Commodity derivative contracts	$	—	$	27.8	$	—	$	27.8

Assets and liabilities measured at estimated fair value on a nonrecurring basis

The following table presents our assets and liabilities measured at estimated fair value on a nonrecurring basis for which an impairment assessment was performed for the periods presented:

	Fair Value Measurements Using
	Quoted Prices in Active Markets (Level 1)		Significant Other Observable Inputs (Level 2)		Significant Unobservable Inputs (Level 3)		Total Losses
(in millions)
For the Nine Months Ended November 30, 2023
Equity method investments	$	94.8	$	0.6	$	0.6	$	136.1
For the Nine Months Ended November 30, 2022
Equity method investments	$	621.4	$	—	$	—	$	1,060.3

XML

Goodwill (Tables)

9 Months Ended

Nov. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Changes in the carrying amount of goodwill

The changes in the carrying amount of goodwill are as follows:

	Beer		Wine and Spirits		Consolidated
(in millions)
Balance, February 28, 2022	$	5,120.7	$	2,741.7	$	7,862.4
Purchase accounting allocations (1)	—		26.3		26.3
Wine Divestiture	—		(24.5)		(24.5)
Foreign currency translation adjustments	68.2		(7.0)		61.2
Balance, February 28, 2023	5,188.9		2,736.5		7,925.4
Purchase accounting allocations (2)	—		6.5		6.5
Foreign currency translation adjustments	46.3		—		46.3
Balance, November 30, 2023	$	5,235.2	$	2,743.0	$	7,978.2

(1)Purchase accounting allocations associated with the acquisitions of Austin Cocktails, Lingua Franca, and My Favorite Neighbor, LLC.

(2)Preliminary purchase accounting allocation associated with the June 2023 acquisition of the Domaine Curry wine business.

Components of gain (loss) on sale of business

The following table summarizes the net gain recognized in connection with this divestiture for the nine months and three months ended November 30, 2022:

(in millions)
Cash received from buyer	$	96.7
Net assets sold	(68.1)
Direct costs to sell (1)	(14.8)
Gain on sale of business (2)	$	13.8

(1)Includes certain contract termination costs.

(2)Included in selling, general, and administrative expenses within our consolidated results of operations.

XML

Intangible Assets (Tables)

9 Months Ended

Nov. 30, 2023

Goodwill and Intangible Assets Disclosure [Abstract]

Major components of intangible assets, Amortizable intangible assets

The major components of intangible assets are as follows:

	November 30, 2023				February 28, 2023
	Gross Carrying Amount		Net Carrying Amount		Gross Carrying Amount		Net Carrying Amount
(in millions)
Amortizable intangible assets
Customer relationships	$	85.4	$	16.5	$	85.7	$	17.7
Other	20.8		0.3		20.8		—
Total	$	106.2	16.8		$	106.5	17.7
Nonamortizable intangible assets
Trademarks			2,715.4				2,710.4
Total intangible assets			$	2,732.2			$	2,728.1

Major components of intangible assets, Nonamortizable intangible assets

The major components of intangible assets are as follows:

	November 30, 2023				February 28, 2023
	Gross Carrying Amount		Net Carrying Amount		Gross Carrying Amount		Net Carrying Amount
(in millions)
Amortizable intangible assets
Customer relationships	$	85.4	$	16.5	$	85.7	$	17.7
Other	20.8		0.3		20.8		—
Total	$	106.2	16.8		$	106.5	17.7
Nonamortizable intangible assets
Trademarks			2,715.4				2,710.4
Total intangible assets			$	2,732.2			$	2,728.1

XML

Equity Method Investments (Tables)

9 Months Ended

Nov. 30, 2023

Equity Method Investments and Joint Ventures [Abstract]

Equity method investments

Our equity method investments are as follows:

	November 30, 2023				February 28, 2023
	Carrying Value		Ownership Percentage		Carrying Value		Ownership Percentage
(in millions)
Canopy Equity Method Investment (1)	$	73.6	20.7	%	$	485.8	34.7	%
Other equity method investments	159.7		20%-50%		177.5		20%-50%
	$	233.3			$	663.3

(1)The fair value based on the closing price of the underlying equity security as of November 30, 2023, and February 28, 2023, was $94.8 million and $398.4 million, respectively.

Amounts included in our consolidated results of operations for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Equity in earnings (losses) from Canopy and related activities	$	(288.3)	$	(876.5)	$	(56.5)	$	(60.8)

XML

Borrowings (Tables)

9 Months Ended

Nov. 30, 2023

Debt Disclosure [Abstract]

Borrowings

Borrowings consist of the following:

	November 30, 2023						February 28, 2023
	Current		Long-term		Total		Total
(in millions)
Short-term borrowings
Commercial paper	$	458.9					$	1,165.3
	$	458.9					$	1,165.3
Long-term debt
Term loan credit facilities	$	—	$	—	$	—	$	799.2
Senior notes	948.8		10,270.8		11,219.6		10,470.6
Other	8.5		11.5		20.0		26.2
	$	957.3	$	10,282.3	$	11,239.6	$	11,296.0

As of November 30, 2023, information with respect to borrowings under the 2022 Credit Agreement is as follows:

	Outstanding borrowings		Interest rate		SOFR margin		Outstanding letters of credit		Remaining borrowing capacity (1)
(in millions)
2022 Credit Agreement
Revolving credit facility (2) (3)	$	—	—	%	—	%	$	11.5	$	1,779.0

(1)Net of outstanding revolving credit facility borrowings and outstanding letters of credit under the 2022 Credit Agreement and outstanding borrowings under our commercial paper program of $459.5 million (excluding unamortized discount) (see “Commercial paper program” below).

(2)Contractual interest rate varies based on our debt rating (as defined in the agreement) and is a function of SOFR plus a margin and a credit spread adjustment, or the base rate plus a margin, or, in certain circumstances where SOFR cannot be adequately ascertained or available, an alternative benchmark rate plus a margin.

(3)We and/or CB International are the borrower under the $2,250.0 million revolving credit facility with a maturity date of April 14, 2027. Includes a sub-facility for letters of credit of up to $200.0 million.

Schedule of maturities of long-term debt

As of November 30, 2023, the required principal repayments under long-term debt obligations (excluding unamortized debt issuance costs and unamortized discounts of $56.6 million and $23.8 million, respectively) for the remaining three months of Fiscal 2024 and for each of the five succeeding fiscal years and thereafter are as follows:

(in millions)
Fiscal 2024	$	2.2
Fiscal 2025	957.5
Fiscal 2026	1,404.9
Fiscal 2027	603.8
Fiscal 2028	1,801.5
Fiscal 2029	500.0
Thereafter	6,050.1
	$	11,320.0

XML

Stockholders' Equity (Tables)

9 Months Ended

Nov. 30, 2023

Equity [Abstract]

Number of shares of common stock issued and treasury stock, and associated share activity

The number of shares of common stock issued and treasury stock, and associated share activity, are as follows:

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Balance at February 28, 2023	212,697,428	—	22,705	29,498,426	—
Share repurchases	—	—	—	153,937	—
Conversion of shares	80	—	(80)	—	—
Exercise of stock options	—	—	800	(129,595)	—
Vesting of restricted stock units (2)	—	—	—	(71,189)	—
Vesting of performance share units (2)	—	—	—	(13,113)	—
Balance at May 31, 2023	212,697,508	—	23,425	29,438,466	—

	Common Stock			Treasury Stock
	Class A	Class B (1)	Class 1	Class A	Class B (1)
Conversion of shares	220	—	(220)	—	—
Exercise of stock options	—	—	606	(364,530)	—
Employee stock purchases	—	—	—	(30,172)	—
Vesting of restricted stock units (2)	—	—	—	(5,172)	—
Balance at August 31, 2023	212,697,728	—	23,811	29,038,592	—
Share repurchases	—	—	—	889,429	—
Conversion of shares	570	—	(570)	—	—
Exercise of stock options	—	—	—	(22,587)	—
Vesting of restricted stock units (2)	—	—	—	(68)	—
Balance at November 30, 2023	212,698,298	—	23,241	29,905,366	—
Balance at February 28, 2022	187,263,859	28,212,340	2,248,679	22,824,607	5,005,800
Share repurchases	—	—	—	4,065,508	—
Conversion of shares	655	(655)	—	—	—
Exercise of stock options	—	—	35	(108,228)	—
Vesting of restricted stock units (2)	—	—	—	(71,064)	—
Vesting of performance share units (2)	—	—	—	(16,326)	—
Balance at May 31, 2022	187,264,514	28,211,685	2,248,714	26,694,497	5,005,800
Share repurchases	—	—	—	1,652,445	—
Conversion of shares	2,196,749	—	(2,196,749)	—	—
Exercise of stock options	—	—	—	(75,482)	—
Employee stock purchases	—	—	—	(27,514)	—
Vesting of restricted stock units (2)	—	—	—	(4,851)	—
Balance at August 31, 2022	189,461,263	28,211,685	51,965	28,239,095	5,005,800
Retirement of treasury shares	—	(5,005,800)	—	—	(5,005,800)
Conversion of shares	23,205,885	(23,205,885)	—	—	—
Exercise of stock options	—	—	470	(63,529)	—
Balance at November 30, 2022	212,667,148	—	52,435	28,175,566	—

(1)Prior to the Reclassification, we had an additional class of common stock with a material number of shares outstanding: Class B Stock. Shares of Class B Stock were convertible into shares of Class A Stock on a one-to-one basis at any time at the option of the holder. For additional information, refer to “Reclassification” below.

(2)Net of the following shares withheld to satisfy tax withholding requirements:

	For the Three Months Ended May 31,	For the Three Months Ended August 31,	For the Three Months Ended November 30,	For the Nine Months Ended November 30,
2023
Restricted Stock Units	39,839	170	—	40,009
Performance Share Units	8,735	—	—	8,735
2022
Restricted Stock Units	37,308	186	—	37,494
Performance Share Units	4,919	—	—	4,919

Summary of share repurchase activity

As of November 30, 2023, total shares repurchased under the 2021 Authorization and the 2023 Authorization are as follows:

			Class A Stock
	Repurchase Authorization		Dollar Value of Shares Repurchased		Number of Shares Repurchased
(in millions, except share data)
2021 Authorization	$	2,000.0	$	1,386.3	5,875,276
2023 Authorization	$	2,000.0	$	—	—

XML

Net Income (Loss) Per Common Share Attributable to CBI (Tables)

9 Months Ended

Nov. 30, 2023

Earnings Per Share [Abstract]

Basic and diluted net income (loss) per common share attributable to CBI

The computation of basic and diluted net income (loss) per common share for Class A Stock are as follows:

	For the Nine Months Ended November 30, 2023		For the Three Months Ended November 30, 2023
(in millions, except per share data)
Net income (loss) attributable to CBI	$	1,335.0	$	509.1
Weighted average common shares outstanding – basic	183.431		183.525
Stock-based awards, primarily stock options	0.665		0.645
Weighted average common shares outstanding – diluted	184.096		184.170
Net income (loss) per common share attributable to CBI – basic	$	7.28	$	2.77
Net income (loss) per common share attributable to CBI – diluted	$	7.25	$	2.76

For the nine months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock and Class B Stock has been computed using the two-class method. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class A Stock has been computed using the if-converted method and assumes the exercise of stock options using the treasury stock method and the conversion of Class B Stock as this method is more dilutive than the two-class method, until such conversion took place pursuant to the Reclassification. For the three months ended November 30, 2022, net income (loss) per common share – diluted for Class B Stock has been computed using the two-class method and does not assume conversion of Class B Stock into shares of Class A Stock. The computation of basic and diluted net income (loss) per common share are as follows:

	For the Nine Months Ended November 30, 2022				For the Three Months Ended November 30, 2022
	Class A Stock		Class B Stock (1)		Class A Stock		Class B Stock (1)
(in millions, except per share data)
Net income (loss) attributable to CBI allocated – basic	$	(247.3)	$	(46.7)	$	426.3	$	41.4
Conversion of Class B common shares into Class A common shares	—		—		41.4		—
Effect of stock-based awards on allocated net income (loss)	—		—		—		(0.1)
Net income (loss) attributable to CBI allocated – diluted	$	(247.3)	$	(46.7)	$	467.7	$	41.3
Weighted average common shares outstanding – basic	164.573		23.206		166.677		23.206
Conversion of Class B common shares into Class A common shares	—		—		17.850		—
Stock-based awards, primarily stock options (2)	—		—		0.764		—
Weighted average common shares outstanding – diluted	164.573		23.206		185.291		23.206
Net income (loss) per common share attributable to CBI – basic	$	(1.48)	$	(2.01)	$	2.58	$	1.78
Net income (loss) per common share attributable to CBI – diluted	$	(1.48)	$	(2.01)	$	2.52	$	1.78

(1)	Net income (loss) per common share attributable to CBI for Class B Stock was determined for the relevant periods through November 10, 2022, the date the Reclassification was completed.
(2)	We have excluded the following weighted average common shares outstanding from the calculation of diluted net income (loss) per common share for the nine months ended November 30, 2022, as the effect of including these would have been anti-dilutive:
		(in millions)
		Class B Stock	21.434
		Stock-based awards, primarily stock options	0.786

XML

Comprehensive Income (Loss) Attributable to CBI (Tables)

9 Months Ended

Nov. 30, 2023

Equity [Abstract]

Reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI

The reconciliation of net income (loss) attributable to CBI to comprehensive income (loss) attributable to CBI is as follows:

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
For the Nine Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	1,335.0
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	264.2	$	—	264.2
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	264.2		—		264.2
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	192.1		(22.9)		169.2
Amounts reclassified	(108.8)		12.6		(96.2)
Net gain (loss) recognized in other comprehensive income (loss)	83.3		(10.3)		73.0
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)
Share of OCI of equity method investments
Net gain (loss)	(0.9)		(0.1)		(1.0)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.9)		(0.1)		(1.0)
Other comprehensive income (loss) attributable to CBI	$	346.2	$	(10.3)	335.9
Comprehensive income (loss) attributable to CBI					$	1,670.9
For the Nine Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	(294.0)
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	85.8	$	—	85.8
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	85.8		—		85.8
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	178.1		(23.4)		154.7
Amounts reclassified	(32.6)		3.2		(29.4)
Net gain (loss) recognized in other comprehensive income (loss)	145.5		(20.2)		125.3
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.4)		0.1		(0.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.4)		0.1		(0.3)

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(2.4)		3.4		1.0
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(2.4)		3.4		1.0
Other comprehensive income (loss) attributable to CBI	$	228.5	$	(16.7)	211.8
Comprehensive income (loss) attributable to CBI					$	(82.2)
For the Three Months Ended November 30, 2023
Net income (loss) attributable to CBI					$	509.1
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	(59.4)	$	—	(59.4)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(59.4)		—		(59.4)
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	29.3		(3.4)		25.9
Amounts reclassified	(39.3)		4.6		(34.7)
Net gain (loss) recognized in other comprehensive income (loss)	(10.0)		1.2		(8.8)
Pension/postretirement adjustments:
Net actuarial gain (loss)	0.1		—		0.1
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	0.1		—		0.1
Share of OCI of equity method investments
Net gain (loss)	(1.7)		(0.2)		(1.9)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(1.7)		(0.2)		(1.9)
Other comprehensive income (loss) attributable to CBI	$	(71.0)	$	1.0	(70.0)
Comprehensive income (loss) attributable to CBI					$	439.1
For the Three Months Ended November 30, 2022
Net income (loss) attributable to CBI					$	467.7
Other comprehensive income (loss) attributable to CBI:
Foreign currency translation adjustments:
Net gain (loss)	$	96.9	$	—	96.9
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	96.9		—		96.9
Unrealized gain (loss) on cash flow hedges:
Net derivative gain (loss)	82.4		(10.3)		72.1
Amounts reclassified	(12.3)		1.3		(11.0)
Net gain (loss) recognized in other comprehensive income (loss)	70.1		(9.0)		61.1
Pension/postretirement adjustments:
Net actuarial gain (loss)	(0.2)		—		(0.2)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(0.2)		—		(0.2)

	Before Tax Amount		Tax (Expense) Benefit		Net of Tax Amount
(in millions)
Share of OCI of equity method investments
Net gain (loss)	(3.3)		—		(3.3)
Amounts reclassified	—		—		—
Net gain (loss) recognized in other comprehensive income (loss)	(3.3)		—		(3.3)
Other comprehensive income (loss) attributable to CBI	$	163.5	$	(9.0)	154.5
Comprehensive income (loss) attributable to CBI					$	622.2

Accumulated other comprehensive income (loss), net of income tax effect

Accumulated other comprehensive income (loss), net of income tax effect, includes the following components:

	Foreign Currency Translation Adjustments		Unrealized Net Gain (Loss) on Derivative Instruments		Pension/ Postretirement Adjustments		Share of OCI of Equity Method Investments		Accumulated Other Comprehensive Income (Loss)
(in millions)
Balance, February 28, 2023	$	(176.4)	$	198.5	$	(3.9)	$	10.3	$	28.5
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	264.2		169.2		(0.3)		(1.0)		432.1
Amounts reclassified from accumulated other comprehensive income (loss)	—		(96.2)		—		—		(96.2)
Other comprehensive income (loss)	264.2		73.0		(0.3)		(1.0)		335.9
Balance, November 30, 2023	$	87.8	$	271.5	$	(4.2)	$	9.3	$	364.4

XML

Business Segment Information (Tables)

9 Months Ended

Nov. 30, 2023

Segment Reporting [Abstract]

Comparable adjustments

Comparable Adjustments that impacted comparability in our segment operating income (loss) for each period are as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$	(28.9)	$	25.3	$	(13.3)	$	(7.8)
Flow through of inventory step-up	(2.7)		(4.0)		(1.2)		(2.1)
Settlements of undesignated commodity derivative contracts	8.5		(68.8)		2.3		(14.2)
Strategic business development costs	—		(1.1)		—		(1.1)
Net flow through of reserved inventory	—		1.2		—		—
Recovery of (loss on) inventory write-down	—		0.2		—		—
Comparable Adjustments, Cost of product sold	(23.1)		(47.2)		(12.2)		(25.2)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(23.6)		(2.8)		(5.3)		(0.2)
Transition services agreements activity	(17.9)		(11.4)		(5.2)		(3.5)
Gain (loss) on sale of business	(15.1)		13.8		(0.2)		13.8
Transaction, integration, and other acquisition-related costs	(0.6)		(1.2)		—		(0.5)
Costs associated with the Reclassification	0.2		(31.5)		—		(10.2)
Other gains (losses) (1)	5.6		11.6		—		2.8
Comparable Adjustments, Selling, general, and administrative expenses	(51.4)		(21.5)		(10.7)		2.2
Comparable Adjustments, Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)

(1)	Primarily includes the following:
		For the Nine Months Ended November 30,				For the Three Months Ended November 30,
		2023		2022		2023		2022
	(in millions)
	Recognition of a previously deferred gain upon release of a related indemnity	$	5.6	$	—	$	—	$	—
	Gain from remeasurement of previously held equity method investments	$	—	$	5.2	$	—	$	—
	Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions	$	—	$	5.9	$	—	$	1.5

Segment information

Segment information is as follows:

	For the Nine Months Ended November 30,				For the Three Months Ended November 30,
	2023		2022		2023		2022
(in millions)
Beer
Net sales	$	6,459.8	$	5,929.4	$	1,968.5	$	1,891.9
Segment operating income (loss)	$	2,509.0	$	2,338.4	$	757.3	$	710.0
Capital expenditures	$	704.4	$	539.3	$	264.1	$	181.5
Depreciation and amortization	$	242.2	$	206.2	$	82.0	$	71.0
Wine and Spirits
Net sales:
Wine	$	1,180.7	$	1,316.6	$	435.8	$	470.5
Spirits	182.1		208.8		66.6		74.1
Net sales	$	1,362.8	$	1,525.4	$	502.4	$	544.6
Segment operating income (loss)	$	287.6	$	325.2	$	127.6	$	134.8
Income (loss) from unconsolidated investments	$	38.1	$	40.3	$	27.5	$	35.4
Equity method investments	$	130.5	$	134.7	$	130.5	$	134.7
Capital expenditures	$	107.1	$	83.2	$	29.6	$	31.6
Depreciation and amortization	$	68.1	$	63.3	$	22.5	$	20.0
Corporate Operations and Other
Segment operating income (loss)	$	(181.8)	$	(218.7)	$	(65.1)	$	(75.1)
Income (loss) from unconsolidated investments	$	(62.7)	$	(132.1)	$	(8.3)	$	(41.1)
Equity method investments	$	102.8	$	636.7	$	102.8	$	636.7
Capital expenditures	$	100.4	$	61.3	$	36.2	$	35.7
Depreciation and amortization	$	12.5	$	11.7	$	3.9	$	4.8
Comparable Adjustments
Operating income (loss)	$	(74.5)	$	(68.7)	$	(22.9)	$	(23.0)
Income (loss) from unconsolidated investments	$	(452.8)	$	(1,852.4)	$	(61.0)	$	(31.5)
Consolidated
Net sales	$	7,822.6	$	7,454.8	$	2,470.9	$	2,436.5
Operating income (loss)	$	2,540.3	$	2,376.2	$	796.9	$	746.7
Income (loss) from unconsolidated investments (1)	$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)
Equity method investments	$	233.3	$	771.4	$	233.3	$	771.4
Capital expenditures	$	911.9	$	683.8	$	329.9	$	248.8
Depreciation and amortization	$	322.8	$	281.2	$	108.4	$	95.8

(1)	Income (loss) from unconsolidated investments consists of:
			For the Nine Months Ended November 30,				For the Three Months Ended November 30,
			2023		2022		2023		2022
		(in millions)
		Impairment of equity method investments	$	(136.1)	$	(1,060.3)	$	(0.3)	$	—
		Unrealized net gain (loss) on securities measured at fair value	(85.4)		(39.1)		(11.0)		(7.4)
		Equity in earnings (losses) from Canopy and related activities	(288.3)		(876.5)		(56.5)		(60.8)
		Equity in earnings (losses) from other equity method investees and related activities	32.1		31.7		25.7		31.0
		Net gain (loss) on sale of unconsolidated investment	0.3		—		0.3		—
			$	(477.4)	$	(1,944.2)	$	(41.8)	$	(37.2)

XML

Basis of Presentation - Narrative (Details)	3 Months Ended	6 Months Ended
	May 31, 2023 segment division	Nov. 30, 2023 division segment
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of business divisions | division	3	2
Number of reportable operating segments | segment	4	3

XML

Inventories - Schedule of Costs of Inventory (Details) - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Inventory Disclosure [Abstract]
Raw materials and supplies	$ 244.0	$ 245.5
In-process inventories	1,098.9	967.8
Finished case goods	645.1	685.4
Inventories, Total	$ 1,988.0	$ 1,898.7

XML

Derivative Instruments - Aggregate Notional Value of Outstanding Derivative Instruments (Details) - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Derivative instruments designated as hedging instruments | Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 2,233.3	$ 1,969.5
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	125.0	0.0
Derivative instruments not designated as hedging instruments | Foreign currency contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	578.9	831.7
Derivative instruments not designated as hedging instruments | Commodity derivative contracts
Derivative [Line Items]
Aggregate notional value of derivative instruments	$ 383.9	$ 416.5

XML

Derivative Instruments - Narrative (Details) $ in Millions	9 Months Ended
	Nov. 30, 2023 USD ($)
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair value of derivative instruments in a net liability position due to counterparties	$ 1.5
Amount of net gains (losses), net of income tax effect, to be reclassified from AOCI to our results of operations within the next 12 months	$ 130.2

XML

Derivative Instruments - Estimated Fair Value and Location of Derivative Instruments (Details) - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Derivative instruments designated as hedging instruments | Foreign currency contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	$ 152.6	$ 109.1
Derivative instruments designated as hedging instruments | Foreign currency contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	4.3	9.8
Derivative instruments designated as hedging instruments | Foreign currency contracts | Other assets
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	166.2	134.5
Derivative instruments designated as hedging instruments | Foreign currency contracts | Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	0.4	3.5
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Interest rate derivative contracts, Assets	0.0	0.0
Derivative instruments designated as hedging instruments | Pre-issuance hedge contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Interest rate derivative contracts, Liabilities	0.1	0.0
Derivative instruments not designated as hedging instruments | Foreign currency contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Assets	8.1	5.9
Derivative instruments not designated as hedging instruments | Foreign currency contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Foreign currency contracts, Liabilities	5.7	3.9
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Prepaid expenses and other
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	6.7	21.2
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Other accrued expenses and liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	24.9	19.5
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Other assets
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Assets	2.8	4.6
Derivative instruments not designated as hedging instruments | Commodity derivative contracts | Deferred income taxes and other liabilities
Fair value and location of our derivative instruments on our balance sheets
Commodity derivative contracts, Liabilities	$ 6.4	$ 8.3

XML

Derivative Instruments - Effects of Designated and Undesignated Hedging Instruments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	$ (23.1)	$ (17.1)	$ (16.2)	$ 13.4
Foreign currency contracts | Selling, general, and administrative expenses
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	(9.8)	(9.3)	12.7	(11.9)
Commodity derivative contracts | Cost of product sold
Effect of our undesignated derivative instruments on our results of operations
Net Gain (Loss) Recognized in Income (Loss)	(13.3)	(7.8)	(28.9)	25.3
Cash flow hedging
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	27.1	75.3	177.6	162.3
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	36.5	11.7	101.7	31.8
Cash flow hedging | Foreign currency contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	27.2	75.3	177.1	146.6
Cash flow hedging | Foreign currency contracts | Sales
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	0.0	(0.2)	(0.2)	(1.4)
Cash flow hedging | Foreign currency contracts | Cost of product sold
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	36.6	12.1	102.3	34.0
Cash flow hedging | Pre-issuance hedge contracts
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Recognized in OCI	(0.1)	0.0	0.5	15.7
Cash flow hedging | Pre-issuance hedge contracts | Interest expense
Effect of our derivative instruments designated in cash flow hedging relationships on our results of operations, net of income tax effect
Net Gain (Loss) Reclassified from AOCI to Income (Loss)	$ (0.1)	$ (0.2)	$ (0.4)	$ (0.8)

XML

Fair Value of Financial Instruments - Debt and Investments (Details) $ in Millions, $ in Millions	Nov. 30, 2023 USD ($)	Apr. 30, 2023 CAD ($)	Feb. 28, 2023 USD ($)
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	$ 11,239.6		$ 11,296.0
Carrying amount
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	11,239.6		11,296.0
Fair value
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Long-term debt, including current portion	10,320.7		$ 10,236.0
Convertible debt securities
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Value of debt securities held, C$		$ 100.0
2018 Canopy Warrants
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of warrants	0.0
2023 Canopy Promissory Note
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Fair value of receivables	$ 0.0

XML

Fair Value of Financial Instruments - Recurring Basis Measurements (Details) - Recurring - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	$ 326.9	$ 249.5
Derivative liability	10.4	17.2
Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	9.5	25.8
Derivative liability	31.3	27.8
Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability	0.1
Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.2
Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		69.6
Quoted Prices in Active Markets (Level 1) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0.0	0.0
Derivative liability	0.0	0.0
Quoted Prices in Active Markets (Level 1) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0.0	0.0
Derivative liability	0.0	0.0
Quoted Prices in Active Markets (Level 1) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability	0.0
Quoted Prices in Active Markets (Level 1) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.0
Quoted Prices in Active Markets (Level 1) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		0.0
Significant Other Observable Inputs (Level 2) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	326.9	249.5
Derivative liability	10.4	17.2
Significant Other Observable Inputs (Level 2) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	9.5	25.8
Derivative liability	31.3	27.8
Significant Other Observable Inputs (Level 2) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability	0.1
Significant Other Observable Inputs (Level 2) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.2
Significant Other Observable Inputs (Level 2) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		69.6
Significant Unobservable Inputs (Level 3) | Foreign currency contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0.0	0.0
Derivative liability	0.0	0.0
Significant Unobservable Inputs (Level 3) | Commodity derivative contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative asset	0.0	0.0
Derivative liability	0.0	0.0
Significant Unobservable Inputs (Level 3) | Pre-issuance hedge contracts
Fair Value, Net Asset (Liability) [Abstract]
Derivative liability	$ 0.0
Significant Unobservable Inputs (Level 3) | Equity securities
Fair Value, Net Asset (Liability) [Abstract]
Equity securities		0.0
Significant Unobservable Inputs (Level 3) | Convertible debt securities
Fair Value, Net Asset (Liability) [Abstract]
Debt securities		$ 0.0

XML

Fair Value of Financial Instruments - Nonrecurring Basis Measurements (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 0.3	$ 0.0	$ 136.1	$ 1,060.3
Nonrecurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses			136.1	1,060.3
Nonrecurring | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	94.8	621.4	94.8	621.4
Nonrecurring | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	0.6	0.0	0.6	0.0
Nonrecurring | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments	$ 0.6	$ 0.0	$ 0.6	$ 0.0

XML

Fair Value of Financial Instruments - Impairment of Equity Method Investments and Long-Lived Assets (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022	Aug. 31, 2023	May 31, 2023	Aug. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, total losses	$ 0.3	$ 0.0	$ 136.1	$ 1,060.3
Corporate Venture Capital, Equity Method Investments, 8/23 Impairment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, carrying value					$ 14.9
Equity method investments					$ 2.6
Equity method investments, total losses			12.3
Canopy Equity Method Investment
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method investments, carrying value						$ 266.2	$ 1,695.1
Equity method investments						$ 142.7	$ 634.8
Equity method investments, total losses		$ 1,060.3	$ 123.5	$ 1,060.3

XML

Goodwill (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended		12 Months Ended
	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022	Feb. 28, 2023	Apr. 30, 2022	Mar. 31, 2022
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period		$ 7,925.4	$ 7,862.4	$ 7,862.4
Purchase accounting allocations		6.5		26.3
2022 Wine Divestiture				(24.5)
Foreign currency translation adjustments		46.3		61.2
Goodwill, end of period		7,978.2		7,925.4
Proceeds from sale of business		5.4	96.7
Disposal Group, Disposed of by Sale, Not Discontinued Operations | 2022 Wine Divestiture
Changes in the carrying amount of goodwill [Roll Forward]
Proceeds from sale of business	$ 96.7		96.7
Net assets sold	(68.1)		(68.1)
Direct costs to sell	(14.8)		(14.8)
Gain (loss) on sale of business	$ 13.8		13.8
Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period					5 years
Lingua Franca Business Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Earn-out period						7 years
Operating Segments | Beer
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period		5,188.9	5,120.7	5,120.7
Purchase accounting allocations		0.0		0.0
2022 Wine Divestiture				0.0
Foreign currency translation adjustments		46.3		68.2
Goodwill, end of period		5,235.2		5,188.9
Operating Segments | Wine and Spirits
Changes in the carrying amount of goodwill [Roll Forward]
Goodwill, beginning of period		2,736.5	$ 2,741.7	2,741.7
Purchase accounting allocations		6.5		26.3
2022 Wine Divestiture				(24.5)
Foreign currency translation adjustments		0.0		(7.0)
Goodwill, end of period		$ 2,743.0		$ 2,736.5
Operating Segments | Wine and Spirits | Austin Cocktails Acquisition
Changes in the carrying amount of goodwill [Roll Forward]
Remaining equity interest					73.00%

XML

Intangible Assets - Component of Intangible Assets (Details) - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	$ 106.2	$ 106.5
Amortizable intangible assets, Net Carrying Amount	16.8	17.7
Indefinite-lived Intangible Assets [Line Items]
Intangible assets	2,732.2	2,728.1
Trademarks
Indefinite-lived Intangible Assets [Line Items]
Nonamortizable intangible assets, Net Carrying Amount	2,715.4	2,710.4
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	85.4	85.7
Amortizable intangible assets, Net Carrying Amount	16.5	17.7
Other
Finite-Lived Intangible Assets [Line Items]
Amortizable intangible assets, Gross Carrying Amount	20.8	20.8
Amortizable intangible assets, Net Carrying Amount	$ 0.3	$ 0.0

XML

Equity Method Investments (Details) shares in Millions, $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Dec. 31, 2023 shares	Nov. 30, 2023 USD ($) shares	Nov. 30, 2022 USD ($)	Nov. 30, 2023 USD ($) shares	Nov. 30, 2022 USD ($)	Feb. 28, 2023 USD ($)	Oct. 31, 2022
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value		$ 233.3	$ 771.4	$ 233.3	$ 771.4	$ 663.3
Canopy | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Reverse stock split, conversion ratio	0.1
Canopy Equity Method Investment
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value		$ 73.6		$ 73.6		$ 485.8
Equity method investment, ownership percentage		20.70%		20.70%		34.70%
Fair value of equity method investment		$ 94.8		$ 94.8		$ 398.4
Equity method investment, in shares | shares		171.5		171.5
Equity in earnings (loss) from Canopy and related activities		$ (56.5)	(60.8)	$ (288.3)	(876.5)
Canopy Equity Method Investment | Subsequent Event
Schedule of Equity Method Investments [Line Items]
Equity method investment, in shares | shares	17.1
Canopy Equity Method Investment | Third Party Investors
Schedule of Equity Method Investments [Line Items]
Ownership percentage							100.00%
Other equity method investments
Schedule of Equity Method Investments [Line Items]
Equity method investments, carrying value		159.7		159.7		$ 177.5
Equity in earnings (loss) from Canopy and related activities		$ 25.7	$ 31.0	$ 32.1	$ 31.7
Other equity method investments | Minimum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage		20.00%		20.00%		20.00%
Other equity method investments | Maximum
Schedule of Equity Method Investments [Line Items]
Equity method investment, ownership percentage		50.00%		50.00%		50.00%

XML

Borrowings - Schedule of Borrowings (Details) - USD ($) $ in Millions	Nov. 30, 2023	Feb. 28, 2023
Schedule of Debt [Line Items]
Short-term borrowings	$ 458.9	$ 1,165.3
Long-term Debt
Other, current	8.5
Other, long-term	11.5
Other, total	20.0	26.2
Long-term debt, current	957.3	9.5
Long-term debt, long-term	10,282.3	11,286.5
Long-term debt, total	11,239.6	11,296.0
Unsecured debt | Term loan credit facilities
Long-term Debt
Unsecured debt, current	0.0
Unsecured debt, long-term	0.0
Unsecured debt, total	0.0	799.2
Unsecured debt | Senior notes
Long-term Debt
Unsecured debt, current	948.8
Unsecured debt, long-term	10,270.8
Unsecured debt, total	11,219.6	10,470.6
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 458.9	$ 1,165.3

XML

Borrowings - Credit Agreements (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Schedule of Debt [Line Items]
Short-term borrowings	$ 458,900,000	$ 1,165,300,000
Revolving credit facility
Schedule of Debt [Line Items]
Short-term borrowings	$ 0
Weighted average interest rate	0.00%
Remaining borrowing capacity	$ 1,779,000,000
Aggregate principal amount	$ 2,250,000,000
Revolving credit facility | SOFR
Schedule of Debt [Line Items]
SOFR margin	0.00%
Letters of credit
Schedule of Debt [Line Items]
Outstanding letters of credit	$ 11,500,000
Aggregate principal amount	200,000,000
Commercial paper
Schedule of Debt [Line Items]
Short-term borrowings	$ 458,900,000	$ 1,165,300,000
Weighted average interest rate	5.80%
Aggregate principal amount	$ 459,500,000		$ 2,250,000,000

XML

Borrowings - Commercial Paper Program (Details) - USD ($)	Nov. 30, 2023	Feb. 28, 2023	Dec. 31, 2022
Schedule of Debt [Line Items]
Short-term borrowings	$ 458,900,000	$ 1,165,300,000
Commercial paper
Schedule of Debt [Line Items]
Aggregate principal amount	459,500,000		$ 2,250,000,000
Short-term borrowings	$ 458,900,000	$ 1,165,300,000
Weighted average interest rate	5.80%
Weighted average remaining term	9 days

XML

Borrowings - Pre-issuance Hedge Contracts (Details) - USD ($) $ in Millions	Dec. 31, 2023	Nov. 30, 2023
Entered November 2023
Schedule of Debt [Line Items]
Amount of hedged item		$ 125.0
Subsequent Event | Pre-issuance hedge contracts
Schedule of Debt [Line Items]
Amount of hedged item	$ 275.0
Subsequent Event | Entered December 2023
Schedule of Debt [Line Items]
Amount of hedged item	$ 150.0

XML

Borrowings - Senior Notes (Details) $ in Millions	1 Months Ended
	May 31, 2023 USD ($)
Schedule of Debt [Line Items]
Basis spread on adjusted treasury rate	0.0025
4.90% May 2023 Senior Notes | Senior Notes
Schedule of Debt [Line Items]
Aggregate principal amount	$ 750.0
Interest rates of notes	4.90%
Proceeds from issuance of debt	$ 739.8
Percentage of outstanding principal amount as redemption price	100.00%

XML

Borrowings - Debt Payments (Details) $ in Millions	Nov. 30, 2023 USD ($)
Debt Disclosure [Abstract]
Unamortized debt issuance costs, long-term debt obligations	$ 56.6
Unamortized discount, long-term debt obligations	23.8
Fiscal 2024	2.2
Fiscal 2025	957.5
Fiscal 2026	1,404.9
Fiscal 2027	603.8
Fiscal 2028	1,801.5
Fiscal 2029	500.0
Thereafter	6,050.1
Total long-term debt, gross	$ 11,320.0

XML

Income Taxes (Details)	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Income Tax Disclosure [Abstract]
Effective tax rate	20.00%	21.50%	21.30%	305.70%

XML

Stockholders' Equity - Summary of Common Stock and Treasury Stock Issued (Details) - shares	3 Months Ended						9 Months Ended
	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022	Nov. 30, 2023	Nov. 30, 2022
Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)			212,697,428				212,697,428
Treasury Stock, beginning of period (in shares)			29,498,426				29,498,426
Number of shares repurchased (in shares)							1,043,366
Common Stock, end of period (in shares)	212,698,298						212,698,298
Treasury Stock, end of period (in shares)	29,905,366						29,905,366
Common Stock | Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	212,697,728	212,697,508	212,697,428	189,461,263	187,264,514	187,263,859	212,697,428	187,263,859
Conversion of shares (in shares)	570	220	80	23,205,885	2,196,749	655
Common Stock, end of period (in shares)	212,698,298	212,697,728	212,697,508	212,667,148	189,461,263	187,264,514	212,698,298	212,667,148
Common Stock | Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	0	0	0	28,211,685	28,211,685	28,212,340	0	28,212,340
Retirement of treasury shares (in shares)				(5,005,800)
Conversion of shares (in shares)				23,205,885		655
Common Stock, end of period (in shares)	0	0	0	0	28,211,685	28,211,685	0	0
Common Stock | Class 1 Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Common Stock, beginning of period (in shares)	23,811	23,425	22,705	51,965	2,248,714	2,248,679	22,705	2,248,679
Conversion of shares (in shares)	570	220	80		2,196,749
Exercise of stock options (in shares)		606	800	470		35
Common Stock, end of period (in shares)	23,241	23,811	23,425	52,435	51,965	2,248,714	23,241	52,435
Treasury Stock | Class A Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	29,038,592	29,438,466	29,498,426	28,239,095	26,694,497	22,824,607	29,498,426	22,824,607
Number of shares repurchased (in shares)	889,429		153,937		1,652,445	4,065,508
Exercise of stock options (in shares)	22,587	364,530	129,595	63,529	75,482	108,228
Employee stock purchases (in shares)		(30,172)			(27,514)
Treasury Stock, end of period (in shares)	29,905,366	29,038,592	29,438,466	28,175,566	28,239,095	26,694,497	29,905,366	28,175,566
Treasury Stock | Class A Stock | Restricted stock units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)	(68)	(5,172)	(71,189)		(4,851)	(71,064)
Shares withheld to satisfy tax withholding requirements (in shares)	0	170	39,839	0	186	37,308	40,009	37,494
Treasury Stock | Class A Stock | Performance share units
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Vesting of stock units (in shares)			(13,113)			(16,326)
Shares withheld to satisfy tax withholding requirements (in shares)	0	0	8,735	0	0	4,919	8,735	4,919
Treasury Stock | Class B Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury Stock, beginning of period (in shares)	0	0	0	5,005,800	5,005,800	5,005,800	0	5,005,800
Retirement of treasury shares (in shares)				(5,005,800)
Treasury Stock, end of period (in shares)	0	0	0	0	5,005,800	5,005,800	0	0

XML

Stockholders' Equity - Narrative (Details)	1 Months Ended		3 Months Ended				9 Months Ended		35 Months Ended
	Nov. 30, 2023 USD ($) shares	Nov. 30, 2022 USD ($) $ / shares	Nov. 30, 2023 USD ($) shares	May 31, 2023 USD ($) shares	Aug. 31, 2022 USD ($) shares	May 31, 2022 USD ($) shares	Nov. 30, 2023 USD ($) shares	Nov. 30, 2022 USD ($) $ / shares	Nov. 30, 2023 USD ($) shares	Jan. 31, 2021 USD ($)
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased			$ 214,700,000	$ 35,000,000.0	$ 392,900,000	$ 1,007,600,000
Conversion of stock ratio		1						1
Payment to holders of Class B Stock in connection with the Reclassification		$ 1,500,000,000					$ 0	$ 1,500,000,000
Three-Year Term Facility | Unsecured debt
Equity, Class of Treasury Stock [Line Items]
Aggregate principal amount		$ 1,000,000,000						$ 1,000,000,000
Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased			214,700,000	$ 35,000,000.0	$ 392,900,000	$ 1,007,600,000
2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization	$ 2,000,000,000		2,000,000,000				2,000,000,000		$ 2,000,000,000
Class A and Class B | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization										$ 2,000,000,000
Class A and Class B | 2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization	$ 2,000,000,000		$ 2,000,000,000				$ 2,000,000,000		$ 2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares							1,043,366
Dollar Value of Shares Repurchased							$ 249,700,000
Class A Stock | Treasury Stock
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares			889,429	153,937	1,652,445	4,065,508
Cash receivable per share held under reclassification agreement (in dollars per share) | $ / shares		$ 64.64						$ 64.64
Class A Stock | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares									5,875,276
Dollar Value of Shares Repurchased									$ 1,386,300,000
Class A Stock | 2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Number of shares repurchased (in shares) | shares	0
Dollar Value of Shares Repurchased	$ 0

XML

Stockholders' Equity - Stock Repurchases (Details) - USD ($)	1 Months Ended	3 Months Ended				9 Months Ended	35 Months Ended
	Nov. 30, 2023	Nov. 30, 2023	May 31, 2023	Aug. 31, 2022	May 31, 2022	Nov. 30, 2023	Nov. 30, 2023	Jan. 31, 2021
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased		$ 214,700,000	$ 35,000,000.0	$ 392,900,000	$ 1,007,600,000
2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization	$ 2,000,000,000	2,000,000,000				$ 2,000,000,000	$ 2,000,000,000
Class A and Class B | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization								$ 2,000,000,000
Class A and Class B | 2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Repurchase Authorization	2,000,000,000	$ 2,000,000,000				2,000,000,000	2,000,000,000
Class A Stock
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased						$ 249,700,000
Number of shares repurchased (in shares)						1,043,366
Class A Stock | 2021 Authorization
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased							$ 1,386,300,000
Number of shares repurchased (in shares)							5,875,276
Class A Stock | 2023 Authorization
Equity, Class of Treasury Stock [Line Items]
Dollar Value of Shares Repurchased	$ 0
Number of shares repurchased (in shares)	0

XML

Net Income (Loss) Per Common Share Attributable to CBI (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 509.1	$ 467.7	$ 1,335.0	$ (294.0)
Basic and diluted net income (loss) per common share attributable to CBI
Antidilutive shares (in shares)			786
Class A Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic	$ 509.1	426.3	$ 1,335.0	(247.3)
Conversion of Class B common shares into Class A common shares		41.4		0.0
Effect of stock-based awards on allocated net income (loss)		0.0		0.0
Net income (loss) attributable to CBI allocated - diluted		$ 467.7		$ (247.3)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)	183,525	166,677	183,431	164,573
Conversion of Class B common shares into Class A common shares (in shares)		17,850		0
Stock-based awards, primarily stock options (in shares)	645	764	665	0
Weighted average common shares outstanding - diluted (in shares)	184,170	185,291	184,096	164,573
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)	$ 2.77	$ 2.58	$ 7.28	$ (1.48)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)	$ 2.76	$ 2.52	$ 7.25	$ (1.48)
Class B Stock
Earnings per share reconciliation
Net income (loss) attributable to CBI allocated - basic		$ 41.4		$ (46.7)
Conversion of Class B common shares into Class A common shares		0.0		0.0
Effect of stock-based awards on allocated net income (loss)		(0.1)		0.0
Net income (loss) attributable to CBI allocated - diluted		$ 41.3		$ (46.7)
Weighted average number of shares outstanding reconciliation
Weighted average common shares outstanding - basic (in shares)		23,206		23,206
Conversion of Class B common shares into Class A common shares (in shares)		0		0
Stock-based awards, primarily stock options (in shares)		0		0
Weighted average common shares outstanding - diluted (in shares)		23,206		23,206
Basic and diluted net income (loss) per common share attributable to CBI
Net income (loss) per common share attributable to CBI - basic (in dollars per share)		$ 1.78		$ (2.01)
Net income (loss) per common share attributable to CBI - diluted (in dollars per share)		$ 1.78		$ (2.01)
Antidilutive shares (in shares)			21,434

XML

Comprehensive Income (Loss) Attributable to CBI - Reconciliation of Net Income (Loss) Attributable to CBI to Comprehensive Income (Loss) Attributable to CBI (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022	Nov. 30, 2023	Nov. 30, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net income (loss) attributable to CBI	$ 509.1			$ 467.7			$ 1,335.0	$ (294.0)
Other comprehensive income (loss) attributable to CBI
Other comprehensive income (loss) attributable to CBI, net of tax amount	(73.9)	$ 200.8	$ 225.3	163.4	$ (193.5)	$ 259.0
Comprehensive income (loss) attributable to CBI	439.1			622.2			1,670.9	(82.2)
Accumulated Other Comprehensive Income (Loss)
Other comprehensive income (loss) attributable to CBI
Net gain (loss), net of tax amount							432.1
Reclassification adjustments, net of tax amount							(96.2)
Other comprehensive income (loss) attributable to CBI, before tax amount	(71.0)			163.5			346.2	228.5
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	1.0			(9.0)			(10.3)	(16.7)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(70.0)	$ 191.5	$ 214.4	154.5	$ (189.1)	$ 246.4	335.9	211.8
Accumulated Other Comprehensive Income (Loss) | Share of OCI of Equity Method Investments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	(1.7)			(3.3)			(0.9)	(2.4)
Net gain (loss), tax (expense) benefit	(0.2)			0.0			(0.1)	3.4
Net gain (loss), net of tax amount	(1.9)			(3.3)			(1.0)	1.0
Reclassification adjustments, before tax amount	0.0			0.0			0.0	0.0
Reclassification adjustments, tax (expense) benefit	0.0			0.0			0.0	0.0
Reclassification adjustments, net of tax amount	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, before tax amount	(1.7)			(3.3)			(0.9)	(2.4)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	(0.2)			0.0			(0.1)	3.4
Other comprehensive income (loss) attributable to CBI, net of tax amount	(1.9)			(3.3)			(1.0)	1.0
Foreign Currency Translation Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	(59.4)			96.9			264.2	85.8
Net gain (loss), tax (expense) benefit	0.0			0.0			0.0	0.0
Net gain (loss), net of tax amount	(59.4)			96.9			264.2	85.8
Reclassification adjustments, before tax amount	0.0			0.0			0.0	0.0
Reclassification adjustments, tax (expense) benefit	0.0			0.0			0.0	0.0
Reclassification adjustments, net of tax amount	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, before tax amount	(59.4)			96.9			264.2	85.8
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(59.4)			96.9			264.2	85.8
Unrealized Net Gain (Loss) on Derivative Instruments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	29.3			82.4			192.1	178.1
Net gain (loss), tax (expense) benefit	(3.4)			(10.3)			(22.9)	(23.4)
Net gain (loss), net of tax amount	25.9			72.1			169.2	154.7
Reclassification adjustments, before tax amount	(39.3)			(12.3)			(108.8)	(32.6)
Reclassification adjustments, tax (expense) benefit	4.6			1.3			12.6	3.2
Reclassification adjustments, net of tax amount	(34.7)			(11.0)			(96.2)	(29.4)
Other comprehensive income (loss) attributable to CBI, before tax amount	(10.0)			70.1			83.3	145.5
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	1.2			(9.0)			(10.3)	(20.2)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(8.8)			61.1			73.0	125.3
Pension/ Postretirement Adjustments
Other comprehensive income (loss) attributable to CBI
Net gain (loss), before tax amount	0.1			(0.2)			(0.4)	(0.4)
Net gain (loss), tax (expense) benefit	0.0			0.0			0.1	0.1
Net gain (loss), net of tax amount	0.1			(0.2)			(0.3)	(0.3)
Reclassification adjustments, before tax amount	0.0			0.0			0.0	0.0
Reclassification adjustments, tax (expense) benefit	0.0			0.0			0.0	0.0
Reclassification adjustments, net of tax amount	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, before tax amount	0.1			(0.2)			(0.4)	(0.4)
Other comprehensive income (loss) attributable to CBI, tax (expense) benefit	0.0			0.0			0.1	0.1
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ 0.1			$ (0.2)			$ (0.3)	$ (0.3)

XML

Comprehensive Income (Loss) Attributable to CBI - Accumulated Other Comprehensive Income (Loss), Net of Income Tax Effect (Details) - USD ($) $ in Millions	3 Months Ended						9 Months Ended
	Nov. 30, 2023	Aug. 31, 2023	May 31, 2023	Nov. 30, 2022	Aug. 31, 2022	May 31, 2022	Nov. 30, 2023	Nov. 30, 2022
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			$ 8,413.6				$ 8,413.6
Other comprehensive income (loss):
Other comprehensive income (loss) attributable to CBI, net of tax amount	$ (73.9)	$ 200.8	225.3	$ 163.4	$ (193.5)	$ 259.0
Stockholders' equity, period end	9,471.0						9,471.0
Accumulated Other Comprehensive Income (Loss)
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			28.5				28.5
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments							432.1
Amounts reclassified from accumulated other comprehensive income (loss)							(96.2)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(70.0)	$ 191.5	214.4	154.5	$ (189.1)	$ 246.4	335.9	$ 211.8
Stockholders' equity, period end	364.4						364.4
Accumulated Other Comprehensive Income (Loss) | Share of OCI of Equity Method Investments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			10.3				10.3
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	(1.9)			(3.3)			(1.0)	1.0
Amounts reclassified from accumulated other comprehensive income (loss)	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(1.9)			(3.3)			(1.0)	1.0
Stockholders' equity, period end	9.3						9.3
Foreign Currency Translation Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			(176.4)				(176.4)
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	(59.4)			96.9			264.2	85.8
Amounts reclassified from accumulated other comprehensive income (loss)	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, net of tax amount	(59.4)			96.9			264.2	85.8
Stockholders' equity, period end	87.8						87.8
Unrealized Net Gain (Loss) on Derivative Instruments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			198.5				198.5
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	25.9			72.1			169.2	154.7
Amounts reclassified from accumulated other comprehensive income (loss)	(34.7)			(11.0)			(96.2)	(29.4)
Other comprehensive income (loss) attributable to CBI, net of tax amount	(8.8)			61.1			73.0	125.3
Stockholders' equity, period end	271.5						271.5
Pension/ Postretirement Adjustments
Accumulated other comprehensive income (loss), net of income tax effect [Roll Forward]
Stockholders' equity, beginning of period			$ (3.9)				(3.9)
Other comprehensive income (loss):
Other comprehensive income (loss) before reclassification adjustments	0.1			(0.2)			(0.3)	(0.3)
Amounts reclassified from accumulated other comprehensive income (loss)	0.0			0.0			0.0	0.0
Other comprehensive income (loss) attributable to CBI, net of tax amount	0.1			$ (0.2)			(0.3)	$ (0.3)
Stockholders' equity, period end	$ (4.2)						$ (4.2)

XML

Business Segment Information - Narrative (Details)	3 Months Ended	6 Months Ended
	May 31, 2023 division segment	Nov. 30, 2023 division segment
Segment Reporting [Abstract]
Number of business divisions | division	3	2
Number of reportable operating segments | segment	4	3

XML

Business Segment Information - Comparable Adjustments (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	$ (23.1)	$ (17.1)	$ (16.2)	$ 13.4
Comparable Adjustments, Cost of product sold	(1,200.3)	(1,209.6)	(3,844.3)	(3,647.0)
Selling, general, and administrative expenses
Gain (loss) on sale of business			(15.1)	13.8
Comparable Adjustments, Selling, general, and administrative expenses	(473.7)	(480.2)	(1,438.0)	(1,431.6)
Comparable Adjustments
Cost of product sold
Flow through of inventory step-up	(1.2)	(2.1)	(2.7)	(4.0)
Strategic business development costs	0.0	(1.1)	0.0	(1.1)
Net flow through of reserved inventory	0.0	0.0	0.0	1.2
Recovery of (loss on) inventory write-down	0.0	0.0	0.0	0.2
Comparable Adjustments, Cost of product sold	(12.2)	(25.2)	(23.1)	(47.2)
Selling, general, and administrative expenses
Restructuring and other strategic business development costs	(5.3)	(0.2)	(23.6)	(2.8)
Transition services agreements activity	(5.2)	(3.5)	(17.9)	(11.4)
Gain (loss) on sale of business	(0.2)	13.8	(15.1)	13.8
Transaction, integration, and other acquisition-related costs	0.0	(0.5)	(0.6)	(1.2)
Costs associated with the Reclassification	0.0	(10.2)	0.2	(31.5)
Other gains (losses)	0.0	2.8	5.6	11.6
Comparable Adjustments, Selling, general, and administrative expenses	(10.7)	2.2	(51.4)	(21.5)
Comparable Adjustments, Operating income (loss)	(22.9)	(23.0)	(74.5)	(68.7)
Recognition of a previously deferred gain upon release of a related indemnity	0.0	0.0	5.6	0.0
Decreases in estimated fair values of contingent liabilities associated with prior period acquisitions	0.0	1.5	0.0	5.9
Comparable Adjustments | Austin Cocktails Acquisition
Selling, general, and administrative expenses
Gain from remeasurement of previously held equity method investments	0.0	0.0	0.0	5.2
Comparable Adjustments | Commodity derivative contracts
Cost of product sold
Net gain (loss) on undesignated commodity derivative contracts	(13.3)	(7.8)	(28.9)	25.3
Settlements of undesignated commodity derivative contracts	$ 2.3	$ (14.2)	$ 8.5	$ (68.8)

XML

Business Segment Information - Segment Information (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Nov. 30, 2023	Nov. 30, 2022	Nov. 30, 2023	Nov. 30, 2022	Feb. 28, 2023
Segment Reporting Information [Line Items]
Net sales	$ 2,470.9	$ 2,436.5	$ 7,822.6	$ 7,454.8
Segment operating income (loss)	796.9	746.7	2,540.3	2,376.2
Income (loss) from unconsolidated investments	(41.8)	(37.2)	(477.4)	(1,944.2)
Equity method investments	233.3	771.4	233.3	771.4	$ 663.3
Capital expenditures	329.9	248.8	911.9	683.8
Depreciation and amortization	108.4	95.8	322.8	281.2
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Impairment of equity method investments	(0.3)	0.0	(136.1)	(1,060.3)
Unrealized net gain (loss) on securities measured at fair value	(11.0)	(7.4)	(85.4)	(39.1)
Net gain (loss) on sale of unconsolidated investment	0.3	0.0	0.3	0.0
Income (loss) from unconsolidated investments	(41.8)	(37.2)	(477.4)	(1,944.2)
Canopy Equity Method Investment
Segment Reporting Information [Line Items]
Equity method investments	73.6		73.6		485.8
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Impairment of equity method investments		(1,060.3)	(123.5)	(1,060.3)
Equity in earnings (losses) of equity method investees and related activities	(56.5)	(60.8)	(288.3)	(876.5)
Other equity method investments
Segment Reporting Information [Line Items]
Equity method investments	159.7		159.7		$ 177.5
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Equity in earnings (losses) of equity method investees and related activities	25.7	31.0	32.1	31.7
Operating Segments | Beer
Segment Reporting Information [Line Items]
Net sales	1,968.5	1,891.9	6,459.8	5,929.4
Segment operating income (loss)	757.3	710.0	2,509.0	2,338.4
Capital expenditures	264.1	181.5	704.4	539.3
Depreciation and amortization	82.0	71.0	242.2	206.2
Operating Segments | Wine and Spirits
Segment Reporting Information [Line Items]
Net sales	502.4	544.6	1,362.8	1,525.4
Segment operating income (loss)	127.6	134.8	287.6	325.2
Income (loss) from unconsolidated investments	27.5	35.4	38.1	40.3
Equity method investments	130.5	134.7	130.5	134.7
Capital expenditures	29.6	31.6	107.1	83.2
Depreciation and amortization	22.5	20.0	68.1	63.3
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	27.5	35.4	38.1	40.3
Operating Segments | Wine and Spirits | Wine
Segment Reporting Information [Line Items]
Net sales	435.8	470.5	1,180.7	1,316.6
Operating Segments | Wine and Spirits | Spirits
Segment Reporting Information [Line Items]
Net sales	66.6	74.1	182.1	208.8
Operating Segments | Corporate Operations and Other
Segment Reporting Information [Line Items]
Segment operating income (loss)	(65.1)	(75.1)	(181.8)	(218.7)
Income (loss) from unconsolidated investments	(8.3)	(41.1)	(62.7)	(132.1)
Equity method investments	102.8	636.7	102.8	636.7
Capital expenditures	36.2	35.7	100.4	61.3
Depreciation and amortization	3.9	4.8	12.5	11.7
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	(8.3)	(41.1)	(62.7)	(132.1)
Comparable Adjustments
Segment Reporting Information [Line Items]
Segment operating income (loss)	(22.9)	(23.0)	(74.5)	(68.7)
Income (loss) from unconsolidated investments	(61.0)	(31.5)	(452.8)	(1,852.4)
Gain (Loss) on Investments, Excluding Other than Temporary Impairments [Abstract]
Income (loss) from unconsolidated investments	$ (61.0)	$ (31.5)	$ (452.8)	$ (1,852.4)

XML

Subsequent Event (Details) $ in Millions	1 Months Ended
	Dec. 31, 2023 USD ($)
Subsequent Event
Subsequent Event [Line Items]
Insurance recoveries	$ 37